
<html lang="en"     class="pb-page"  data-request-id="3ebd38d2-ca85-4a00-a70e-dd3d3e88f45c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-13;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.6b01915;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Development of Selective Clk1 and -4 Inhibitors for Cellular Depletion of Cancer-Relevant Proteins" /></meta><meta name="dc.Creator" content="Ahmed K.  ElHady" /></meta><meta name="dc.Creator" content="Mohammad  Abdel-Halim" /></meta><meta name="dc.Creator" content="Ashraf H.  Abadi" /></meta><meta name="dc.Creator" content="Matthias  Engel" /></meta><meta name="dc.Description" content="In cancer cells, kinases of the Clk family control the supply of full-length, functional mRNAs coding for a variety of proteins essential to cell growth and survival. Thus, inhibition of Clks might..." /></meta><meta name="Description" content="In cancer cells, kinases of the Clk family control the supply of full-length, functional mRNAs coding for a variety of proteins essential to cell growth and survival. Thus, inhibition of Clks might..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 31, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01915" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01915" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01915" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01915" /></link>
        
    
    

<title>Development of Selective Clk1 and -4 Inhibitors for Cellular Depletion of Cancer-Relevant Proteins | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01915" /></meta><meta property="og:title" content="Development of Selective Clk1 and -4 Inhibitors for Cellular Depletion of Cancer-Relevant Proteins" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0008.jpeg" /></meta><meta property="og:description" content="In cancer cells, kinases of the Clk family control the supply of full-length, functional mRNAs coding for a variety of proteins essential to cell growth and survival. Thus, inhibition of Clks might become a novel anticancer strategy, leading to a selective depletion of cancer-relevant proteins after turnover. On the basis of a Weinreb amide hit compound, we designed and synthesized a diverse set of methoxybenzothiophene-2-carboxamides, of which the N-benzylated derivative showed enhanced Clk1 inhibitory activity. Introduction of a m-fluorine in the benzyl moiety eventually led to the discovery of compound 21b, a potent inhibitor of Clk1 and -4 (IC50 = 7 and 2.3 nM, respectively), exhibiting an unprecedented selectivity over Dyrk1A. 21b triggered the depletion of EGFR, HDAC1, and p70S6 kinase from the cancer cells, with potencies in line with the measured GI50 values. In contrast, the cellular effects of congener 21a, which inhibited Clk1 only weakly, were substantially lower." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01915"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01915">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01915&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01915&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01915&amp;href=/doi/10.1021/acs.jmedchem.6b01915" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 5377-5391</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01870" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00059" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of Selective Clk1 and -4 Inhibitors for Cellular Depletion of Cancer-Relevant Proteins</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ahmed+K.++ElHady">Ahmed K. ElHady</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mohammad++Abdel-Halim">Mohammad Abdel-Halim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-1326-4219" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ashraf+H.++Abadi">Ashraf H. Abadi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthias++Engel">Matthias Engel</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-5065-8634" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11835, Egypt</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Pharmaceutical and Medicinal Chemistry, Saarland University, Campus C2.3, D-66123 Saarbrücken, Germany</span></div><div class="corresp-info"><strong>*</strong>Phone: +49 681 302 70312. Fax: +49 681 302 70308. E-mail: <a href="/cdn-cgi/l/email-protection#2a474b044f444d4f466a4752045f444307594b4b58464b444e044e4f"><span class="__cf_email__" data-cfemail="a6cbc788c3c8c1c3cae6cbde88d3c8cf8bd5c7c7d4cac7c8c288c2c3">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01915&amp;href=/doi/10.1021%2Facs.jmedchem.6b01915" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 5377–5391</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 31, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 January 2017</li><li><span class="item_label"><b>Published</b> online</span>31 May 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 July 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01915" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01915</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5377%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAhmed%2BK.%2BElHady%252C%2BMohammad%2BAbdel-Halim%252C%2BAshraf%2BH.%2BAbadi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D13%26contentID%3Dacs.jmedchem.6b01915%26title%3DDevelopment%2Bof%2BSelective%2BClk1%2Band%2B-4%2BInhibitors%2Bfor%2BCellular%2BDepletion%2Bof%2BCancer-Relevant%2BProteins%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5391%26publicationDate%3DJuly%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01915"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1588</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">19</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01915" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of Selective Clk1 and -4 Inhibitors for Cellular Depletion of Cancer-Relevant Proteins&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ahmed&quot;,&quot;last_name&quot;:&quot;K. ElHady&quot;},{&quot;first_name&quot;:&quot;Mohammad&quot;,&quot;last_name&quot;:&quot;Abdel-Halim&quot;},{&quot;first_name&quot;:&quot;Ashraf&quot;,&quot;last_name&quot;:&quot;H. Abadi&quot;},{&quot;first_name&quot;:&quot;Matthias&quot;,&quot;last_name&quot;:&quot;Engel&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;5377-5391&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01915&quot;},&quot;abstract&quot;:&quot;In cancer cells, kinases of the Clk family control the supply of full-length, functional mRNAs coding for a variety of proteins essential to cell growth and survival. Thus, inhibition of Clks might become a novel anticancer strategy, leading to a selective depletion of cancer-relevant proteins after turnover. On the basis of a Weinreb amide hit compound, we designed and synthesized a diverse set of methoxybenzothiophene-2-carboxamides, of which the N-benzylated derivative showed enhanced Clk1 inhibitory activity. Introduction of a m-fluorine in the benzyl moiety eventually led to the discovery of compound 21b, a potent inhibitor of Clk1 and -4 (IC50 = 7 and 2.3 nM, respectively), exhibiting an unprecedented selectivity over Dyrk1A. 21b triggered the depletion of EGFR, HDAC1, and p70S6 kinase from the cancer cells, with potencies in line with the measured GI50 values. In contrast, the cellular effects of congener 21a, which inhibited Clk1 only weakly, were substantially lower.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01915&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01915" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01915&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01915" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01915&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01915" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01915&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01915&amp;href=/doi/10.1021/acs.jmedchem.6b01915" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01915" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01915" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01915%26sid%3Dliteratum%253Aachs%26pmid%3D28561591%26genre%3Darticle%26aulast%3DElHady%26date%3D2017%26atitle%3DDevelopment%2Bof%2BSelective%2BClk1%2Band%2B-4%2BInhibitors%2Bfor%2BCellular%2BDepletion%2Bof%2BCancer-Relevant%2BProteins%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D13%26spage%3D5377%26epage%3D5391%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/jmcmar.2017.60.issue-13/20170713/jmcmar.2017.60.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01915&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In cancer cells, kinases of the Clk family control the supply of full-length, functional mRNAs coding for a variety of proteins essential to cell growth and survival. Thus, inhibition of Clks might become a novel anticancer strategy, leading to a selective depletion of cancer-relevant proteins after turnover. On the basis of a Weinreb amide hit compound, we designed and synthesized a diverse set of methoxybenzothiophene-2-carboxamides, of which the N-benzylated derivative showed enhanced Clk1 inhibitory activity. Introduction of a <i>m</i>-fluorine in the benzyl moiety eventually led to the discovery of compound <b>21b</b>, a potent inhibitor of Clk1 and -4 (IC<sub>50</sub> = 7 and 2.3 nM, respectively), exhibiting an unprecedented selectivity over Dyrk1A. <b>21b</b> triggered the depletion of EGFR, HDAC1, and p70S6 kinase from the cancer cells, with potencies in line with the measured GI<sub>50</sub> values. In contrast, the cellular effects of congener <b>21a</b>, which inhibited Clk1 only weakly, were substantially lower.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16867" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16867" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The Clks (Cdc2-like kinases) are dual specificity protein kinases that are implicated in the regulation of pre-mRNA splicing. In the nucleus, the Clks phosphorylate serine/arginine (SR)-rich proteins, triggering the release of the latter into the nucleoplasm, where they modulate the selection of splice sites during pre-mRNA processing.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The Clk family consists of four highly homologous members: Clk1/STY and Clks 2–4. While Clk1, -2, and -4 are expressed in a variety of tissues, the highest levels of Clk3 protein are found in mature spermatozoa, suggesting a role in the fertilization process.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> With respect to Clk1, -2, and -4, distinct physiological roles were barely identified so far. However, when the involvement of the Clk isoforms was probed in a pathological context, functional differences were found: e.g., overexpressed Clk1 increased the production of viral gag protein, whereas Clk2 suppressed it.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Compared with the other major family of SR protein kinases, the splicing-related protein kinases (SRPKs), Clks have a less constrained substrate recognition, allowing them to perform the functionally important hyperphosphorylation of splicing factors such as ASF/SF2.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Therefore, in cells with different active Clks, it can be expected that they have at least partially overlapping substrate specificities. Indeed, it was previously shown that in endothelial HUVEC cells, which express all Clk isoforms, siRNA-mediated downregulation of both Clk1 and -4 was required to decrease the generation of mature full-length tissue factor (TF) mRNA from pre-mRNA. On the other hand, the alternatively spliced TF mRNA was depleted through downregulation of either Clk1 or -4.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> These data demonstrated that in cells expressing more than one Clk isoform, simultaneous inhibition of several Clks might be more effective in modulating particular splicing events.</div><div class="NLM_p">Direct links between Clk1 activity and cancer growth were established, such as the multisite phosphorylation of the alternative splicing factor SPF45, which is overexpressed in cancer and stimulates cell migration and invasion through exon skipping in several target mRNAs, including Fas mRNA. Phosphorylation by Clk1 increased SPF45 protein expression, whereas inhibition of Clk1 enhanced SPF45 degradation through a proteasome-dependent pathway.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Clk1 not only regulates the production of different proteins derived from splice variants but also maintains the supply of correct mRNAs coding for full-length proteins.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In this case, Clk1 prevents exon skipping which would lead to frameshifts and premature termination codons downstream of the junctions. Consequently, inhibition of Clk1 results in nonsense-mediated decay (NMD) of faulty mRNAs, finally leading to depletion of the corresponding proteins after cellular protein turnover. Interestingly, Araki et al. had demonstrated in a whole transcriptome analysis that the majority of genes whose splicing was affected by Clk1/2 inhibition play roles in metabolic processes and cell cycle pathways, all of which promoted cell growth and survival.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Recent studies provided evidence that Clk1 and also Clk4 are mediators of cell survival especially in hypoxic tumor cells.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Under hypoxic conditions, hypoxia-inducible factors (HIFs) up-regulate Clk1/4 at mRNA and protein levels. It was shown that siRNA-mediated knock-down of Clk1 decreases hypoxia-dependent full-length carbonic anhydrase IX mRNA and protein levels, and modulates the hypoxia-dependent cysteine-rich angiogenic inducer 61.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Although Clk4 was less well studied so far, it may have even greater importance for cancer development, as it was found, along with Clk2, to be one of the most frequently overexpressed kinases in a variety of human tumors.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The closely related isoenzyme Clk2 was already demonstrated to have oncogenic potential and was found amplified and overexpressed in a significant fraction of human breast tumors.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">Among the previously published Clk inhibitors, (1<i>Z</i>)-1-(3-ethyl-5-methoxy-2(3<i>H</i>)-benzothiazolylidene)-2-propanone (<b>31</b>), known as TG003, found widespread use as a tool compound that inhibits Clk1 and Clk4 with comparable potencies (IC<sub>50</sub> reported between 15 and 49 nM in different studies).<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> However, <b>31</b> also inhibited nonsplicing-related kinases such as CK1δ and CK1γ2 (<i>K</i><sub>d</sub> values of 150 and 270 nM, respectively; see Figure 3 in ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a>) as well as Dyrk2 and haspin (see Table S3, Supporting Information in ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">16</a>). The most frequently reported off-targets of Clk inhibitors, irrespective of the chemotype, are mainly Dyrk1A/1B but also haspin, STK17, CK2, and MLCK2.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Although Dyrk1A is also involved in the regulation of alternative splicing, another confirmed role is to counteract cardiac hypertrophy through phosphorylation of NFAT,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> suggesting that pharmacological inhibition might implicate severe side effects. Another compound, ethyl 3-[(<i>E</i>)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methylindole-2-carboxylate (KH-CB19), while showing good overall selectivity, equally inhibited Clk1, Clk4, and Dyrk1A in the two digit nM range.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Further Clk/Dyrk1A co-inhibitors comprise imidazo[1,2-<i>b</i>]pyridazines<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and benzobisthiazoles,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> which were not tested against further typical off-target kinases. Araki et al. identified in a high-throughput screening three imidazopyridine derivatives as potent inhibitors of Clk2 and, to a lesser extent, of Clk1.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> However, in the extended selectivity profiling, neither Clk4 nor the above-mentioned challenging off-targets were included; hence the true selectivity cannot be evaluated.</div><div class="NLM_p last">In the present study, we describe the development of new Clk1/4 inhibitors with high selectivity over Dyrk1A and other major off-target kinases. Furthermore, selective depletion of cell growth-related proteins is demonstrated following Clk inhibition in tumor cell lines.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35527" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35527" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Compound Design</h3><div class="NLM_p">In a previous study, we described the development of the fragment-like hydroxybenzothiophene ketone <b>29</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> from the larger ketone <b>28</b> as a Dyrk1A/Clk1 co-inhibitor (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). <b>29</b> displayed potencies in the higher nM range. Interestingly, the Weinreb amide derivative <b>30</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> was also well tolerated by the Clk1 binding site. On the other hand, the modifications in <b>30</b>, also including a replacement of the free hydroxyl group by methoxy, had decreased the potency toward Dyrk1A. Hence <b>30</b> was identified as moderately selective hit for Clk1 (9-fold selectivity over Dyrk1A), with an IC<sub>50</sub> of about 100 nM.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In order to optimize the hit compound, molecular modeling was performed based on the Clk1 cocrystal structure with hymenialdisine (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z57">1Z57</a>);<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> the binding model suggested that the ether oxygen of <b>30</b> might interact with the backbone NH of Leu244 and the amide carbonyl with the ε-amino function of Lys191 (cf. <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). In the resulting binding orientation, the side chains of Phe172, Asp325, and Asn293, as well as several backbone amides, were all located within reach of the amide-linked moieties, potentially enabling a variety of interactions (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). On the basis of this model, we chose a diversification strategy for our library design, envisaging the introduction of various structural extensions at the amide function, which could establish different types of interactions (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). This should increase the chances to improve the potency while maintaining or even enhancing the selectivity for Clks.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. From previous hit compounds against Clk1 to the design of a diverse library of methoxybenzothiophene amides. Previously identified co-inhibitors of Clk1 and Dyrk1A such as <b>28</b> could be downsized to the fragment-like compound <b>29</b> without loss of potency, and the carboxamide derivative <b>30</b> was also tolerated by the Clk1 binding site.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a>A hypothetical binding model was derived, in which both <i>N</i>- and <i>O</i>-methyl groups of <b>30</b> pointed outside the ATP-binding pocket (marked by small yellow circles); thus, several H-bond donor/acceptor functions (e.g., from the peptide backbones of Ala171 and Glu292), an acidic (Asp325), and an aromatic moiety (Phe172) were all located within a 4.5 Å radius (large yellow circle), which could potentially be addressed by amide-linked molecule extensions. Following these considerations, a focused library of methoxybenzothiophene amides was designed and synthesized (see <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01915&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Screening of a Diversified Library of Methoxybenzothiophene-2-carboxylamides Derivatives against Clk1</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0004.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0005.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Data shown are the mean of at least two independent experiments; SD ≤ 10%.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> ± SD.</p></div></div><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">The synthesis of the methoxybenzothiophene-2-carboxamides was accomplished through a three-step synthesis (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), where ethyl thioglycolate was reacted with 2-fluoro-5-methoxybenzaldehyde in the presence of potassium carbonate to afford the 5-methoxybenzothiophene-2-carboxylic acid ethyl ester (<b>1</b>) in good yield. After alkaline hydrolysis of the ethyl ester, the methoxybenzothiophene-2-carboxamides (<b>1a</b>–<b>27a</b>) were synthesized by direct coupling of the 5-methoxybenzothiophene-2-carboxylic acid (<b>2</b>) with different amines using HBTU in the presence of triethylamine. The N-methylation of some secondary amide derivatives was done through deprotonation using potassium bis(trimethylsilyl)amide (KHMDS) at 0 °C, followed by trapping of the resulting anion by the addition of iodomethane (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). An additional step of ester hydrolysis was required to deprotect the carboxyl group to prepare the amide derivatives of the glycine, <span class="smallcaps smallerCapital">l</span>-valine and <span class="smallcaps smallerCapital">l</span>-alanine amino acids (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1a</b>–<b>27a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01915&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) K<sub>2</sub>CO<sub>3</sub> in DMF at 0 °C, 1.2 equiv of ethyl thioglyoclate, 20 min, 1 equiv of 2-fluoro-5-methoxybenzaldehyde in DMF, 70 °C, 4 h; (ii) 4 equiv of KOH in ethanol/water, 80 °C, 3 h; (iii) 2 equiv of HBTU, 4 equiv of triethylamine, 4 equiv of the appropriate amine in DCM, room temperature, overnight.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of N-Methylated Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01915&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 3 equiv of KHMDS, 0 °C, 1 h, 1.5 equiv of CH<sub>3</sub>I, room temperature, 24 h.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Carboxylic Acids <b>8c</b>–<b>10c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01915&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 4 equiv of KOH in ethanol/water, 80 °C, 3 h.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Biological Evaluation</h3><div class="NLM_p">When the diverse set of probe compounds was screened against human Clk1, it became clear that hydrophobic and/or aromatic interactions rather than hydrogen (H−) bond formation enhanced the potency of the methoxybenzothiophene amides, as clearly seen with <b>2a</b>, <b>5a</b>, <b>6a</b>, <b>14a</b>, and <b>15a</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). With 59% inhibition at 100 nM, the benzylamide <b>2a</b> was the most potent compound of this first series; hence a small focused library of benzyl, arylmethyl, and phenylethyl amides was synthesized in the next step (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). After determination of the Clk1 inhibition at 100 nM, the following general SAR could be deduced: (i) Among the homologous pairs of compounds, the one-carbon spacer between the aromatic ring and the nitrogen gave more potent analogs than the two-carbon spacer (compare <b>2a</b> and <b>17a</b>, <b>16a</b>, and <b>17b</b>; <a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). (ii) N-methylation of the amide greatly enhanced the inhibitory activity with all matched pairs of methylated vs unmethylated analogs (e.g., compare <b>2a</b> with <b>16a</b>, <b>19a</b> with <b>19b</b>, <b>23a</b> with <b>23b</b>, etc.). This suggested that the N-methylation increased the rotational flexibility of the amide bond by mitigating the tautomerism and/or allowing cis-configurations; it is assumed that this enabled more favorable interactions of the phenyl ring with its binding site (cf. predicted binding mode in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). (iii) Replacement of the phenyl by heterocycles generally decreased the activity (cf., <b>18b</b>, <b>19b</b>, <b>25a</b>–<b>27a</b>), suggesting that the heteroatoms did not form H-bonds but rather caused polar repulsion from the assumed binding pocket (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Model for the hypothetical interaction of <b>21b</b> with Clk1 as supported by the SAR. <b>21b</b> (cyan) was docked into the ATP binding-pocket of Clk1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z57">1Z57</a>) using MOE. Some residues that might be important for the binding are labeled. In the binding model, <b>21b</b> is anchored between the conserved Lys191 and the hinge region residue Leu244 via two hydrogen bonds (indicated in red). In addition, two CH−π interactions involving Val324 and an edge-to-face CH−π interaction with the Phe241 benzene ring were predicted. The 3-fluorophenyl ring probably binds in a partially lipophilic pocket enframed by the glycine-rich loop, also involving an orthogonal dipolar interaction of the 3-fluorine with the Glu169 carbonyl. Interactions are indicated by dashed lines, and distances between the heavy atoms are given in Å (H-bonds, red; CH−π and orthogonal dipolar interactions, brown). In the color code of the ATP binding pocket surface, green denotes the most lipophilic and magenta the most hydrophilic areas.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01915&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition of Clk1 by the Optimized Series of Methoxybenzothiophene-2-carboxylamides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0006.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0007.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Data shown are the mean of at least two independent experiments; SD ≤ 10%.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> ± SD; n.d., not determined.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Selectivity Profiling of Compounds <b>16a</b> and <b>21b</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">% inhibition at 1 μM<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (IC<sub>50</sub> ± SD)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center"><b>16a</b></th><th class="colsep0 rowsep0" align="center"><b>21b</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DYRK1A</td><td class="colsep0 rowsep0" align="left">54</td><td class="colsep0 rowsep0" align="left">72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">(520 ± 28.3 nM)</td><td class="colsep0 rowsep0" align="left">(340 ± 21.2 nM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DYRK1B</td><td class="colsep0 rowsep0" align="left">58</td><td class="colsep0 rowsep0" align="left">77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">(206 ± 10 nM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DYRK3</td><td class="colsep0 rowsep0" align="left">n.i.</td><td class="colsep0 rowsep0" align="left">n.i.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DYRK4</td><td class="colsep0 rowsep0" align="left">n.i.</td><td class="colsep0 rowsep0" align="left">n.i.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Clk1</td><td class="colsep0 rowsep0" align="left">81</td><td class="colsep0 rowsep0" align="left">92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">(45 ± 6 nM)</td><td class="colsep0 rowsep0" align="left">(7 ± 0.12 nM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Clk2</td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="left">86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">(19.1 ± 0.5 nM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Clk3</td><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left">58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Clk4</td><td class="colsep0 rowsep0" align="left">101</td><td class="colsep0 rowsep0" align="left">101</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">(2.3 ± 0.24 nM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Haspin</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MLCK2</td><td class="colsep0 rowsep0" align="left">n.i.</td><td class="colsep0 rowsep0" align="left">n.i.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">STK17A</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SRPK1</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SRPK2</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CK2</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">1.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">The screening list was especially composed to include all kinases that were frequently reported as off-targets for diverse chemical classes of Dyrk inhibitors.<a onclick="showRef(event, 'ref17 ref27 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref17 ref27 ref29 ref30 ref31 ref32">(17, 27, 29-32)</a> Screenings were performed as a service at Thermo Fisher Scientific at an ATP concentration of 100 μM. n.i., no inhibition. n.d., not determined. Data represent mean values of duplicates that differed by less than 7%.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">IC<sub>50</sub> values were determined mainly for <b>21b</b> for inhibition values of >50% in the primary screening. ATP concentration was 15 μM.</p></div></div></div><div class="NLM_p">Having identified the benzylamide derivative <b>16a</b> as the most promising scaffold, we aimed at fine-tuning of the Clk1 inhibitory potency through modulation of the π-electron density. The obtained SAR indicated that this parameter strongly influenced the activity, with the electron withdrawing <i>m</i>-fluorine substitution being most advantageous. The resulting inhibitor <b>21b</b> was more potent than the unsubstituted analog <b>16a</b>, showing an IC<sub>50</sub> of 7 nM (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). In contrast, the analogs with electron-donating methyl (<b>24a</b>) or methoxy substituents (<b>23b</b>) exhibited a substantially reduced activity compared with <b>16a</b>. Interestingly, fluorine was only favorable in the meta-position, since the ortho- and para-regioisomers (<b>20b</b> and <b>22b</b>, respectively) were also less active than <b>16a</b>. In our binding model, the <i>m</i>-fluorophenyl ring was buried in a small, partially hydrophobic pocket in the lid of the ATP-binding site (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). While such a pocket was not induced by the type of compounds bound in the four available Clk1 cocrystal structures, it was observed before in cocrystals of the highly homologous Dyrk1A with compounds containing a branched 3-chlorobenzyl motif at the corresponding position (cf. PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WO6">2WO6</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VX3">2VX3</a>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Due to the limited size of this pocket, the <i>m</i>-methyl (<b>24a</b>), <i>m</i>-methoxy (<b>23b</b>), but also the <i>p</i>-fluorine substituent (<b>22b</b>) would be expected to cause steric collisions (<i>p</i>-fluorine with the carbonyl of Gly173), in agreement with the markedly lower activity of these three compounds compared with the unsubstituted <b>16a</b> (cf. <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Placing the fluorine in the meta-position (<b>21b</b>) apparently avoided too close contacts and moreover increased the potency 6.5-fold compared with the unsubstituted analog <b>16a</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). This improvement in potency might at least partially be attributed to an enhancement of hydrophobic interactions. In addition, our docking model suggested that a C–F···C═O interaction with the backbone of Glu169 might also occur. In some docking poses, the fluorine was found in a favorable position for such an orthogonal dipolar interaction (see <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), with the distance (2.9 Å) and angles (∠F···C═O, 96°; ∠C–F···C, 152°) being in typical ranges found in cocrystal structures.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In a previous study, introduction of a single fluorine in a benzyl ring of a thrombin inhibitor led to a comparable 6-fold increase in potency owing to C–F···C═O interactions.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p last">The methyl group of <b>21b</b> was expected to induce an out-of-plane rotation of the amide group, thus favoring the biologically active conformation as predicted by the docking simulation (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). In addition, the methyl was placed in a van der Waals distance to Val324, suggesting an additional contribution to the binding affinity. Further major contributions were expected from the H-bond of the ether oxygen with Leu244, the CH−π interaction of the benzothiophene with Phe241, and the H-bond between the carbonyl and Lys191, altogether explaining the high potency of <b>21b</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Overall, this binding model agreed well with the observed SAR for the Clk1 inhibitors.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Kinase Selectivity Profiling</h3><div class="NLM_p">As described in the <a class="ref internalNav" href="#sec1" aria-label="Introduction">Introduction</a>, a quite reliable way to assess the selectivity of Clk inhibitors (apart from a full kinome scan) is to check the kinases that are supposed to be the most similar in the ATP binding pocket, which were frequently identified as off-targets in previous studies. A strong co-inhibition of Clk4 was anticipated for our compounds <b>16a</b> and <b>21b</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) because Clk1 and Clk4 possess fully identical amino acid residues in and around the ATP binding pocket, suggesting that selective inhibition of either of the isoenzymes might not be possible using small molecules. Similarly, the still highly homologous Clk2 was markedly inhibited by <b>21b</b>, although with somewhat reduced potency. Our selectivity profiling revealed that the notorious off-targets haspin, STK17, and MLCK2 were not inhibited by <b>16a</b> and <b>21b</b>. The most strongly inhibited non-Clk kinases were Dyrk1A/1B; however, determination of the IC<sub>50</sub> values toward Dyrk1A revealed that <b>16a</b> was still 11.5-fold selective for Clk1 (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), and notably, <b>21b</b> inhibited Clk1 48.5 times and 30 times more strongly than Dyrk1A and Dyrk1B, respectively (IC<sub>50</sub>: Clk1 = 6.9 nM; Dyrk1A and Dyrk1B = 340 nM and 206 nM, respectively). Thus, compound <b>21b</b> turned out to be one of the most selective Clk1/4 inhibitors described to date, with somewhat weaker effect on Clk2 as well.</div><div class="NLM_p last">How is the selectivity over Dyrk1A achieved? It is likely that the methoxy group in the 5-position of the benzothiophene forms a markedly stronger H-bond with the hinge region of Clk1 than of Dyrk1A. In our previous benzothiophene ketone series, a free 5-hydroxy group was necessary for potent inhibition of Dyrk1A, whereas the corresponding methoxy derivative was inactive.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Similarly, the hydroxyl derivative of the benzothiazoylidene-2-propanone <b>31</b>, termed “INDY”, was 3-fold more potent toward Dyrk1A than <b>31</b> itself.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Molecular docking of <b>21b</b> in the Dyrk1A crystal structure from PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W06">2W06</a><a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> also supported this notion, since no H-bond between the NH of Leu241 (corresponding to Leu244 in Clk1) and the 5-methoxy was formed using the same docking conditions as for Clk1 (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01915/suppl_file/jm6b01915_si_001.pdf" class="ext-link">Supporting Information, Figure S1</a>).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Inhibition of Tumor Cell Growth</h3><div class="NLM_p">In previous studies, important anticancer effects of Clk inhibitors were shown to be mediated through the modulation of pre-mRNA splicing, which in several cases led to NMD of the mRNAs of genes important for cell growth and survival.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Thus, treatment of cancer cells by Clk1/4 inhibitors cuts off the supply of intact mRNA, triggering the disappearance of the affected proteins depending on their cellular half-life.</div><div class="NLM_p">First, we determined the potency of our best Clk1/4 inhibitors to inhibit the growth of different cancer cell lines. To this end, we selected five human cell lines of different tissue origin which differed in the expression levels of Clk1 mRNA as published in the Expression Atlas database (<a href="https://www.ebi.ac.uk/gxa/home" class="extLink">https://www.ebi.ac.uk/gxa/home</a>): two cell lines with low expression (T47D (breast carcinoma) and THP-1 (monocytic leukemia)) and three cell lines with higher Clk1 expression (T24 (urinary bladder carcinoma), MDA-MB-231 (breast adenocarcinoma), and HepG2 (hepatocellular carcinoma)). Hence, a differential sensitivity toward the Clk1/4 inhibitors was expected. As shown in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, the sensitivity of the cell lines toward the most potent compounds <b>21b</b> and <b>16a</b> varied, with T24 and HepG2 cells being most responsive (GI<sub>50</sub> for <b>21b</b>: 0.63 μM and 2.8 μM, respectively). Intriguingly, these two cell lines also exhibited the highest mRNA and protein expression levels of Clk1. In contrast, both THP-1 and T47D were considerably less sensitive toward our inhibitors, which correlated with lower mRNA and protein expression levels of Clk1. In line with this relationship, the MDA-MB-231 cell line showed moderate sensitivity toward <b>21b</b> and intermediate Clk1 expression (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Altogether, our results suggested that enhanced Clk1 expression may indicate a stronger dependence of tumor cell growth and survival on this kinase, translating into higher sensitivity toward chemical Clk1 inhibition. In further support of this notion, the efficacy of the chosen compound series <b>21b</b>, <b>21a</b>, <b>16a</b>, and <b>19b</b> to suppress cell growth of a specific cell line correlated with their relative potency against Clk1 (cf. T24 and MDA-MB-231 cells, <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), suggesting that the compounds act through inhibition of Clk1/4 rather than by another mechanism.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Correlation between Clk1 Inhibitory Potency, GI<sub>50</sub> Values, and Relative Clk1 Expression Levels in Different Cancer Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center">T24</th><th class="colsep0 rowsep0" align="center">MDA-MB-231</th><th class="colsep0 rowsep0" align="center">HepG2</th><th class="colsep0 rowsep0" align="center">THP-1</th><th class="colsep0 rowsep0" align="center">T47D</th><th class="colsep0 rowsep0" align="center"> </th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Clk1 mRNA levels<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Clk1 protein levels<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>compd</b></td><td class="colsep0 rowsep0" align="left"><b>GI<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></b></td><td class="colsep0 rowsep0" align="left"><b>GI<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></b></td><td class="colsep0 rowsep0" align="left"><b>GI<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></b></td><td class="colsep0 rowsep0" align="left"><b>GI<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></b></td><td class="colsep0 rowsep0" align="left"><b>GI<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></b></td><td class="colsep0 rowsep0" align="left"><b>Clk1 inhibition IC<sub>50</sub> ± SD (nM)<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21b</b></td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">9.6</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">27.2</td><td class="colsep0 rowsep0" align="left">15.3</td><td class="colsep0 rowsep0" align="left">6.9 ± 0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21a</b></td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">24.2</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">28.8</td><td class="colsep0 rowsep0" align="left">45 ± 6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="left">12.5</td><td class="colsep0 rowsep0" align="left">25.7</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">25.4</td><td class="colsep0 rowsep0" align="left">81.6 ± 2.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Levels relative to the expression in T47D (set = 1).</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Data taken from the Expression Atlas Database (<a href="https://www.ebi.ac.uk/gxa/home" class="extLink">https://www.ebi.ac.uk/gxa/home</a>).</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Values obtained by densitometry (SD < 8%).</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Data shown are the mean of at least two independent experiments, SD ≤ 12%. n.d., not determined.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Values taken from <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Lack of Cytotoxicity against Nontumor Cells</h3><div class="NLM_p">In order to assess the potential therapeutic window of our Clk1/4 inhibitors, we performed a cytotoxicity assay using normal peripheral blood lymphocytes (PBLs) and human embryonic kidney cells (HEK293). Neither <b>21b</b> nor the second most potent congener <b>16a</b> showed a significant cytotoxicity toward the nonproliferating PBLs and the proliferating HEK293 cells (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). This result suggested that in nontumor cells, the activity of the Clk1 and -4 isoforms might not be essential to ensure cell viability and/or proliferation.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Evaluation of Cytotoxicity of Compounds <b>16a</b> and <b>21b</b> against Nontumor Cells</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">cell type: PBLs</th><th class="colsep0 rowsep0" align="center">cell type: HEK293</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">LC<sub>50</sub> (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">GI<sub>50</sub> (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21b</b></td><td class="colsep0 rowsep0" align="left">29.4</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Data shown are the mean of at least two independent experiments; SD ≤ 12%.</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Selective Depletion of Cancer-Relevant Proteins</h3><div class="NLM_p">Next, we analyzed the effect of <b>21b</b> on the levels of selected cancer-associated proteins in the three most sensitive tumor cell lines (cf. <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>); again, the substantially less active congener <b>21a</b> served as a control. After treatment of T24 cells with different concentrations of <b>21b</b>, the protein levels of EGFR and HDAC1 were significantly diminished in a concentration-dependent manner (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). A significant reduction of EGFR protein was already observed at 1.25 μM (IC<sub>50</sub> = 2.2 μM, <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), which was in a good agreement with the observed GI<sub>50</sub>. Notably, the other analyzed proteins, p70S6K, PARP-1, ERK2, CD44, PCNA, and GRP94, were not influenced (exemplarily shown are the CD44 signals). The control compound <b>21a</b>, which was much less potent against recombinant Clk1 (see <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) and did not reach the GI<sub>50</sub> at the highest concentration tested (40 μM), showed a substantially weaker effect on the protein levels of both EGFR and HDAC1 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A, <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). With the less sensitive cell line MDA-MB-231, higher concentrations of <b>21b</b> were needed to decrease protein levels (cf. IC<sub>50</sub> values in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>); in this case it concerned EGFR and, surprisingly, not HDAC1 but S6K. However, the IC<sub>50</sub> for S6K reduction in the MDA-MB-231 cells was not reached at the highest concentration of <b>21b</b> (20 μM). Again, all other proteins in the analyzed panel remained unchanged, with respect to amount and size. Thus, in both T24 and MDA-MB-231 cells, the effect of <b>21b</b> on EGFR might be a major reason for the suppression of cell growth because the IC<sub>50</sub> values for EGFR depletion were in good agreement with the respective GI<sub>50</sub> values. In the light of this finding, it was interesting to analyze the effects of <b>21b</b> in the HepG2 cells, which lack a strong expression of EGFR.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Indeed, we could not detect any EGFR protein signals in this cell line, indicating a rather low expression. On the other hand, although there was a 44% reduction of both HDAC1 and S6K protein levels at 20 μM <b>21b</b>, the main target of the Clk1/4-triggered protein depletion was not found within the analyzed set of proteins (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01915/suppl_file/jm6b01915_si_001.pdf" class="ext-link">Figure S2, Supporting Information</a>). Thus, in cell lines that overexpress EGFR, the selective depletion of EGFR is likely a major mechanism through which Clk inhibitors lead to cell growth inhibition, whereas in cell lines displaying weak or no EGFR expression, the mainly affected proteins remain to be identified in future studies.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0011.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>21b</b> induces cellular depletion of cancer-relevant proteins. T24 (A) and MDA-MB-231 cells (B) were treated by <b>21b</b> and the weak Clk1 inhibitor <b>21a</b> as a comparison for 3 days at the indicated concentrations. The total cellular proteins extracted from the cells were analyzed by immunoblotting using a set of antibodies directed against eight cancer-related proteins (EGFR, p70S6 kinase α, PARP-1, ERK2, HDAC1, CD44, PCNA, GRP94). Shown are the signals belonging to proteins that were significantly reduced depending on the <b>21b</b> concentrations; for comparison, one of the unchanged signal sets is also exemplarily shown (corresponding to CD44). In parts A and B, one representative result out of two separate experiments is shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01915&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Correlation between Clk1 Inhibitory Potency, Reduction of Cellular Proteins, and Relative Clk1 Expression Levels in the Cell Lines MDA-MB-231 and T24</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">cell line (Clk1 rel expression levels): T24 (17)</th><th class="rowsep1 colsep0" colspan="2" align="center">cell line (Clk1 rel expression levels): MDA-MB-231 (14)</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">IC<sub>50</sub> of protein reduction (μM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">EGFR</th><th class="colsep0 rowsep0" align="center">HDAC</th><th class="colsep0 rowsep0" align="center">EGFR</th><th class="colsep0 rowsep0" align="center">S6 kinase</th><th class="colsep0 rowsep0" align="center">Clk1 IC<sub>50</sub> ± SD (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21b</b></td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">9.5</td><td class="colsep0 rowsep0" align="left">4.2</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">6.9 ± 0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21a</b></td><td class="colsep0 rowsep0" align="left">>15</td><td class="colsep0 rowsep0" align="left">>15</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values were derived by densitometric quantification of the signals from the immunoblot shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> after normalization. The values represent an average of two independent determinations; SD ≤ 15%.</p></div></div></div><div class="NLM_p last">It is further noteworthy that only a fraction of the analyzed cancer-relevant proteins was actually affected in the three cell lines, which was rather unexpected given the supposed ubiquitous role of the Clk isoenzymes in the regulation of alternative splicing. It could be speculated that in a given cell line, the activities of the remaining SR protein kinases, such as SRPKs and Dyrk1A, might differentially modulate the impact of Clk inhibition on exon splicings of particular pre-mRNAs. In addition to potential modulating or compensating effects of other SR protein kinases, the selection of exon-splicing sites specifically regulated through Clks seems to be determined already at the level of the branch sequence composition and length of polypyrimidine tracts in the exons. In a recent comparative transcriptomic analysis which employed the model Clk inhibitor <b>31</b>, targeting rules for exon skipping were derived from treated skeletal muscle cells. Exons skipped after treatment by <b>31</b> were shorter, had fewer splicing factor binding sites and shorter stretches of polypyrimidine tracts than the insensitive exons.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions and Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76500" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76500" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We developed a novel series of benzylated <i>N</i>-methylbenzothiophene-2-carboxamides as potent inhibitors of Clk1/4 and, to a somewhat lower extent, of Clk2. The introduction of <i>m</i>-fluorine in the benzyl moiety was key to the discovery of compound <b>21b</b>, which exhibited previously unreported selectivity over Dyrk1A, a highly homologous kinase also involved in the regulation of alternative splicing. This is considered an important advancement since Dyrk1A inhibition was previously shown to induce cardiac hypertrophy as a deleterious side effect, related to its role in antagonizing calcineurin signaling.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> While it might be assumed that inhibition of Clk isoforms will have detrimental effects due to the vast number of influenced splicing events, our results suggest that when selective Clk inhibitors are used, the number of modulated pre-mRNA splicings might be lower than expected. Thus, although further studies are needed that specifically address this issue, it could be speculated that the application of selective Clk inhibitors in vivo might have fewer adverse side effects than one might have anticipated. In a future potential application of Clk inhibitors for anticancer therapy, prior analysis of Clk isoenzyme overexpression might be performed to identify tumors that are particularly responsive toward Clk inhibition.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21805" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21805" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Chemistry</h3><div class="NLM_p last">Solvents and reagents were obtained from commercial suppliers and used as received. Melting points were determined on a Stuart SMP3 melting point apparatus. All final compounds had a percentage purity of at least 95%, and this could be verified by means of HPLC coupled with mass spectrometry. Mass spectra (HPLC–ESIMS) were obtained using a TSQ quantum (Thermo Electron Corp.) instrument prepared with a triple quadrupole mass detector (Thermo Finnigan) and an ESI source. All samples were injected using an autosampler (Surveyor, Thermo Finnigan) by an injection volume of 10 μL. The MS detection was determined using a source CID of 10 V and carried out at a spray voltage of 4.2 kV, a nitrogen sheath gas pressure of 4.0 × 10<sup>5</sup> Pa, a capillary temperature of 400 °C, a capillary voltage of 35 V, and an auxiliary gas pressure of 1.0 × 10<sup>5</sup> Pa. The stationary phase used was an RP C18 NUCLEODUR 100-3 (125 mm × 3 mm) column (Macherey & Nagel). The solvent system consisted of water containing 0.1% TFA (A) and 0.1% TFA in acetonitrile (B). The HPLC method used a flow rate of 400 μL/min. The percentage of B started at 5%, was increased up to 100% during 7 min, was kept at 100% for 2 min, and was flushed back to 5% in 2 min and was kept at 5% for 2 min. High resolution precise mass spectra were recorded on ThermoFisher Scientific (TF, Dreieich, Germany) Q Exactive Focus system equipped with heated electrospray ionization (HESI)-II source and Xcalibur (version 4.0.27.19) software. Before analysis external mass calibration was done according to the manufacturer’s recommendations. The samples were dissolved and diluted in methanol in a concentration of 3 μM and directly injected onto the Q Exactive Focus using the integrated syringe pump. All the data analyses were done in positive ion mode using voltage scans and the data collected in continuous mode. A Bruker DRX 500 spectrometer was used to obtain the <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra, and a Varian Mercury VX 300 spectrometer was used to obtain spectra for two of the final amide derivatives. The chemical shifts are referenced to the residual protonated solvent signals. The IR spectra were measured on a PerkinElmer Spectrum 100 FT-IR spectrometer, PerkinElmer, Rodgau, Germany.</div></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Synthetic Methods and Experimental Details for Some Key Compounds. Procedure A, Synthesis of 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid Ethyl Ester (<b>1</b>)</h3><div class="NLM_p last">To an ice cooled suspension of 7.2 g (2 equiv) of K<sub>2</sub>CO<sub>3</sub> in DMF (20 mL) was added ethyl thioglycolate (31.2 mmol, 1.2 equiv). The reaction mixture was stirred for 20 min at 0 °C under nitrogen, and this was followed by the gradual addition of 2-fluoro-5-methoxybenzaldehyde (26 mmol, 1 equiv) in DMF (10 mL). The mixture was heated to reflux at 70 °C for 4 h. Afterward the suspension was cooled to room temperature and poured over 100 mL of 2 M HCl, the aqueous layer was extracted by DCM (5 × 10 mL), and the combined organic layers were thoroughly washed with water and brine, dried over anhydrous MgSO<sub>4</sub>, evaporated under reduced pressure, and the resulting residue was purified by column chromatography (CC) using a solvent system of (petroleum ether/DCM 3:2), giving the pure carboxylic acid ethyl ester <b>1</b> as a yellow solid in a yield of 2.9 g (47%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.09 (s, 1H), 7.93 (d, <i>J</i> = 8.9 Hz, 1H), 7.53 (d, <i>J</i> = 2.5 Hz, 1H), 7.17 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 4.34 (q, <i>J</i> = 7.1 Hz, 2H), 3.82 (s, 3H), 1.32 (t, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.98, 157.48, 139.64, 133.92, 133.80, 130.35, 123.75, 118.04, 107.07, 61.36, 55.33, 14.11.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Procedure B, General Procedure for Ester Hydrolysis</h3><div class="NLM_p last">The ethyl/methyl ester was suspended in a mixture of 50 mL of ethanol and 25 mL of water; this was followed by the addition of 4 equiv of KOH. The mixture was heated to reflux at 80 °C for 3 h. Afterward, the solvent was removed under reduced pressure, and the resulting aqueous layer was cooled to 0 °C, followed by gradual addition of conc HCl until the pH was adjusted to 1. The aqueous layer was then extracted using DCM (5 × 50 mL), and the combined organic extracts were filtered over anhydrous MgSO<sub>4</sub> and evaporated under reduced pressure giving the carboxylic acid derivative. The product was used in the next step without further purification.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Procedure C, General Procedure for the Synthesis of 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid Amide Derivatives</h3><div class="NLM_p last">5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic acid (<b>2</b>) (0.1 g, 0.5 mmol) was dissolved in DCM (30 mL), and then 0.3 g of HBTU and 2 mL of TEA were added. The reaction mixture was stirred for 30 min. Following this, the appropriate amine (4 equiv) was added dropwise, and the reaction mixture was stirred at room temperature overnight. The solvent was evaporated under reduced pressure. The residue was partitioned between 50 mL of ethyl acetate and 20 mL of water, and then the aqueous layer was extracted with three 20 mL portions of ethyl acetate. The combined organic extracts were filtered over anhydrous MgSO<sub>4</sub>, the solvent was removed under reduced pressure, and the product was purified by CC to give the 5-methoxybenzo[<i>b</i>]thiophene-2-carboxylic acid amide derivatives in different yields.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Procedure D, General Procedure for the Synthesis of 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid Methylamide Derivatives</h3><div class="NLM_p last">The respective amide derivative was dissolved in dry THF and stirred at 0 °C. This was followed by the gradual addition of 3 equiv of potassium bis(trimethylsilyl)amide (0.5 M solution in THF). The reaction mixture was left to stir for 1 h, and after that CH<sub>3</sub>I (1.5 equiv) was added. The reaction mixture was left to stir for 24 h at room temperature, and afterward, the solvent was removed under reduced pressure, then a small amount of water was added, and extraction was carried out using DCM (5 × 30 mL). The organic layers were combined, dried over anhydrous MgSO<sub>4</sub>, the solvent was removed under reduced pressure, and the product was purified by CC or by salting out to give the methylated 5-methoxybenzo[<i>b</i>]thiophene-2-carboxylic acid amide derivatives in different yields.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid (<b>2</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure B, to give a white solid in a yield of 2.3 g (90%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.01 (d, <i>J</i> = 0.6 Hz, 1H), 7.91 (d, <i>J</i> = 8.9 Hz, 1H), 7.52 (d, <i>J</i> = 2.5 Hz, 1H), 7.15 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 3.82 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.51, 157.38, 139.84, 135.64, 133.82, 129.90, 123.73, 117.74, 106.93, 55.33.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (5-Methoxybenzo[<i>b</i>]thiophen-2-yl)(4-methylpiperazin-1-yl)methanone(<b>1a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using 1-methylpiperazine to give a yellow solid: yield 0.05 g (31.2%). The product was purified by CC (DCM/MeOH 100:2); mp 84–85 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.90 (d, <i>J</i> = 8.9 Hz, 1H), 7.68 (s, 1H), 7.44 (d, <i>J</i> = 2.5 Hz, 1H), 7.11 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 3.83 (s, 3H), 3.12–3.10 (m, 4H), 3.09 (t, <i>J</i> = 3.4 Hz, 4H), 2.63 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.71, 157.45, 139.69, 136.99, 131.83, 125.81, 123.33, 116.59, 106.61, 55.32, 52.87, 45.76, 43.15; MS (ESI) <i>m</i>/<i>z</i> = 291.01 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>15</sub>H<sub>19</sub>N<sub>2</sub>O<sub>2</sub>S) 291.11672, found 291.11591 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 1620 (C═O).</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid Benzylamide (<b>2a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C (with the exception of the reaction time being limited to 2 h), using benzylamine to give a yellow solid: yield 0.015 g (10.7%). The product was purified by CC (DCM/petroleum ether 3:1); mp 208–209 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.31 (t, <i>J</i> = 6.0 Hz, 1H), 8.04 (s, 1H), 7.89 (d, <i>J</i> = 8.9 Hz, 1H), 7.43 (d, <i>J</i> = 2.5 Hz, 1H), 7.36–7.33 (m, 4H), 7.28–7.25 (m, 1H), 7.10 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 4.49 (d, <i>J</i> = 6.0 Hz, 2H), 3.83 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.51, 157.37, 140.87, 140.28, 139.28, 132.67, 128.34, 127.30, 126.88, 124.61, 123.57, 116.67, 106.73, 55.39, 42.64; MS (ESI) <i>m</i>/<i>z</i> = 298.03 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>17</sub>H<sub>16</sub>NO<sub>2</sub>S) 298.09017, found 298.08941 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3279 (NH), 1609 (C═O).</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (5-Methoxybenzo[<i>b</i>]thiophen-2-yl)piperidin-1-ylmethanone(<b>3a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using piperidine to give a white solid: yield 0.04 g (30.8%). The product was purified by CC (DCM/petroleum ether 2:1); mp 90.9 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.87 (d, <i>J</i> = 8.9 Hz, 1H), 7.57 (s, 1H), 7.44 (d, <i>J</i> = 2.5 Hz, 1H), 7.07 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 3.82 (s, 3H), 3.63–3.59 (m, 4H), 1.68–1.63 (m, 2H), 1.59–1.54 (m, 4H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.27, 157.37, 139.74, 138.24, 131.44, 124.52, 123.22, 116.15, 106.51, 55.29, 54.87, 23.98; MS (ESI) <i>m</i>/<i>z</i> = 275.97 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>15</sub>H<sub>18</sub>NO<sub>2</sub>S) 276.10582, found 276.10524 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 1608 (C═O).</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (5-Methoxybenzo[<i>b</i>]thiophen-2-yl)morpholin-4-ylmethanone (<b>4a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using morpholine to give a yellow solid: yield 0.05 g (28%). The product was purified by CC (ethyl acetate/hexane 1:1); mp 109–110 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.88 (d, <i>J</i> = 8.9 Hz, 1H), 7.65 (d, <i>J</i> = 0.6 Hz, 1H), 7.44 (d, <i>J</i> = 2.5 Hz, 1H), 7.09 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 3.82 (s, 3H), 3.70–3.67 (m, 4H), 3.66–3.63 (m, 4H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 164.51, 158.39, 140.16, 137.69, 133.23, 125.75, 123.62, 117.14, 106.68, 67.42, 56.08, 26.46, 26.27; MS (ESI) <i>m</i>/<i>z</i> = 278 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>14</sub>H<sub>16</sub>NO<sub>3</sub>S) 278.08509, found 278.08447 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 1600 (C═O).</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid Allylamide (<b>5a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using allylamine to give an orange solid: yield 0.05 g (42%). The product was purified by CC (DCM); mp 130–131 °C; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.94 (t, <i>J</i> = 5.6 Hz, 1H), 8.02 (s, 1H), 7.89 (d, <i>J</i> = 8.8 Hz, 1H), 7.43 (d, <i>J</i> = 2.5 Hz, 1H), 7.10 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 5.92 (ddt, <i>J</i> = 17.1, 10.4, 5.3 Hz, 1H), 5.21 (dd, <i>J</i> = 17.2, 1.7 Hz, 1H), 5.13 (dd, <i>J</i> = 10.2, 1.6 Hz, 1H), 3.92 (t, <i>J</i> = 5.5 Hz, 2H), 3.84 (s, 3H); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.80, 157.87, 141.44, 140.78, 135.61, 133.13, 124.96, 124.04, 117.13, 115.94, 107.21, 55.89, 42.01; MS (ESI) <i>m</i>/<i>z</i> = 247.99 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>13</sub>H<sub>14</sub>NO<sub>2</sub>S) 248.07452, found 248.07393 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3303 (NH), 1617 (C═O).</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid Cyclopropylamide (<b>6a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using cyclopropylamine to give an orange solid: yield 0.04 g (33.7%). The product was purified by CC (DCM); mp 164–165 °C; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.73 (d, <i>J</i> = 3.8 Hz, 1H), 7.94 (s, 1H), 7.88 (d, <i>J</i> = 8.9 Hz, 1H), 7.41 (d, <i>J</i> = 2.5 Hz, 1H), 7.10 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 3.83 (s, 3H), 2.85 (ddd, <i>J</i> = 11.1, 7.5, 3.9 Hz, 1H), 0.73 (dt, <i>J</i> = 7.0, 4.9 Hz, 2H), 0.60 (dt, <i>J</i> = 5.7, 4.0 Hz, 2H); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.17, 157.85, 141.55, 140.77, 133.10, 124.88, 124.04, 117.01, 107.21, 55.89, 23.48, 6.25; MS (ESI) <i>m</i>/<i>z</i> = 248.02 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>13</sub>H<sub>14</sub>NO<sub>2</sub>S) 248.07452, found 248.07391 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3254 (NH), 1621 (C═O).</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid (2-Hydroxyethyl)amide (<b>7a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using ethanolamine to give a white solid: yield 0.042 g (34.8%). The product was purified by CC (DCM/MeOH 100:3); mp 119–120 °C; <sup>1</sup>H NMR (500 MHz, MeOD) δ 7.87 (s, 1H), 7.76 (d, <i>J</i> = 8.9 Hz, 1H), 7.37 (d, <i>J</i> = 2.5 Hz, 1H), 7.09 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 3.87 (s, 3H), 3.72 (t, <i>J</i> = 5.8 Hz, 2H), 3.51 (t, <i>J</i> = 5.9 Hz, 2H); <sup>13</sup>C NMR (126 MHz, MeOD) δ 165.10, 159.45, 141.84, 141.01, 134.92, 126.33, 124.29, 118.33, 107.40, 61.57, 55.97, 43.58; MS (ESI) <i>m</i>/<i>z</i> = 251.93 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>12</sub>H<sub>14</sub>NO<sub>3</sub>S) 252.06944, found 252.06878 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3537 (OH), 3311 (NH), 1615 (C═O).</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> [(5-Methoxybenzo[<i>b</i>]thiophene-2-carbonyl)amino]acetic Acid Methyl Ester (<b>8a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using glycine methyl ester to give a white solid: yield 0.035 g (26.2%). The product was purified by CC (DCM); mp 121–122 °C; <sup>1</sup>H NMR (500 MHz, MeOD) δ 7.90 (s, 1H), 7.78 (d, <i>J</i> = 8.9 Hz, 1H), 7.39 (d, <i>J</i> = 2.4 Hz, 1H), 7.10 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 4.13 (s, 2H), 3.87 (s, 3H), 3.76 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.18, 162.00, 157.42, 140.20, 139.97, 132.73,125.15, 123.60, 116.92, 106.80, 55.41, 51.83, 41.14 ; MS (ESI) <i>m</i>/<i>z</i> = 279.01 (M)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>13</sub>H<sub>14</sub>NO<sub>4</sub>S) 280.06435, found 280.06357 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3390 (NH), 1728 (C═O), 1645 (C═O).</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> [(5-Methoxybenzo[<i>b</i>]thiophene-2-carbonyl)amino]acetic Acid (<b>8c</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure B, using compound <b>8a</b> to give a white solid: yield 0.015 g (95%); mp 121.2 °C; <sup>1</sup>H NMR (500 MHz, MeOD) δ 7.90 (d, <i>J</i> = 0.6 Hz, 1H), 7.77 (d, <i>J</i> = 8.9 Hz, 1H), 7.39 (d, <i>J</i> = 2.5 Hz, 1H), 7.10 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 4.09 (s, 2H), 3.87 (s, 3H); <sup>13</sup>C NMR (126 MHz, MeOD) δ 173.11, 165.31, 159.60, 141.91, 140.47, 135.18, 126.95, 124.46, 118.65, 107.60, 56.13, 42.38; MS (ESI) <i>m</i>/<i>z</i> = 265 (M)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>12</sub>H<sub>12</sub>NO<sub>4</sub>S) 266.04870, found 266.04776 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3324 (NH), 3000–2980 (OH), 1736 (C═O), 1618 (C═O).</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>S</i>)-Methyl 2-(5-Methoxybenzo[<i>b</i>]thiophene-2-carboxamido)-3-methylbutanoate (<b>9a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using <span class="smallcaps smallerCapital">l</span>-valine methyl ester to give a yellow solid: yield 0.14 g (91%). The product was purified by CC (DCM); mp 124.7 °C; <sup>1</sup>H NMR (500 MHz, MeOD) δ 8.00 (s, 1H), 7.76 (d, <i>J</i> = 8.9 Hz, 1H), 7.38 (d, <i>J</i> = 2.5 Hz, 1H), 7.10 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 4.49 (d, <i>J</i> = 7.0 Hz, 1H), 3.87 (s, 3H), 3.76 (s, 3H), 2.28 (dq, <i>J</i> = 13.7, 6.8 Hz, 1H), 1.06 (d, <i>J</i> = 6.8 Hz, 3H), 1.03 (d, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (126 MHz, MeOD) δ 173.63, 165.05, 159.49, 141.82, 140.30, 135.12, 126.93, 124.31, 118.48, 107.57, 60.19, 56.00, 52.55, 31.79, 19.62, 19.15; MS (ESI) <i>m</i>/<i>z</i> = 322.03 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>16</sub>H<sub>20</sub>NO<sub>4</sub>S) 322.11130, found 322.11071 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>S</i>)-2-[(5-Methoxybenzo[<i>b</i>]thiophene-2-carbonyl)amino]-3-methylbutyric Acid (<b>9c</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure B, using compound <b>9a</b> to give a yellow solid: yield 0.08 g (60.2%); mp 137.6 °C; <sup>1</sup>H NMR (500 MHz, MeOD) δ 8.00 (s, 1H), 7.97 (s, 1H), 7.75 (d, <i>J</i> = 8.9 Hz, 1H), 7.37 (s, 1H), 7.08 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 4.50 (d, <i>J</i> = 6.4 Hz, 1H), 3.86 (s, 3H), 2.30 (dq, <i>J</i> = 13.5, 6.8 Hz, 1H), 1.07 (d, <i>J</i> = 3.9 Hz, 3H), 1.06 (d, <i>J</i> = 3.9 Hz, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.88, 161.91, 157.36, 140.32, 140.29, 132.77, 125.40, 123.55, 116.63, 106.85, 58.40, 55.38, 29.53, 19.27, 18.73; MS (ESI) <i>m</i>/<i>z</i> = 308.01 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>15</sub>H<sub>18</sub>NO<sub>4</sub>S) 308.09565, found 308.09483 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3305 (NH), 2960–2930 (OH), 1718 (C═O), 1631(C═O).</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>S</i>)-2-[(5-Methoxybenzo[<i>b</i>]thiophene-2-carbonyl)amino]propionic Acid Ethyl Ester (<b>10a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using <span class="smallcaps smallerCapital">l</span>-alanine ethyl ester to give a yellowish white solid: yield 0.09 g (57%). The product was purified by CC (DCM); mp 101.5 °C; <sup>1</sup>H NMR (500 MHz, MeOD) δ 7.95 (s, 1H), 7.76 (d, <i>J</i> = 8.9 Hz, 1H), 7.37 (d, <i>J</i> = 2.5 Hz, 1H), 7.09 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 4.60 (q, <i>J</i> = 7.3 Hz, 1H), 4.22 (q, <i>J</i> = 7.1 Hz, 2H), 3.86 (s, 3H), 1.53 (d, <i>J</i> = 7.3 Hz, 3H), 1.29 (t, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (126 MHz, MeOD) δ 174.24, 164.72, 159.44, 141.81, 140.39, 135.07, 126.84, 124.31, 118.48, 107.45, 62.45, 55.98, 50.28, 17.26, 14.48; MS (ESI) <i>m</i>/<i>z</i> = 307.95 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>15</sub>H<sub>18</sub>NO<sub>4</sub>S) 308.09565, found 308.09479 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3400 (NH), 1731 (C═O), 1646 (C═O).</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>S</i>)-2-[(5-Methoxybenzo[<i>b</i>]thiophene-2-carbonyl)amino]propionic Acid (<b>10c</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure B, using compound <b>10a</b> to give a white solid: yield 0.043 g (95.6%); mp 187.8 °C. <sup>1</sup>H NMR (500 MHz, MeOD) δ 7.95 (d, <i>J</i> = 0.5 Hz, 1H), 7.76 (d, <i>J</i> = 8.9 Hz, 1H), 7.37 (d, <i>J</i> = 2.5 Hz, 1H), 7.09 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 4.60 (q, <i>J</i> = 7.3 Hz, 1H), 3.87 (s, 3H), 1.54 (d, <i>J</i> = 7.4 Hz, 3H); <sup>13</sup>C NMR (126 MHz, MeOD) δ 176.32, 164.97, 159.78, 142.17, 140.88, 135.39, 127.10, 124.63, 118.77, 107.78, 56.31, 50.31, 17.84; MS (ESI) <i>m</i>/<i>z</i> = 279.88 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>13</sub>H<sub>14</sub>NO<sub>4</sub>S) 280.06435, found 280.06352 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3324 (NH), 2960–2930 (OH), 1708 (C═O), 1622 (C═O).</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid (2-Aminoethyl)amide (<b>11a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using ethylenediamine to give an orange solid: yield 0.06 g (38.4%). The product was purified by CC (DCM/MeOH/TEA 100:2:1); mp 100.2 °C; <sup>1</sup>H NMR (500 MHz, MeOD) δ 7.87 (s, 1H), 7.75 (d, <i>J</i> = 8.9 Hz, 1H), 7.36 (d, <i>J</i> = 2.4 Hz, 1H), 7.08 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 3.85 (s, 3H), 3.74–3.72 (m, 2H), 3.47 (t, <i>J</i> = 6.4 Hz, 2H), 3.02 (s, 1H), 2.98 (s, 2H); <sup>13</sup>C NMR (126 MHz, MeOD) δ 165.19, 159.43, 141.84, 140.96, 134.91, 126.39, 124.31, 118.36, 107.44, 56.01, 43.41, 41.99; MS (ESI) <i>m</i>/<i>z</i> = 250.94 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>12</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>S) 251.08542, found 251.08457 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3260–3200 (NH<sub>2</sub>), 3065 (NH), 1620 (C═O).</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid Phenylamide (<b>12a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using aniline to give a yellow solid: yield 0.03 g (25%). The product was purified by CC (DCM/petroleum ether 3:1); mp 169.8 °C; <sup>1</sup>H NMR (500 MHz, MeOD) δ 8.08 (d, <i>J</i> = 0.5 Hz, 1H), 7.80 (d, <i>J</i> = 8.9 Hz, 1H), 7.71–7.70 (m, 1H), 7.70–7.68 (m, 1H), 7.42 (d, <i>J</i> = 2.5 Hz, 1H), 7.40–7.36 (m, 2H), 7.19–7.15 (m, 1H), 7.12 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 3.89 (s, 3H); <sup>13</sup>C NMR (126 MHz, MeOD) δ 163.17, 159.50, 141.91, 141.68, 139.50, 135.27, 129.88, 126.77, 125.76, 124.34, 122.26, 118.56, 107.53, 56.00; MS (ESI) <i>m</i>/<i>z</i> = 283.95 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>16</sub>H<sub>14</sub>NO<sub>2</sub>S) 284.07452, found 284.07371 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (<i>R</i>)-5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid (1,2,2-Trimethylpropyl)amide (<b>13a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using (<i>R</i>)-3,3-dimethyl-2-butylamine to give a white solid: yield 0.1 g (71.4%). The product was purified by CC (DCM); mp 155.3 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.19 (d, <i>J</i> = 9.4 Hz, 1H), 8.09 (s, 1H), 7.86 (d, <i>J</i> = 8.8 Hz, 1H), 7.41 (d, <i>J</i> = 2.5 Hz, 1H), 7.09 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 3.94 (dq, <i>J</i> = 13.9, 6.9 Hz, 1H), 3.82 (s, 3H), 1.11 (d, <i>J</i> = 6.9 Hz, 3H), 0.91 (s, 9H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 161.06, 157.32, 141.48, 140.31, 132.63, 124.35, 123.54, 116.27, 106.83, 55.38, 52.63, 34.76, 26.36, 15.47; MS (ESI) <i>m</i>/<i>z</i> = 291.99 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>16</sub>H<sub>22</sub>NO<sub>2</sub>S) 292.13712, found 292.13625 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3310 (NH), 1616 (C═O).</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid (2,2,2-Trifluoroethyl)amide (<b>14a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using 2,2,2-trifluoroethylamine to give a yellow solid: yield 0.02 g (14.8%). The product was purified by CC (DCM/petroleum ether 2:1); mp 130.8 °C; <sup>1</sup>H NMR (500 MHz, MeOD) δ 7.92 (s, 1H), 7.77 (d, <i>J</i> = 8.9 Hz, 1H), 7.38 (d, <i>J</i> = 2.5 Hz, 1H), 7.10 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 4.09 (q, <i>J</i> = 9.3 Hz, 2H), 3.86 (s, 3H); <sup>13</sup>C NMR (126 MHz, MeOD) δ 163.57, 157.99, 140.18, 138.27, 133.68, 125.64, 124.40 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 278.4 Hz), 122.82, 117.24, 106.00, 54.47, 41.89; MS (ESI) <i>m</i>/<i>z</i> = 289.05 (M)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>12</sub>H<sub>11</sub>F<sub>3</sub>NO<sub>2</sub>S) 290.04626, found 290.04572 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3283 (NH), 1619 (C═O).</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid Thiazol-2-ylamide (<b>15a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using 2-aminothiazole to give a yellow solid: yield 0.023 g (16.5%). The product was purified by CC (DCM/MeOH 100:1); mp 177.4 °C; <sup>1</sup>H NMR (500 MHz, acetone-<i>d</i><sub>6</sub>) δ 8.39 (s, 1H), 7.92 (d, <i>J</i> = 8.9 Hz, 1H), 7.50 (d, <i>J</i> = 3.6 Hz, 1H), 7.48 (d, <i>J</i> = 2.5 Hz, 1H), 7.20 (d, <i>J</i> = 3.6 Hz, 1H), 7.17 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 3.89 (s, 3H); <sup>13</sup>C NMR (126 MHz, acetone-<i>d</i><sub>6</sub>) δ 161.27, 159.30, 159.09, 141.49, 139.44, 138.18, 135.13, 127.69, 124.36, 118.79, 114.51, 107.61, 55.89; MS (ESI) <i>m</i>/<i>z</i> = 290 (M)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>13</sub>H<sub>11</sub>N<sub>2</sub>O<sub>2</sub>S<sub>2</sub>) 291.02619, found 291.02539 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3159 (NH), 1670 (C═O).</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid Benzylmethylamide (<b>16a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using <i>N</i>-benzylmethylamine to give a white solid: yield 0.103 g (68.9%). The product was purified by CC (DCM); mp 121.9 °C; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.69 (d, <i>J</i> = 8.8 Hz, 1H), 7.45–7.37 (m, 3H), 7.36–7.28 (m, 3H), 7.19 (s, 1H), 7.04 (dd, <i>J</i> = 8.7, 1.7 Hz, 1H), 4.81 (s, 2H), 3.84 (s, 3H), 3.13 (s, 3H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 165.22, 157.70, 139.72, 138.34, 136.54, 132.86, 128.87, 127.65, 126.74, 124.87, 123.00, 116.57, 106.08, 55.49, 36.96, 34.36; MS (ESI) <i>m</i>/<i>z</i> = 313.01 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>18</sub>H<sub>18</sub>NO<sub>2</sub>S) 312.10582, found 312.10479 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 1613 (C═O).</div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid Phenethylamide (<b>17a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using 2-phenylethylamine to give a white solid: yield 0.11 g (81.7%). The product was purified by CC (DCM/petroleum ether 4:1); mp 153.8 °C; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.69 (d, <i>J</i> = 8.9 Hz, 1H), 7.61 (s, 1H), 7.36–7.33 (m, 2H), 7.28–7.26 (m, 1H), 7.26–7.24 (m, 2H), 7.22 (d, <i>J</i> = 2.5 Hz, 1H), 7.07 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 3.86 (s, 3H), 3.73 (dd, <i>J</i> = 12.9, 6.9 Hz, 2H), 2.95 (t, <i>J</i> = 6.9 Hz, 2H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.41, 157.36, 141.14, 140.27, 139.35, 132.58, 128.66, 128.35, 126.13, 124.27, 123.55, 116.58, 106.69, 55.39, 40.91, 35.03; MS (ESI) <i>m</i>/<i>z</i> = 312 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>18</sub>H<sub>18</sub>NO<sub>2</sub>S) 312.10582, found 312.10484 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3337 (NH), 1629 (C═O).</div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid Methylphenethylamide (<b>17b</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure D, using compound <b>17a</b>, to give a yellow solid: yield 0.012 g (57%). The product was purified by CC (DCM/petroleum ether 4:1); mp 180–181 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.87 (dd, <i>J</i> = 8.8, 5.5 Hz, 1H), 7.43 (d, <i>J</i> = 2.5 Hz, 1H), 7.32–7.27 (m, 3H), 7.24 (ddd, <i>J</i> = 15.9, 9.2, 4.4 Hz, 3H), 7.08 (ddd, <i>J</i> = 8.4, 5.8, 2.5 Hz, 1H), 3.82 (s, 3H), 3.70 (t, <i>J</i> = 7.2 Hz, 2H), 3.17 (s, 3H), 2.91 (t, <i>J</i> = 6.9 Hz, 2H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.45, 157.37, 141.15, 140.30, 139.38, 132.60, 128.78, 128.45, 126.34, 124.30, 123.22, 116.61, 106.59, 55.42, 55.34, 40.94, 35.06; MS (ESI) <i>m</i>/<i>z</i> = 326 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>19</sub>H<sub>20</sub>NO<sub>2</sub>S) 326.12147, found 326.12052 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid (Pyridin-2-ylmethyl)amide (<b>18a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using 2-picolylamine to give a white solid: yield 0.064 (55.85%). The product was purified by CC (DCM/MeOH 100:1); mp 137–138 °C; <sup>1</sup>H NMR (500 MHz, MeOD) δ 8.50 (ddd, <i>J</i> = 5.0, 1.8, 0.9 Hz, 1H), 7.94 (d, <i>J</i> = 0.5 Hz, 1H), 7.82 (td, <i>J</i> = 7.8, 1.8 Hz, 1H), 7.77 (d, <i>J</i> = 8.9 Hz, 1H), 7.46 (dt, <i>J</i> = 7.9, 1.0 Hz, 1H), 7.38 (d, <i>J</i> = 2.4 Hz, 1H), 7.34–7.31 (m, 1H), 7.10 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 4.70 (s, 2H), 3.86 (s, 3H); <sup>13</sup>C NMR (126 MHz, MeOD) δ 165.01, 159.49, 159.24, 149.82, 141.83, 140.63, 138.94, 135.03, 126.70, 124.34, 123.87, 122.95, 118.50, 107.45, 55.98, 45.94; MS (ESI) <i>m</i>/<i>z</i> = 299.01 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>16</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>S) 299.08542, found 299.08468 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3281 (NH), 1610 (C═O).</div></div><div id="sec4_2_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid Methylpyridin-2-ylmethylamide (<b>18b</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure D, using compound <b>18a</b>, to give a yellow solid: yield 0.025 g (47%). The product was purified by CC (DCM/MeOH 100:2); mp 144.9 °C; <sup>1</sup>H NMR (500 MHz, acetone-<i>d</i><sub>6</sub>) δ 8.56 (s, 1H), 7.79 (d, <i>J</i> = 9.2 Hz, 2H), 7.71–7.63 (m, 1H), 7.38–7.35 (m, 2H), 7.28 (s, 1H), 7.04 (d, <i>J</i> = 9.4 Hz, 1H), 4.86 (s, 2H), 3.81 (s, 3H), 3.27 (s, 3H); <sup>13</sup>C NMR (126 MHz, acetone-<i>d</i><sub>6</sub>) δ 164.64, 158.87, 150.45, 141.15, 140.18, 137.71, 133.42, 126.11, 123.83, 123.33, 122.56, 117.40, 114.67, 107.20, 56.05, 55.80, 49.80; MS (ESI) <i>m</i>/<i>z</i> = 313 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>17</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub>S) 313.10107, found 313.10015 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 1604 (C═O).</div></div><div id="sec4_2_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid (Pyridin-3-ylmethyl)amide (<b>19a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using 3-picolylamine to give a white solid: yield 0.051 g (44.5%). The product was purified by CC (DCM/MeOH 100:2); mp 167.3 °C; <sup>1</sup>H NMR (500 MHz, MeOD) δ 8.47 (d, <i>J</i> = 1.7 Hz, 1H), 8.35 (dd, <i>J</i> = 4.9, 1.5 Hz, 1H), 7.79–7.76 (m, 2H), 7.65 (d, <i>J</i> = 8.9 Hz, 1H), 7.33 (ddd, <i>J</i> = 7.9, 4.9, 0.8 Hz, 1H), 7.26 (d, <i>J</i> = 2.5 Hz, 1H), 6.98 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 4.51 (s, 2H), 3.75 (s, 3H); <sup>13</sup>C NMR (126 MHz, MeOD) δ 164.92, 159.49, 149.48, 148.87, 141.79, 140.52, 137.80, 136.75, 135.00, 126.63, 125.33, 124.33, 118.51, 107.45, 55.98, 42.07; MS (ESI) <i>m</i>/<i>z</i> = 298.98 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>16</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>S) 299.08542, found 299.08473 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3276 (NH), 1610 (C═O).</div></div><div id="sec4_2_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid Methylpyridin-3-ylmethylamide (<b>19b</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure D, using compound <b>19a</b> to give a yellow solid: yield 0.02 g (47.77%). The compound was purified by salting out, through addition of 3 mL of DCM, then addition of 30 mL of petroleum ether to salt out compound <b>19a</b> leaving the product in filtrate, which was then filtered over anhydrous MgSO<sub>4</sub>. The solvent was then removed under reduced pressure to give the final product; mp 132–133 °C; <sup>1</sup>H NMR (500 MHz, acetone-<i>d</i><sub>6</sub>) δ 8.62 (s, 1H), 8.54 (dd, <i>J</i> = 4.7, 1.6 Hz, 1H), 7.84 (d, <i>J</i> = 8.9 Hz, 1H), 7.80 (d, <i>J</i> = 7.3 Hz, 1H), 7.69 (s, 1H), 7.41 (dd, <i>J</i> = 7.4, 4.9 Hz, 2H), 7.09 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 4.86 (s, 2H), 3.85 (s, 3H), 3.25 (s, 3H); <sup>13</sup>C NMR (126 MHz, MeOD) δ 159.56, 149.45, 149.42, 141.40, 137.85, 134.84, 134.81, 125.60, 125.56, 125.39, 124.06, 124.01, 118.20, 107.43, 55.97, 49.85, 30.77; MS (ESI) <i>m</i>/<i>z</i> = 313.03 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>17</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub>S) 313.10107, found 313.10021 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 1609 (C═O).</div></div><div id="sec4_2_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid 2-Fluorobenzylamide (<b>20a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using 2-fluorobenzylamine to give a white solid: yield 0.134 g (74%). The product was purified by CC (DCM); mp 152.8 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.30 (t, <i>J</i> = 5.8 Hz, 1H), 8.06 (s, 1H), 7.89 (d, <i>J</i> = 8.9 Hz, 1H), 7.43 (d, <i>J</i> = 2.5 Hz, 1H), 7.41 (td, <i>J</i> = 7.7, 1.6 Hz, 1H), 7.33 (ddd, <i>J</i> = 9.6, 6.4, 1.8 Hz, 1H), 7.22–7.20 (m, 1H), 7.19–7.17 (m, 1H), 7.10 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 4.53 (d, <i>J</i> = 5.8 Hz, 2H), 3.83 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.62, 160.04 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 244.5 Hz), 157.37, 140.58, 140.25, 132.69, 129.63 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 4.4 Hz), 129.01 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 8.1 Hz), 125.76 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 14.7 Hz), 124.81 (s), 124.36 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.4 Hz), 123.56, 116.71, 115.12 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.1 Hz), 106.74, 55.38, 36.51 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 4.6 Hz); MS (ESI) <i>m</i>/<i>z</i> = 315.98 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>17</sub>H<sub>15</sub>FNO<sub>2</sub>S) 316.08075, found 316.08001 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3288 (NH), 1612 (C═O).</div></div><div id="sec4_2_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid (2-Fluorobenzyl)methylamide (<b>20b</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure D using compound <b>20a</b>, to give a yellowish white solid: yield 0.065 g (62.5%). The product was purified by CC (DCM); mp 110–111 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.88 (d, <i>J</i> = 8.9 Hz, 1H), 7.78 (s, 1H), 7.43 (s, 1H), 7.38 (ddd, <i>J</i> = 12.7, 8.9, 4.3 Hz, 2H), 7.24 (t, <i>J</i> = 9.0 Hz, 2H), 7.11–7.07 (m, 1H), 4.80 (s, 2H), 3.81 (s, 3H), 3.22 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.37 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 245.9 Hz), 157.37, 140.59, 139.90, 138.40, 131.85, 129.52 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 4.6 Hz), 129.47, 124.72, 123.73 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 14.4 Hz), 123.57, 123.23, 116.58, 115.46 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 20.9 Hz), 106.63, 55.39, 55.30, 45.92; MS (ESI) <i>m</i>/<i>z</i> = 329.99 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>18</sub>H<sub>17</sub>FNO<sub>2</sub>S) 330.09640, found 330.09567 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 1601 (C═O).</div></div><div id="sec4_2_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid 3-Fluorobenzylamide (<b>21a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using 3-fluorobenzylamine to give a white solid: yield 0.13 g (71.5%). The product was purified by CC (DCM); mp 164.9 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.35 (t, <i>J</i> = 6.0 Hz, 1H), 8.05 (d, <i>J</i> = 0.6 Hz, 1H), 7.91–7.88 (m, 1H), 7.44 (d, <i>J</i> = 2.4 Hz, 1H), 7.39 (ddd, <i>J</i> = 10.7, 7.0, 5.1 Hz, 1H), 7.20–7.17 (m, 1H), 7.17–7.13 (m, 1H), 7.12–7.07 (m, 2H), 4.50 (d, <i>J</i> = 6.0 Hz, 2H), 3.83 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.20 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 243.4 Hz), 161.28, 157.38, 142.29 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 7.0 Hz), 140.59, 140.25, 132.69, 130.31 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 8.3 Hz), 124.78, 123.57, 123.25 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.6 Hz), 116.73, 113.93 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.5 Hz), 113.64 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 20.9 Hz), 106.74, 55.38, 42.17 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 1.2 Hz); MS (ESI) <i>m</i>/<i>z</i> = 315.98 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>17</sub>H<sub>15</sub>FNO<sub>2</sub>S) 316.08075, found 316.08003 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3286 (NH), 1614 (C═O).</div></div><div id="sec4_2_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid (3-Fluorobenzyl)methylamide (<b>21b</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure D, using compound <b>21a</b> to give a white solid: yield 0.05 g (48%). The product was purified by CC (DCM); mp 109.6 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.89 (dd, <i>J</i> = 8.8, 4.3 Hz, 1H), 7.47–7.41 (m, 2H), 7.20–7.06 (m, 5H), 4.76 (s, 2H), 3.80 (s, 3H), 3.22 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.39 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 243.1 Hz), 161.64, 157.37, 140.13 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 6.5 Hz), 139.93, 138.44, 132.71 131.85, 130.69 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 8.0 Hz), 124.79, 123.58, 116.60, 114.15 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 20.7 Hz), 113.65 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.2 Hz), 106.63, 55.30, 42.19, 37.29; MS (ESI) <i>m</i>/<i>z</i> = 330.01 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>18</sub>H<sub>17</sub>FNO<sub>2</sub>S) 330.09640, found 330.09556 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 1612 (C═O).</div></div><div id="sec4_2_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid 4-Fluorobenzylamide (<b>22a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using 4-fluorobenzylamine to give a white solid: yield 0.11 g (73%). The product was purified by CC (DCM); mp 185.8 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.31 (d, <i>J</i> = 4.9 Hz, 1H), 8.02 (d, <i>J</i> = 3.8 Hz, 1H), 7.88 (dd, <i>J</i> = 8.8, 3.9 Hz, 1H), 7.43 (d, <i>J</i> = 2.7 Hz, 1H), 7.41–7.35 (m, 2H), 7.20–7.14 (m, 2H), 7.12–7.08 (m, 1H), 4.47 (d, <i>J</i> = 3.9 Hz, 2H), 3.83 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.51, 161.20 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 241.5 Hz), 157.36, 140.75, 140.25, 135.46 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.7 Hz), 132.67, 129.31 (<sup>3</sup><i>J</i><sub>C–F</sub>, <i>J</i> = 8.1 Hz), 124.66, 123.56, 116.68, 115.05 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.3 Hz), 106.72, 55.37, 41.96; MS (ESI) <i>m</i>/<i>z</i> = 316 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>17</sub>H<sub>15</sub>FNO<sub>2</sub>S) 316.08075, found 316.08010 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3279 (NH), 1615 (C═O).</div></div><div id="sec4_2_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid (4-Fluorobenzyl)methylamide (<b>22b</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure D, using compound <b>22a</b> to give a yellow solid: yield 0.05 g (53.19%). The compound was purified by salting out, through addition of 3 mL DCM, followed by the addition of 30 mL of petroleum ether that will salt out compound <b>22a</b> leaving the product in the filtrate, which was then filtered over anhydrous MgSO<sub>4</sub>. The solvent was then removed under reduced pressure to give the final product; mp 125–126 °C; <sup>1</sup>H NMR (500 MHz, acetone-<i>d</i><sub>6</sub>) δ 7.85–7.81 (m, 1H), 7.64 (d, <i>J</i> = 8.8 Hz, 1H), 7.45–7.37 (m, 3H), 7.16 (t, <i>J</i> = 8.7 Hz, 2H), 7.08 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 4.80 (s, 2H), 3.84 (s, 3H), 3.18 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.47 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 242.9 Hz), 157.37, 140.77, 140.27, 139.92, 131.82, 129.32 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 8.1 Hz), 124.68, 123.56, 123.22, 116.56, 115.47 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.1 Hz), 106.62, 55.38, 55.30, 41.97; MS (ESI) <i>m</i>/<i>z</i> = 330 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>18</sub>H<sub>17</sub>FNO<sub>2</sub>S) 330.09640, found 330.09566 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 1601 (C═O).</div></div><div id="sec4_2_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid 3-Methoxybenzylamide (<b>23a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using 3-methoxybenzylamine, to give a white solid: yield 0.12 g (63.6%). The product was purified by CC (DCM); mp 147.1 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.29 (t, <i>J</i> = 6.0 Hz, 1H), 8.04 (d, <i>J</i> = 0.6 Hz, 1H), 7.89 (dd, <i>J</i> = 8.9, 0.6 Hz, 1H), 7.43 (d, <i>J</i> = 2.4 Hz, 1H), 7.28–7.24 (m, 1H), 7.10 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 6.92–6.90 (m, 2H), 6.84–6.82 (m, 1H), 4.46 (d, <i>J</i> = 6.0 Hz, 2H), 3.83 (s, 3H), 3.74 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.50, 159.30, 157.36, 140.86, 140.84, 140.27, 132.67, 129.42, 124.61, 123.56, 119.42, 116.67, 113.02, 112.17, 106.72, 55.37, 54.96, 42.58; MS (ESI) <i>m</i>/<i>z</i> = 328.02 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>18</sub>H<sub>18</sub>NO<sub>3</sub>S) 328.10074, found 328.09998 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3290 (NH), 1610 (C═O).</div></div><div id="sec4_2_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid (3-Methoxybenzyl)methylamide (<b>23b</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure D, using compound <b>23a</b> to give a yellow solid: yield 0.05 g (42%). The compound was purified by salting out, through addition of a 3 mL of DCM, then addition of 30 mL of petroleum ether to salt out compound <b>23a</b> leaving the product in the filtrate. which was then filtered over MgSO<sub>4</sub>. Then the solvent was removed under reduced pressure to give the final product; mp 111.7 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.88 (d, <i>J</i> = 8.8 Hz, 1H), 7.42 (s, 1H), 7.31 (t, <i>J</i> = 7.9 Hz, 1H), 7.11–7.06 (m, 1H), 6.95–6.76 (m, 4H), 4.72 (s, 2H), 3.80 (s, 3H), 3.75 (s, 3H), 3.19 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.52, 159.54, 157.37, 140.87, 139.91, 138.63, 131.79, 129.84, 124.63, 123.56, 123.22, 119.44, 116.54, 112.64, 106.61, 55.39, 55.30, 54.99, 42.59 ; MS (ESI) <i>m</i>/<i>z</i> = 342.02 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>19</sub>H<sub>20</sub>NO<sub>3</sub>S) 342.11639, found 342.11554(M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 1617 (C═O).</div></div><div id="sec4_2_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid Methyl-(3-methylbenzyl)amide (<b>24a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using <i>N</i>-methyl-1-(<i>m</i>-tolyl)methanamine to give a yellow solid: yield 0.134 g (73.6%). The product was purified by CC (DCM); mp 125.7 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.88 (d, <i>J</i> = 8.8 Hz, 1H), 7.79 (s, 1H), 7.42 (s, 1H), 7.28 (t, <i>J</i> = 7.5 Hz, 1H), 7.10 (dd, <i>J</i> = 16.0, 7.9 Hz, 4H), 4.71 (s, 2H), 3.80 (s, 3H), 3.17 (s, 3H), 2.31 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.37, 157.36, 139.90, 138.53, 137.86, 136.90, 131.78, 128.61, 128.00, 126.09, 124.60, 123.87, 123.21, 116.51, 106.60, 55.29, 51.07, 37.19, 21.02; MS (ESI) <i>m</i>/<i>z</i> = 325.95 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>19</sub>H<sub>20</sub>NO<sub>2</sub>S) 326.12147, found 342.12078(M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 1614 (C═O).</div></div><div id="sec4_2_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid (Furan-2-ylmethyl)amide (<b>25a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using furfurylamine to give a yellow solid: yield 0.1 g (58%). The product was purified by CC (DCM); mp 118.9 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.24 (t, <i>J</i> = 5.6 Hz, 1H), 8.03 (s, 1H), 7.88 (d, <i>J</i> = 8.9 Hz, 1H), 7.60 (dd, <i>J</i> = 1.8, 0.9 Hz, 1H), 7.42 (d, <i>J</i> = 2.5 Hz, 1H), 7.10 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 6.41 (dd, <i>J</i> = 3.2, 1.8 Hz, 1H), 6.31 (dd, <i>J</i> = 3.2, 0.7 Hz, 1H), 4.47 (d, <i>J</i> = 5.7 Hz, 2H), 3.82 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.38, 157.36, 151.94, 142.16, 140.58, 140.24, 132.68, 124.79, 123.55, 116.73, 110.50, 107.16, 106.71, 55.37, 35.97; MS (ESI) <i>m</i>/<i>z</i> = 288 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>15</sub>H<sub>14</sub>NO<sub>3</sub>S) 288.06944, found 288.06872(M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3306 (NH), 1616 (C═O).</div></div><div id="sec4_2_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid (2-Imidazol-1-ylethyl)amide (<b>26a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using 2-(1<i>H</i>-imidazol-1-yl)ethanamine to give a white solid: yield 0.025 g (34.7%). The product was purified by CC (DCM/MeOH 100:3); mp 143 °C; <sup>1</sup>H NMR (500 MHz, MeOD) δ 7.88 (s, 1H), 7.78 (d, <i>J</i> = 0.5 Hz, 1H), 7.74 (d, <i>J</i> = 8.9 Hz, 1H), 7.34 (d, <i>J</i> = 2.4 Hz, 1H), 7.24 (s, 1H), 7.08 (dd, <i>J</i> = 8.9, 2.5 Hz, 2H), 4.33–4.29 (m, 2H), 3.85 (s, 3H), 3.75–3.72 (m, 2H); <sup>13</sup>C NMR (126 MHz, MeOD) δ 165.15, 159.49, 141.74, 140.38, 138.39, 134.94, 127.83, 126.60, 124.31, 121.49, 118.53, 107.44, 55.99, 47.56, 41.77; MS (ESI) <i>m</i>/<i>z</i> = 302 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>15</sub>H<sub>16</sub>N<sub>3</sub>O<sub>2</sub>S) 302.09632, found 302.09546 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3300 (NH), 1612 (C═O).</div></div><div id="sec4_2_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid (2-Imidazol-1-yl-ethyl)methylamide (<b>26b</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure D, using compound <b>26a</b> to give a white solid: yield 0.08 g (36%). The product was purified by CC (DCM/MeOH 100:2.5); mp 117–118 °C; <sup>1</sup>H NMR (500 MHz, acetone-<i>d</i><sub>6</sub>) δ 7.82 (d, <i>J</i> = 8.8 Hz, 1H), 7.63 (s, 1H), 7.51 (d, <i>J</i> = 2.4 Hz, 1H), 7.40 (s, 1H), 7.16 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 7.08 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 6.97 (s, 1H), 4.37 (t, <i>J</i> = 6.0 Hz, 2H), 3.91 (t, <i>J</i> = 5.9 Hz, 2H), 3.86 (s, 3H), 3.10 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 157.34, 139.88, 139.84, 137.42, 131.73, 128.18, 128.16, 123.20, 119.76, 119.72, 116.45, 106.58, 55.31, 54.89, 43.66, 29.00; MS (ESI) <i>m</i>/<i>z</i> = 315.97 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>16</sub>H<sub>18</sub>N<sub>3</sub>O<sub>2</sub>S) 316.11197, found 316.11123 (M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 1626 (C═O).</div></div><div id="sec4_2_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 5-Methoxybenzo[<i>b</i>]thiophene-2-carboxylic Acid (1<i>H</i>-Imidazol-2-ylmethyl)amide (<b>27a</b>)</h3><div class="NLM_p last">The compound was synthesized according to procedure C, using 2-aminomethyl-1<i>H</i>-imidazole dihydrochloride, giving a white solid: yield 0.1 g (60%). The compound precipitated after reaction completion. The reaction mixture was filtered, and the residue was washed using petroleum ether (3 × 10 mL) to give the desired product; mp 239.7 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.27 (t, <i>J</i> = 5.7 Hz, 1H), 8.04 (d, <i>J</i> = 0.6 Hz, 1H), 7.89 (d, <i>J</i> = 8.9 Hz, 1H), 7.42 (d, <i>J</i> = 2.4 Hz, 1H), 7.10 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 6.93 (s, 2H), 4.50 (d, <i>J</i> = 5.7 Hz, 2H), 3.83 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.60, 157.36, 144.55, 140.71, 140.66, 140.28, 132.69, 124.86, 123.54, 121.73, 116.72, 106.70, 55.38, 36.99; MS (ESI) <i>m</i>/<i>z</i> = 387.96 (M + H)<sup>+</sup>. HRMS (ESI): calcd for (C<sub>14</sub>H<sub>14</sub>N<sub>3</sub>O<sub>2</sub>S) 288.08067, found 288.07992(M + H)<sup>+</sup>. IR (cm<sup>–1</sup>): ν̃ 3288 (NH), 1629 (C═O).</div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Biological Assays. Protein Kinases and Inhibition Assays</h3><div class="NLM_p last">Human Dyrk1A was expressed and purified as described earlier.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Active human Clk1 was purchased from Life Technologies (lot no. 1095729A, catalog no. PV3315). Woodtide substrate peptide for Dyrk1A (KKISGRLSPIMTEQ) and RS repeat substrate peptide for Clk1 (GRSRSRSRSRSRSRSR) were custom synthesized at the Department of Medical Biochemistry and Molecular Biology, Saarland University, Homburg, Germany. Kinase inhibition assays for Dyrk1A, Dyrk1B, Clk1, and CK2 were performed as described previously, in the presence of 15 μM ATP.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The calculated IC<sub>50</sub> values are representative of at least two independent determinations. The larger panel of kinases shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> was screened by the SelectScreen Kinase Profiling Service, Thermo Fisher Scientific, Paisley, U.K.</div></div><div id="secz" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> MTT Cell Growth Assay</h3><div class="NLM_p last">The T24 bladder carcinoma cell line, the hepatocellular carcinoma cell line HepG2, and the breast cancer cell lines MDA-MB-231 and T47D were cultured in Dulbecco’s modified Eagle medium (DMEM, Sigma-Aldrich). The acute monocytic leukemia cell line THP-1 and peripheral blood lymphocytes (PBLs, pooled samples from three healthy donors) were maintained in RPMI-1640 medium (Sigma-Aldrich). Both media were supplemented with 1% pen/strep solution (Invitrogen) and 5% fetal calf serum (FCS, Sigma-Aldrich). For the MTT assay, all cells except PBLs were seeded in a 96-well plate (5000 cells per well) already containing DMSO as a control (0.2% final concentration) or the test compounds dissolved in DMSO. The cells were grown for 5 days at 37 °C in a humidified incubator containing 5% CO<sub>2</sub>, without further change of medium, before the detection was carried out as described.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> PBLs were suspended in 96 well plates at 30 000 cells per well and maintained in the presence of compounds or DMSO for 2 days prior to measurement.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Treatment of Cell Lines and Immunoblotting Analysis</h3><div class="NLM_p last">T24, MDA-MB-231, and HepG2 cells were seeded in Petri dishes (5.5 cm diameter) and grown to 70% confluency in DMEM medium as specified under “<a class="ref internalNav" href="#secz" aria-label="MTT Cell Growth Assay">MTT Cell Growth Assay</a>”. The compounds were diluted from DMSO stocks in DMEM to the final concentrations indicated in the figure legend, and then the medium in the plates was exchanged by compound-containing medium. After 3 days in the incubator, the cells were washed once with phosphate buffered saline (PBS), harvested by the addition of 0.6 mL of 0.8× concentrated SDS-Laemmli buffer, and scraping off using a rubber cell scraper. The solution containing the lysed cells was concentrated to half the volume in a SpeedVac concentrator. For Western blot analysis, the high molecular weight DNA was sheared by passing the samples through a 23 gauge needle and syringe several times. Then the samples were separated by SDS–PAGE on 4–20% gradient gels (PAGEr Gels, Lonza) and then transferred to Immobilon FLPVDF membranes (Millipore), using a discontinuous buffer system in a semidry blotter (anode buffer, 60 mM Tris base, 40 mM <i>N</i>-cyclohexyl-3-aminopropanesulfonic acid (CAPS), pH 9.6, 15% methanol; cathode buffer, 60 mM Tris, 40 mM CAPS, 0.1% SDS). The membranes were blocked in blocking buffer (3% BSA in PBS) and incubated with suitable combinations of the following primary monoclonal antibodies in blocking buffer (all from Santa Cruz Biotechnology, dilutions all 1:660, antibody clone number in parentheses): EGFR (A-10), p70S6 kinase α (H-9), PARP-1 (F-2), ERK2 (D-2), HDAC1 (10E2), HCAM (=CD44) (DF1485), PCNA (PC10), GRP 94 (9G10) at 4 °C overnight. When the Clk1 protein expression was analyzed, total cell protein from untreated cells was harvested and subject to Western Blotting as above, and anti-Clk1/4 antibody (Santa Cruz Biotechnology catalog no. sc-515307, dilution 1:660) was applied. After incubation with the primary antibody, the membrane was washed four times using PBS with 0.1% Tween 20, incubated with the IRDye 680-conjugated anti-mouse IgG secondary antibody (diluted 1:10 000 in blocking buffer) for 1 h, and washed again four times as above. Finally the membrane was scanned using an Odyssey infrared imaging system (LI-COR). All cell treatments and immunoblotting analyses were performed two times in duplicates. The normalization of the signals according to the amount of loaded protein was performed in two ways: the gel used for the Western transfer was stained afterward using Coomassie blue, and the remaining protein bands quantified using GelQuant.NET software provided by <a href="http://biochemlabsolutions.com" class="extLink">biochemlabsolutions.com</a>. In addition, the relative protein load was measured using signals from primary antibodies that were insensitive to the compound treatments.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Molecular Docking</h3><div class="NLM_p last">All procedures were performed using the Molecular Operating Environment (MOE) software package (version 2010, Chemical Computing Group). For the docking simulations, PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z57">1Z57</a> (Clk1 cocrystallized with hymenialdisine)<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WO6">2WO6</a> (Dyrk1A cocrystallized with <i>N</i>-(5-1<i>H</i>-indazol-3-yl)benzamide) were used.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Molecular docking simulations with <b>21b</b> as a ligand were performed using the MMFF94x and OPLS-AA force fields and the “triangle matcher” method (number of return poses set to 2000) and “Force field” as refinement. The refinement setting was further configured as follows: free side chain movements enabled, cutoff 10 Å. By use of these settings, docking runs were performed in two different ways: (i) the binding pocket was defined by selecting residues Leu244, Lys191, and Gly173 (Clk1) or Leu241, Lys188, and Gly171 (Dyrk1A); (ii) after an initial run using condition (i), a pharmacophore was defined based on a suitable pose after energy minimization using the MOE LigX routine (settings: receptor strength = 1, ligand strength = 5000), by selecting both the methoxy oxygen close to the NH of the leucine and the carbonyl oxygen near the conserved lysine as acceptor points (this binding orientation prevailed among the poses with the compound docked deep in the pocket). In the pharmacophore definition window, the radius of the pharmacophore points was raised to 1.6 Å. The subsequent docking was performed using the pharmacophore-supported placement. The number of retained poses was set to 500 each time. Only the poses with the top 10 scoring values were further evaluated for plausibility. The final selected poses were optimized again using the LigX routine.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01915">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42170" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42170" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01915" class="ext-link">10.1021/acs.jmedchem.6b01915</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Figures S1 and S2 (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01915/suppl_file/jm6b01915_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01915/suppl_file/jm6b01915_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01915/suppl_file/jm6b01915_si_001.pdf">jm6b01915_si_001.pdf (577.53 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01915/suppl_file/jm6b01915_si_002.csv">jm6b01915_si_002.csv (1.69 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01915" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86175" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86175" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthias Engel</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical and Medicinal Chemistry, Saarland University, Campus C2.3, D-66123 Saarbrücken, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5065-8634" title="Orcid link">http://orcid.org/0000-0001-5065-8634</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3e535f105b50595b527e5346104b5057134d5f5f4c525f505a105a5b"><span class="__cf_email__" data-cfemail="b3ded29dd6ddd4d6dff3decb9dc6ddda9ec0d2d2c1dfd2ddd79dd7d6">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ahmed K. ElHady</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11835, Egypt</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mohammad Abdel-Halim</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11835, Egypt</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1326-4219" title="Orcid link">http://orcid.org/0000-0003-1326-4219</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ashraf H. Abadi</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11835, Egypt</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d46e4813-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45205" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45205" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Prof. Dr. R. W. Hartmann and Prof. Dr. Christian Ducho for generously providing lab facilities to the M.E. group. A.K.E. and M.A.-H. acknowledge The Science & Technology Development Fund in Egypt (STDF) for funding through the GE-SEED, Project 17391. The support by the Deutsche Forschungsgemeinschaft (DFG) (Grant EN381/2-3) to M.E. is greatly acknowledged. The authors are particularly thankful to Dr. Jessica Hoppstädter for her constant support and supply with reagents and cells.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i72" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i72"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i73" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i73"> Abbreviations Used</h2><tr><td class="NLM_term">CC</td><td class="NLM_def"><p class="first last">column chromatography</p></td></tr><tr><td class="NLM_term">CID</td><td class="NLM_def"><p class="first last">collision induced dissociation</p></td></tr><tr><td class="NLM_term">Clk</td><td class="NLM_def"><p class="first last">cdc2-like kinase</p></td></tr><tr><td class="NLM_term">CK</td><td class="NLM_def"><p class="first last">casein kinase</p></td></tr><tr><td class="NLM_term">Dyrk</td><td class="NLM_def"><p class="first last">dual specificity protein kinase</p></td></tr><tr><td class="NLM_term">GI<sub>50</sub></td><td class="NLM_def"><p class="first last">the concentration for 50% of maximal inhibition of cell proliferation</p></td></tr><tr><td class="NLM_term">GRP94</td><td class="NLM_def"><p class="first last">glucose regulated protein 94</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyl-<i>O</i>-(1<i>H</i>-benzotriazol-1-yl)uronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HCAM</td><td class="NLM_def"><p class="first last">(=CD44) homing cell adhesion molecule</p></td></tr><tr><td class="NLM_term">HIF</td><td class="NLM_def"><p class="first last">hypoxia inducible factor</p></td></tr><tr><td class="NLM_term">HUVEC</td><td class="NLM_def"><p class="first last">human umbilical vein endothelial cell</p></td></tr><tr><td class="NLM_term">KHMDS</td><td class="NLM_def"><p class="first last">potassium bis(trimethylsilyl)amide</p></td></tr><tr><td class="NLM_term">MLCK2</td><td class="NLM_def"><p class="first last">myosin light chain kinase 2</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">NFAT</td><td class="NLM_def"><p class="first last">nuclear factor of activated T-cell</p></td></tr><tr><td class="NLM_term">NMD</td><td class="NLM_def"><p class="first last">nonsense-mediated decay</p></td></tr><tr><td class="NLM_term">p70S6 kinase</td><td class="NLM_def"><p class="first last">ribosomal protein S6 kinase</p></td></tr><tr><td class="NLM_term">PARP-1</td><td class="NLM_def"><p class="first last">poly ADP ribose polymerase 1</p></td></tr><tr><td class="NLM_term">PCNA</td><td class="NLM_def"><p class="first last">proliferating cell nuclear antigen</p></td></tr><tr><td class="NLM_term">SPF45</td><td class="NLM_def"><p class="first last">splicing factor 45</p></td></tr><tr><td class="NLM_term">STK17</td><td class="NLM_def"><p class="first last">serine threonine kinase 17</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25842" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25842" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Duncan, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojdl, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marius, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheit, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, J. C.</span><span> </span><span class="NLM_article-title">The Clk2 and Clk3 dual-specificity protein kinases regulate the intranuclear distribution of SR proteins and influence pre-mRNA splicing</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">241</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span><span class="refDoi"> DOI: 10.1006/excr.1998.4083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1006%2Fexcr.1998.4083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=9637771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADyaK1cXktVShsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=1998&pages=300-308&author=P.+I.+Duncanauthor=D.+F.+Stojdlauthor=R.+M.+Mariusauthor=K.+H.+Scheitauthor=J.+C.+Bell&title=The+Clk2+and+Clk3+dual-specificity+protein+kinases+regulate+the+intranuclear+distribution+of+SR+proteins+and+influence+pre-mRNA+splicing&doi=10.1006%2Fexcr.1998.4083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Clk2 and Clk3 dual-specificity protein kinases regulate the intranuclear distribution of SR proteins and influence pre-mRNA splicing</span></div><div class="casAuthors">Duncan, Peter I.; Stojdl, David F.; Marius, Ricardo M.; Scheit, Karl H.; Bell, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-308</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The three members of the Clk family of kinases (Clk1, 2, and 3) have been shown to undergo conserved alternative splicing to generate catalytically active (Clk) and inactive (ClkT) isoforms.  The prototype, murine Clk1 (mClk1), is a nuclear dual-specificity kinase that can interact with, and cause the nuclear redistribution of, SR proteins.  In this study, we demonstrate that the human Clk2 and Clk3 (hClk2 and 3) are also found within the nucleus and display dual-specificity kinase activity.  The truncated isoforms, hClk2T and hClk3T, colocalize with SR proteins in nuclear speckles.  We also show catalytically active hClk2 and hClk3 cause the redistribution of SR proteins and can regulate the alternative splicing of a model precursor mRNA substrate in vivo.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozcPUoUEj-ArVg90H21EOLACvtfcHk0ljl_Smw5q5gLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktVShsbY%253D&md5=470be0643b247eefc754e0865439cdb0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1006%2Fexcr.1998.4083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.1998.4083%26sid%3Dliteratum%253Aachs%26aulast%3DDuncan%26aufirst%3DP.%2BI.%26aulast%3DStojdl%26aufirst%3DD.%2BF.%26aulast%3DMarius%26aufirst%3DR.%2BM.%26aulast%3DScheit%26aufirst%3DK.%2BH.%26aulast%3DBell%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520Clk2%2520and%2520Clk3%2520dual-specificity%2520protein%2520kinases%2520regulate%2520the%2520intranuclear%2520distribution%2520of%2520SR%2520proteins%2520and%2520influence%2520pre-mRNA%2520splicing%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1998%26volume%3D241%26spage%3D300%26epage%3D308%26doi%3D10.1006%2Fexcr.1998.4083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Menegay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeslein, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G.</span><span> </span><span class="NLM_article-title">The dual specificity protein kinase CLK3 is abundantly expressed in mature mouse spermatozoa</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span><span class="refDoi"> DOI: 10.1006/excr.1999.4655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1006%2Fexcr.1999.4655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10585269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADyaK1MXns1anu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1999&pages=463-473&author=H.+Menegayauthor=F.+Moesleinauthor=G.+Landreth&title=The+dual+specificity+protein+kinase+CLK3+is+abundantly+expressed+in+mature+mouse+spermatozoa&doi=10.1006%2Fexcr.1999.4655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The Dual Specificity Protein Kinase CLK3 Is Abundantly Expressed in Mature Mouse Spermatozoa</span></div><div class="casAuthors">Menegay, Harry; Moeslein, Fred; Landreth, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">463-473</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">CLK3, a member of the LAMMER family of dual-specificity protein kinases, is abundantly expressed in the reproductive system of male mice.  Specifically, high levels of CLK3 protein expression are found in mature spermatozoa in the testis and epididymis.  The majority of the CLK3 protein in the testis is a full-length kinase-contg. form, and only a small amt. of a catalytically inactive N-terminally truncated splice variant protein product is obsd.  Within the mature spermatozoa CLK3 is localized to the acrosome and tail.  CLK3 is expelled from the sperm following the acrosome reaction and inactivated, likely by degrdn. by the proteases released by the sperm during the acrosome reaction.  The CLK family of kinases has previously been implicated in mRNA splicing; however, the bulk of the CLK3 protein in these cells is located in the cytoplasm, suggesting that CLK3 may have addnl. roles in the cell.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoscRF4gBjzvrVg90H21EOLACvtfcHk0ljl_Smw5q5gLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXns1anu7k%253D&md5=4a2b48b9388183e95145a5e4919c704f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1006%2Fexcr.1999.4655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.1999.4655%26sid%3Dliteratum%253Aachs%26aulast%3DMenegay%26aufirst%3DH.%26aulast%3DMoeslein%26aufirst%3DF.%26aulast%3DLandreth%26aufirst%3DG.%26atitle%3DThe%2520dual%2520specificity%2520protein%2520kinase%2520CLK3%2520is%2520abundantly%2520expressed%2520in%2520mature%2520mouse%2520spermatozoa%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1999%26volume%3D253%26spage%3D463%26epage%3D473%26doi%3D10.1006%2Fexcr.1999.4655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balachandran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray-Owen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochrane, A.</span><span> </span><span class="NLM_article-title">Differential effect of CLK SR kinases on HIV-1 gene expression: potential novel targets for therapy</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="refDoi"> DOI: 10.1186/1742-4690-8-47</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1186%2F1742-4690-8-47" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=47&author=R.+Wongauthor=A.+Balachandranauthor=A.+Y.+Maoauthor=W.+Dobsonauthor=S.+Gray-Owenauthor=A.+Cochrane&title=Differential+effect+of+CLK+SR+kinases+on+HIV-1+gene+expression%3A+potential+novel+targets+for+therapy&doi=10.1186%2F1742-4690-8-47"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-8-47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-8-47%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DR.%26aulast%3DBalachandran%26aufirst%3DA.%26aulast%3DMao%26aufirst%3DA.%2BY.%26aulast%3DDobson%26aufirst%3DW.%26aulast%3DGray-Owen%26aufirst%3DS.%26aulast%3DCochrane%26aufirst%3DA.%26atitle%3DDifferential%2520effect%2520of%2520CLK%2520SR%2520kinases%2520on%2520HIV-1%2520gene%2520expression%253A%2520potential%2520novel%2520targets%2520for%2520therapy%26jtitle%3DRetrovirology%26date%3D2011%26volume%3D8%26spage%3D47%26doi%3D10.1186%2F1742-4690-8-47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debreczeni, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rellos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niesen, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papagrigoriou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amos, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span><span class="refDoi"> DOI: 10.1016/j.str.2008.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1016%2Fj.str.2008.12.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=352-362&author=A.+N.+Bullockauthor=S.+Dasauthor=J.+E.+Debreczeniauthor=P.+Rellosauthor=O.+Fedorovauthor=F.+H.+Niesenauthor=K.+Guoauthor=E.+Papagrigoriouauthor=A.+L.+Amosauthor=S.+Choauthor=B.+E.+Turkauthor=G.+Ghoshauthor=S.+Knapp&title=Kinase+domain+insertions+define+distinct+roles+of+CLK+kinases+in+SR+protein+phosphorylation&doi=10.1016%2Fj.str.2008.12.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2008.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2008.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DDebreczeni%26aufirst%3DJ.%2BE.%26aulast%3DRellos%26aufirst%3DP.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DNiesen%26aufirst%3DF.%2BH.%26aulast%3DGuo%26aufirst%3DK.%26aulast%3DPapagrigoriou%26aufirst%3DE.%26aulast%3DAmos%26aufirst%3DA.%2BL.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DTurk%26aufirst%3DB.%2BE.%26aulast%3DGhosh%26aufirst%3DG.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DKinase%2520domain%2520insertions%2520define%2520distinct%2520roles%2520of%2520CLK%2520kinases%2520in%2520SR%2520protein%2520phosphorylation%26jtitle%3DStructure%26date%3D2009%26volume%3D17%26spage%3D352%26epage%3D362%26doi%3D10.1016%2Fj.str.2008.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Colwill, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeakley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cáceres, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X. D.</span><span> </span><span class="NLM_article-title">SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">24569</span><span class="NLM_x">–</span> <span class="NLM_lpage">24575</span><span class="refDoi"> DOI: 10.1074/jbc.271.40.24569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1074%2Fjbc.271.40.24569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=8798720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADyaK28XmtFehsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=24569-24575&author=K.+Colwillauthor=L.+L.+Fengauthor=J.+M.+Yeakleyauthor=G.+D.+Gishauthor=J.+F.+C%C3%A1ceresauthor=T.+Pawsonauthor=X.+D.+Fu&title=SRPK1+and+Clk%2FSty+protein+kinases+show+distinct+substrate+specificities+for+serine%2Farginine-rich+splicing+factors&doi=10.1074%2Fjbc.271.40.24569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors</span></div><div class="casAuthors">Colwill, Karen; Feng, Lana L.; Yeakley, Joanne M.; Gish, Gerald D.; Caceres, Javier F.; Pawson, Tony; Fu, Xiang-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">24569-24575</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Serine/arginine-rich (SR) proteins are essential for pre-mRNA splicing, and modify the choice of splice site during alternative splicing in a process apparently regulated by protein phosphorylation.  Two protein kinases have been cloned that can phosphorylate SR proteins in vitro: SRPK1 and Clk/Sty.  These 2 kinases are shown to phosphorylate the same SR proteins in vitro, but SRPK1 has the higher specific activity toward ASF/SF2.  SRPK1, like Clk/Sty, phosphorylates ASF/SF2 in vitro on sites that are also phosphorylated in vivo.  Tryptic peptide mapping of ASF/SF2 revealed that 3 of the phosphopeptides from full-length ASF/SF2 phosphorylated in vitro contain consecutive phosphoserine-arginine residues or phosphoserine-proline residues.  In vitro, the Clk/Sty kinase phosphorylated Ser-Arg, Ser-Lys, or Ser-Pro sites, whereas SRPK1 had a strong preference for Ser-Arg sites.  These results suggest that SRPK1 and Clk/Sty may play different roles in regulating SR splicing factors, and suggest that Clk/Sty has a broader substrate specificity than SRPK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRlThMXIzMFrVg90H21EOLACvtfcHk0lhBX8ZnqVHmbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtFehsLs%253D&md5=03cbddc0f785f952147945c61381acdc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.40.24569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.40.24569%26sid%3Dliteratum%253Aachs%26aulast%3DColwill%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DL.%2BL.%26aulast%3DYeakley%26aufirst%3DJ.%2BM.%26aulast%3DGish%26aufirst%3DG.%2BD.%26aulast%3DC%25C3%25A1ceres%26aufirst%3DJ.%2BF.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DFu%26aufirst%3DX.%2BD.%26atitle%3DSRPK1%2520and%2520Clk%252FSty%2520protein%2520kinases%2520show%2520distinct%2520substrate%2520specificities%2520for%2520serine%252Farginine-rich%2520splicing%2520factors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D24569%26epage%3D24575%26doi%3D10.1074%2Fjbc.271.40.24569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Eisenreich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdanov, V. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakrzewicz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pries, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antoniak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poller, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultheiss, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, U.</span><span> </span><span class="NLM_article-title">Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span><span class="refDoi"> DOI: 10.1161/CIRCRESAHA.108.183905</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1161%2FCIRCRESAHA.108.183905" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2009&pages=589-599&author=A.+Eisenreichauthor=V.+Y.+Bogdanovauthor=A.+Zakrzewiczauthor=A.+Priesauthor=S.+Antoniakauthor=W.+Pollerauthor=H.+P.+Schultheissauthor=U.+Rauch&title=Cdc2-like+kinases+and+DNA+topoisomerase+I+regulate+alternative+splicing+of+tissue+factor+in+human+endothelial+cells&doi=10.1161%2FCIRCRESAHA.108.183905"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.108.183905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.108.183905%26sid%3Dliteratum%253Aachs%26aulast%3DEisenreich%26aufirst%3DA.%26aulast%3DBogdanov%26aufirst%3DV.%2BY.%26aulast%3DZakrzewicz%26aufirst%3DA.%26aulast%3DPries%26aufirst%3DA.%26aulast%3DAntoniak%26aufirst%3DS.%26aulast%3DPoller%26aufirst%3DW.%26aulast%3DSchultheiss%26aufirst%3DH.%2BP.%26aulast%3DRauch%26aufirst%3DU.%26atitle%3DCdc2-like%2520kinases%2520and%2520DNA%2520topoisomerase%2520I%2520regulate%2520alternative%2520splicing%2520of%2520tissue%2520factor%2520in%2520human%2520endothelial%2520cells%26jtitle%3DCirc.%2520Res.%26date%3D2009%26volume%3D104%26spage%3D589%26epage%3D599%26doi%3D10.1161%2FCIRCRESAHA.108.183905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conaway, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford Bethard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Ayoubi, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson Bradley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weed, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eblen, S. T.</span><span> </span><span class="NLM_article-title">Phosphorylation of the alternative mRNA splicing factor 45 (SPF45) by Clk1 regulates its splice site utilization, cell migration and invasion</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4949</span><span class="NLM_x">–</span> <span class="NLM_lpage">4962</span><span class="refDoi"> DOI: 10.1093/nar/gkt170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1093%2Fnar%2Fgkt170" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=4949-4962&author=Y.+Liuauthor=L.+Conawayauthor=J.+Rutherford+Bethardauthor=A.+M.+Al-Ayoubiauthor=A.+Thompson+Bradleyauthor=H.+Zhengauthor=S.+A.+Weedauthor=S.+T.+Eblen&title=Phosphorylation+of+the+alternative+mRNA+splicing+factor+45+%28SPF45%29+by+Clk1+regulates+its+splice+site+utilization%2C+cell+migration+and+invasion&doi=10.1093%2Fnar%2Fgkt170"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt170%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DConaway%26aufirst%3DL.%26aulast%3DRutherford%2BBethard%26aufirst%3DJ.%26aulast%3DAl-Ayoubi%26aufirst%3DA.%2BM.%26aulast%3DThompson%2BBradley%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DWeed%26aufirst%3DS.%2BA.%26aulast%3DEblen%26aufirst%3DS.%2BT.%26atitle%3DPhosphorylation%2520of%2520the%2520alternative%2520mRNA%2520splicing%2520factor%252045%2520%2528SPF45%2529%2520by%2520Clk1%2520regulates%2520its%2520splice%2520site%2520utilization%252C%2520cell%2520migration%2520and%2520invasion%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2013%26volume%3D41%26spage%3D4949%26epage%3D4962%26doi%3D10.1093%2Fnar%2Fgkt170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Araki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairiki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyashita, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, O.</span><span> </span><span class="NLM_article-title">Inhibitors of CLK protein kinases suppress cell growth and induce apoptosis by modulating pre-mRNA splicing</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0116929</span><span class="refDoi"> DOI: 10.1371/journal.pone.0116929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1371%2Fjournal.pone.0116929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=25581376" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0116929&author=S.+Arakiauthor=R.+Dairikiauthor=Y.+Nakayamaauthor=A.+Muraiauthor=R.+Miyashitaauthor=M.+Iwataniauthor=T.+Nomuraauthor=O.+Nakanishi&title=Inhibitors+of+CLK+protein+kinases+suppress+cell+growth+and+induce+apoptosis+by+modulating+pre-mRNA+splicing&doi=10.1371%2Fjournal.pone.0116929"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0116929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0116929%26sid%3Dliteratum%253Aachs%26aulast%3DAraki%26aufirst%3DS.%26aulast%3DDairiki%26aufirst%3DR.%26aulast%3DNakayama%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DA.%26aulast%3DMiyashita%26aufirst%3DR.%26aulast%3DIwatani%26aufirst%3DM.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DO.%26atitle%3DInhibitors%2520of%2520CLK%2520protein%2520kinases%2520suppress%2520cell%2520growth%2520and%2520induce%2520apoptosis%2520by%2520modulating%2520pre-mRNA%2520splicing%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0116929%26doi%3D10.1371%2Fjournal.pone.0116929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Jakubauskiene, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilys, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poellinger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanopka, A.</span><span> </span><span class="NLM_article-title">Increased serine-arginine (SR) protein phosphorylation changes pre-mRNA splicing in hypoxia</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">18079</span><span class="NLM_x">–</span> <span class="NLM_lpage">18089</span><span class="refDoi"> DOI: 10.1074/jbc.M115.639690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1074%2Fjbc.M115.639690" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=18079-18089&author=E.+Jakubauskieneauthor=L.+Vilysauthor=Y.+Makinoauthor=L.+Poellingerauthor=A.+Kanopka&title=Increased+serine-arginine+%28SR%29+protein+phosphorylation+changes+pre-mRNA+splicing+in+hypoxia&doi=10.1074%2Fjbc.M115.639690"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.639690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.639690%26sid%3Dliteratum%253Aachs%26aulast%3DJakubauskiene%26aufirst%3DE.%26aulast%3DVilys%26aufirst%3DL.%26aulast%3DMakino%26aufirst%3DY.%26aulast%3DPoellinger%26aufirst%3DL.%26aulast%3DKanopka%26aufirst%3DA.%26atitle%3DIncreased%2520serine-arginine%2520%2528SR%2529%2520protein%2520phosphorylation%2520changes%2520pre-mRNA%2520splicing%2520in%2520hypoxia%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D18079%26epage%3D18089%26doi%3D10.1074%2Fjbc.M115.639690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Eisenreich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakrzewicz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thierbach, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepke, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldin-Lang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultheiss, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pries, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, U.</span><span> </span><span class="NLM_article-title">Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span><span class="refDoi"> DOI: 10.3892/or.2013.2413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.3892%2For.2013.2413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=23604472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Wit7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=462-470&author=A.+Eisenreichauthor=A.+Zakrzewiczauthor=K.+Huberauthor=H.+Thierbachauthor=W.+Pepkeauthor=P.+Goldin-Langauthor=H.+P.+Schultheissauthor=A.+Priesauthor=U.+Rauch&title=Regulation+of+pro-angiogenic+tissue+factor+expression+in+hypoxia-induced+human+lung+cancer+cells&doi=10.3892%2For.2013.2413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells</span></div><div class="casAuthors">Eisenreich, Andreas; Zakrzewicz, Andreas; Huber, Kilian; Thierbach, Hannes; Pepke, Wojciech; Goldin-Lang, Petra; Schultheiss, Heinz-Peter; Pries, Axel; Rauch, Ursula</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">462-470</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Alternative splicing is a key regulatory mechanism for cellular metab. controlling cell proliferation and angiogenesis, both of which are crucial processes for tumorigenesis under hypoxia.  Human cells express two tissue factor (TF) isoforms, alternatively spliced TF (asTF) and 'full length' TF (flTF).  FlTF is the major source of thrombogenicity whereas, the function of sol. asTF, particularly in cancer, is widely unknown.  In the present study, we examd. the impact of alternative splicing on the pro-angiogenic potential and the TF expression pattern of A549 cells under hypoxia.  We focused our efforts toward alternative splicing factors, such as Clk1, and pro-angiogenic proliferation-regulating factors, such as Cyr61.  We further examd. the influence of asTF overexpression on the expression of MCP-1, Cyr61 and VEGF, as well as on cell no. and pro-angiogenic properties of A549 cells.  Notably, we found hypoxia to induce the expression of alternative splicing factors (Clk1 and Clk4) as well as proliferation- and angiogenesis-promoting factors (Cyr61 and flTF).  AsTF overexpression in A549 cells also increased both cell no. and tube formation.  These effects were mediated by the induction of Cyr61, MCP-1 and VEGF, as well as by integrin αvβ3.  Taken together, our results suggest that the pro-angiogenic potential of A549 lung cancer cells is modulated under hypoxic conditions via modulation of TF isoform expression which in turn is controlled by alternative splicing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrymkTrMsmF7Vg90H21EOLACvtfcHk0ljECPGcqDsiHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Wit7fJ&md5=22fb1eca27baaf2921b8b04eb6405b44</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3892%2For.2013.2413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2013.2413%26sid%3Dliteratum%253Aachs%26aulast%3DEisenreich%26aufirst%3DA.%26aulast%3DZakrzewicz%26aufirst%3DA.%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DThierbach%26aufirst%3DH.%26aulast%3DPepke%26aufirst%3DW.%26aulast%3DGoldin-Lang%26aufirst%3DP.%26aulast%3DSchultheiss%26aufirst%3DH.%2BP.%26aulast%3DPries%26aufirst%3DA.%26aulast%3DRauch%26aufirst%3DU.%26atitle%3DRegulation%2520of%2520pro-angiogenic%2520tissue%2520factor%2520expression%2520in%2520hypoxia-induced%2520human%2520lung%2520cancer%2520cells%26jtitle%3DOncol.%2520Rep.%26date%3D2013%26volume%3D30%26spage%3D462%26epage%3D470%26doi%3D10.3892%2For.2013.2413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Capra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuciforo, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Confalonieri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quarto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebuloni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boldorini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallotti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viale, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gishizky, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draetta, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, P. P.</span><span> </span><span class="NLM_article-title">Frequent alterations in the expression of serine/threonine kinases in human cancers</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8147</span><span class="NLM_x">–</span> <span class="NLM_lpage">8154</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-3489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1158%2F0008-5472.CAN-05-3489" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=8147-8154&author=M.+Capraauthor=P.+G.+Nuciforoauthor=S.+Confalonieriauthor=M.+Quartoauthor=M.+Bianchiauthor=M.+Nebuloniauthor=R.+Boldoriniauthor=F.+Pallottiauthor=G.+Vialeauthor=M.+L.+Gishizkyauthor=G.+F.+Draettaauthor=P.+P.+Di+Fiore&title=Frequent+alterations+in+the+expression+of+serine%2Fthreonine+kinases+in+human+cancers&doi=10.1158%2F0008-5472.CAN-05-3489"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-3489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-3489%26sid%3Dliteratum%253Aachs%26aulast%3DCapra%26aufirst%3DM.%26aulast%3DNuciforo%26aufirst%3DP.%2BG.%26aulast%3DConfalonieri%26aufirst%3DS.%26aulast%3DQuarto%26aufirst%3DM.%26aulast%3DBianchi%26aufirst%3DM.%26aulast%3DNebuloni%26aufirst%3DM.%26aulast%3DBoldorini%26aufirst%3DR.%26aulast%3DPallotti%26aufirst%3DF.%26aulast%3DViale%26aufirst%3DG.%26aulast%3DGishizky%26aufirst%3DM.%2BL.%26aulast%3DDraetta%26aufirst%3DG.%2BF.%26aulast%3DDi%2BFiore%26aufirst%3DP.%2BP.%26atitle%3DFrequent%2520alterations%2520in%2520the%2520expression%2520of%2520serine%252Fthreonine%2520kinases%2520in%2520human%2520cancers%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8147%26epage%3D8154%26doi%3D10.1158%2F0008-5472.CAN-05-3489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weremowicz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polyak, K.</span><span> </span><span class="NLM_article-title">CLK2 is an oncogenic kinase and splicing regulator in breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1516</span><span class="NLM_x">–</span> <span class="NLM_lpage">1526</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-2443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1158%2F0008-5472.CAN-14-2443" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=1516-1526&author=T.+Yoshidaauthor=J.+H.+Kimauthor=K.+Carverauthor=Y.+Suauthor=S.+Weremowiczauthor=L.+Mulveyauthor=S.+Yamamotoauthor=C.+Brennanauthor=S.+Meiauthor=H.+Longauthor=J.+Yaoauthor=K.+Polyak&title=CLK2+is+an+oncogenic+kinase+and+splicing+regulator+in+breast+cancer&doi=10.1158%2F0008-5472.CAN-14-2443"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-2443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-2443%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DCarver%26aufirst%3DK.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DWeremowicz%26aufirst%3DS.%26aulast%3DMulvey%26aufirst%3DL.%26aulast%3DYamamoto%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DC.%26aulast%3DMei%26aufirst%3DS.%26aulast%3DLong%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DPolyak%26aufirst%3DK.%26atitle%3DCLK2%2520is%2520an%2520oncogenic%2520kinase%2520and%2520splicing%2520regulator%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D1516%26epage%3D1526%26doi%3D10.1158%2F0008-5472.CAN-14-2443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Muraki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkawara, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onogi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yomoda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krainer, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span> </span><span class="NLM_article-title">Manipulation of alternative splicing by a newly developed inhibitor of Clks</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">24246</span><span class="NLM_x">–</span> <span class="NLM_lpage">24254</span><span class="refDoi"> DOI: 10.1074/jbc.M314298200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1074%2Fjbc.M314298200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=24246-24254&author=M.+Murakiauthor=B.+Ohkawaraauthor=T.+Hosoyaauthor=H.+Onogiauthor=J.+Koizumiauthor=T.+Koizumiauthor=K.+Sumiauthor=J.+Yomodaauthor=M.+V.+Murrayauthor=H.+Kimuraauthor=K.+Furuichiauthor=H.+Shibuyaauthor=A.+R.+Krainerauthor=M.+Suzukiauthor=M.+Hagiwara&title=Manipulation+of+alternative+splicing+by+a+newly+developed+inhibitor+of+Clks&doi=10.1074%2Fjbc.M314298200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M314298200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M314298200%26sid%3Dliteratum%253Aachs%26aulast%3DMuraki%26aufirst%3DM.%26aulast%3DOhkawara%26aufirst%3DB.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DKoizumi%26aufirst%3DJ.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DSumi%26aufirst%3DK.%26aulast%3DYomoda%26aufirst%3DJ.%26aulast%3DMurray%26aufirst%3DM.%2BV.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DFuruichi%26aufirst%3DK.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DKrainer%26aufirst%3DA.%2BR.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DManipulation%2520of%2520alternative%2520splicing%2520by%2520a%2520newly%2520developed%2520inhibitor%2520of%2520Clks%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D24246%26epage%3D24254%26doi%3D10.1074%2Fjbc.M314298200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenreich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szklarczyk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trappe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracher, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2010.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1016%2Fj.chembiol.2010.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=21276940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlarsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=67-76&author=O.+Fedorovauthor=K.+Huberauthor=A.+Eisenreichauthor=P.+Filippakopoulosauthor=O.+Kingauthor=A.+N.+Bullockauthor=D.+Szklarczykauthor=L.+J.+Jensenauthor=D.+Fabbroauthor=J.+Trappeauthor=U.+Rauchauthor=F.+Bracherauthor=S.+Knapp&title=Specific+CLK+inhibitors+from+a+novel+chemotype+for+regulation+of+alternative+splicing&doi=10.1016%2Fj.chembiol.2010.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing</span></div><div class="casAuthors">Fedorov, Oleg; Huber, Kilian; Eisenreich, Andreas; Filippakopoulos, Panagis; King, Oliver; Bullock, Alex N.; Szklarczyk, Damian; Jensen, Lars J.; Fabbro, Doriano; Trappe, Jorg; Rauch, Ursula; Bracher, Franz; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-76</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">There is a growing recognition of the importance of protein kinases in the control of alternative splicing.  To define the underlying regulatory mechanisms, highly selective inhibitors are needed.  Here, we report the discovery and characterization of the dichloroindolyl enaminonitrile KH-CB19, a potent and highly specific inhibitor of the CDC2-like kinase isoforms 1 and 4 (CLK1/CLK4).  Cocrystal structures of KH-CB19 with CLK1 and CLK3 revealed a non-ATP mimetic binding mode, conformational changes in helix αC and the phosphate binding loop and halogen bonding to the kinase hinge region.  KH-CB19 effectively suppressed phosphorylation of SR (serine/arginine) proteins in cells, consistent with its expected mechanism of action.  Chem. inhibition of CLK1/CLK4 generated a unique pattern of splicing factor dephosphorylation and had at low nM concn. a profound effect on splicing of the two tissue factor isoforms flTF (full-length TF) and asHTF (alternatively spliced human TF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqnKjNEjPBHbVg90H21EOLACvtfcHk0lghkvYFyiV9mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlarsLw%253D&md5=b2b17a9934f15f2d0d9a76a8d3179e95</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DEisenreich%26aufirst%3DA.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKing%26aufirst%3DO.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DSzklarczyk%26aufirst%3DD.%26aulast%3DJensen%26aufirst%3DL.%2BJ.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DRauch%26aufirst%3DU.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DSpecific%2520CLK%2520inhibitors%2520from%2520a%2520novel%2520chemotype%2520for%2520regulation%2520of%2520alternative%2520splicing%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D67%26epage%3D76%26doi%3D10.1016%2Fj.chembiol.2010.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Mott, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanega, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marugan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misteli, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auld, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, C. J.</span><span> </span><span class="NLM_article-title">Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6700</span><span class="NLM_x">–</span> <span class="NLM_lpage">6705</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.09.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1016%2Fj.bmcl.2009.09.121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6700-6705&author=B.+T.+Mottauthor=C.+Tanegaauthor=M.+Shenauthor=D.+J.+Maloneyauthor=P.+Shinnauthor=W.+Leisterauthor=J.+J.+Maruganauthor=J.+Ingleseauthor=C.+P.+Austinauthor=T.+Misteliauthor=D.+S.+Auldauthor=C.+J.+Thomas&title=Evaluation+of+substituted+6-arylquinazolin-4-amines+as+potent+and+selective+inhibitors+of+cdc2-like+kinases+%28Clk%29&doi=10.1016%2Fj.bmcl.2009.09.121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.09.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.09.121%26sid%3Dliteratum%253Aachs%26aulast%3DMott%26aufirst%3DB.%2BT.%26aulast%3DTanega%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26aulast%3DShinn%26aufirst%3DP.%26aulast%3DLeister%26aufirst%3DW.%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DMisteli%26aufirst%3DT.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26atitle%3DEvaluation%2520of%2520substituted%25206-arylquinazolin-4-amines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520cdc2-like%2520kinases%2520%2528Clk%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6700%26epage%3D6705%26doi%3D10.1016%2Fj.bmcl.2009.09.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovelman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, K. J.</span><span> </span><span class="NLM_article-title">A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">451</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span><span class="refDoi"> DOI: 10.1042/BJ20121418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1042%2FBJ20121418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=23398362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFOgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=451&publication_year=2013&pages=313-328&author=Y.+Gaoauthor=S.+P.+Daviesauthor=M.+Augustinauthor=A.+Woodwardauthor=U.+A.+Patelauthor=R.+Kovelmanauthor=K.+J.+Harvey&title=A+broad+activity+screen+in+support+of+a+chemogenomic+map+for+kinase+signalling+research+and+drug+discovery&doi=10.1042%2FBJ20121418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery</span></div><div class="casAuthors">Gao, Yinghong; Davies, Stephen P.; Augustin, Martin; Woodward, Anna; Patel, Umesh A.; Kovelman, Robert; Harvey, Kevin J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">451</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">313-328</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Despite the development of a no. of efficacious kinase inhibitors, the strategies for rational design of these compds. have been limited by target promiscuity.  In an effort to better understand the nature of kinase inhibition across the kinome, esp. as it relates to off-target effects, we screened a well-defined collection of kinase inhibitors using biochem. assays for inhibitory activity against 234 active human kinases and kinase complexes, representing all branches of the kinome tree.  For our study we employed 158 small mols. initially identified in the literature as potent and specific inhibitors of kinases important as therapeutic targets and/or signal transduction regulators.  Hierarchical clustering of these benchmark kinase inhibitors on the basis of their kinome activity profiles illustrates how they relate to chem. structure similarities and provides new insights into inhibitor specificity and potential applications for probing new targets.  Using this broad dataset, we provide a framework for assessing polypharmacol.  We not only discover likely off-target inhibitor activities and recommend specific inhibitors for existing targets, but also identify potential new uses for known small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNLU0ONM4SALVg90H21EOLACvtfcHk0lghkvYFyiV9mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFOgs7g%253D&md5=9e0f17ec5cac10198fe28b27e70b4966</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1042%2FBJ20121418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20121418%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DDavies%26aufirst%3DS.%2BP.%26aulast%3DAugustin%26aufirst%3DM.%26aulast%3DWoodward%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DU.%2BA.%26aulast%3DKovelman%26aufirst%3DR.%26aulast%3DHarvey%26aufirst%3DK.%2BJ.%26atitle%3DA%2520broad%2520activity%2520screen%2520in%2520support%2520of%2520a%2520chemogenomic%2520map%2520for%2520kinase%2520signalling%2520research%2520and%2520drug%2520discovery%26jtitle%3DBiochem.%2520J.%26date%3D2013%26volume%3D451%26spage%3D313%26epage%3D328%26doi%3D10.1042%2FBJ20121418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Schmitt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miralinaghi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, M.</span><span> </span><span class="NLM_article-title">Hydroxybenzothiophene ketones are efficient pre-mRNA splicing modulators due to dual inhibition of Dyrk1A and Clk1/4</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span><span class="refDoi"> DOI: 10.1021/ml500059y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500059y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=963-907&author=C.+Schmittauthor=P.+Miralinaghiauthor=M.+Marianoauthor=R.+W.+Hartmannauthor=M.+Engel&title=Hydroxybenzothiophene+ketones+are+efficient+pre-mRNA+splicing+modulators+due+to+dual+inhibition+of+Dyrk1A+and+Clk1%2F4&doi=10.1021%2Fml500059y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fml500059y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500059y%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DC.%26aulast%3DMiralinaghi%26aufirst%3DP.%26aulast%3DMariano%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3DHydroxybenzothiophene%2520ketones%2520are%2520efficient%2520pre-mRNA%2520splicing%2520modulators%2520due%2520to%2520dual%2520inhibition%2520of%2520Dyrk1A%2520and%2520Clk1%252F4%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D963%26epage%3D907%26doi%3D10.1021%2Fml500059y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kuhn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaschinski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frauen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katus, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, N.</span><span> </span><span class="NLM_article-title">DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">17320</span><span class="NLM_x">–</span> <span class="NLM_lpage">17327</span><span class="refDoi"> DOI: 10.1074/jbc.M109.006759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1074%2Fjbc.M109.006759" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=17320-17327&author=C.+Kuhnauthor=D.+Frankauthor=R.+Willauthor=C.+Jaschinskiauthor=R.+Frauenauthor=H.+A.+Katusauthor=N.+Frey&title=DYRK1A+is+a+novel+negative+regulator+of+cardiomyocyte+hypertrophy&doi=10.1074%2Fjbc.M109.006759"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.006759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.006759%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DC.%26aulast%3DFrank%26aufirst%3DD.%26aulast%3DWill%26aufirst%3DR.%26aulast%3DJaschinski%26aufirst%3DC.%26aulast%3DFrauen%26aufirst%3DR.%26aulast%3DKatus%26aufirst%3DH.%2BA.%26aulast%3DFrey%26aufirst%3DN.%26atitle%3DDYRK1A%2520is%2520a%2520novel%2520negative%2520regulator%2520of%2520cardiomyocyte%2520hypertrophy%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D17320%26epage%3D17327%26doi%3D10.1074%2Fjbc.M109.006759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Bendjeddou, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loaëc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villiers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Späth, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galons, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oumata, N.</span><span> </span><span class="NLM_article-title">Exploration of the imidazo[1,2-b]pyridazine scaffold as a protein kinase inhibitor</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">696</span><span class="NLM_x">–</span> <span class="NLM_lpage">709</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.09.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1016%2Fj.ejmech.2016.09.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2017&pages=696-709&author=L.+Z.+Bendjeddouauthor=N.+Loa%C3%ABcauthor=B.+Villiersauthor=E.+Prinaauthor=G.+F.+Sp%C3%A4thauthor=H.+Galonsauthor=L.+Meijerauthor=N.+Oumata&title=Exploration+of+the+imidazo%5B1%2C2-b%5Dpyridazine+scaffold+as+a+protein+kinase+inhibitor&doi=10.1016%2Fj.ejmech.2016.09.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.09.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.09.064%26sid%3Dliteratum%253Aachs%26aulast%3DBendjeddou%26aufirst%3DL.%2BZ.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DVilliers%26aufirst%3DB.%26aulast%3DPrina%26aufirst%3DE.%26aulast%3DSp%25C3%25A4th%26aufirst%3DG.%2BF.%26aulast%3DGalons%26aufirst%3DH.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DOumata%26aufirst%3DN.%26atitle%3DExploration%2520of%2520the%2520imidazo%255B1%252C2-b%255Dpyridazine%2520scaffold%2520as%2520a%2520protein%2520kinase%2520inhibitor%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D125%26spage%3D696%26epage%3D709%26doi%3D10.1016%2Fj.ejmech.2016.09.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Prak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriston-Vizi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pengo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketteler, R.</span><span> </span><span class="NLM_article-title">Benzobisthiazoles represent a novel scaffold for kinase inhibitors of CLK family members</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">608</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span><span class="refDoi"> DOI: 10.1021/acs.biochem.5b01128</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.5b01128" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=608-617&author=K.+Prakauthor=J.+Kriston-Viziauthor=A.+W.+Chanauthor=C.+Luftauthor=J.+R.+Costaauthor=N.+Pengoauthor=R.+Ketteler&title=Benzobisthiazoles+represent+a+novel+scaffold+for+kinase+inhibitors+of+CLK+family+members&doi=10.1021%2Facs.biochem.5b01128"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.5b01128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.5b01128%26sid%3Dliteratum%253Aachs%26aulast%3DPrak%26aufirst%3DK.%26aulast%3DKriston-Vizi%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DA.%2BW.%26aulast%3DLuft%26aufirst%3DC.%26aulast%3DCosta%26aufirst%3DJ.%2BR.%26aulast%3DPengo%26aufirst%3DN.%26aulast%3DKetteler%26aufirst%3DR.%26atitle%3DBenzobisthiazoles%2520represent%2520a%2520novel%2520scaffold%2520for%2520kinase%2520inhibitors%2520of%2520CLK%2520family%2520members%26jtitle%3DBiochemistry%26date%3D2016%26volume%3D55%26spage%3D608%26epage%3D617%26doi%3D10.1021%2Facs.biochem.5b01128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Soundararajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitsky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettenbach, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eswaran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, J. M.</span><span> </span><span class="NLM_article-title">Structures of down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">986</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span><span class="refDoi"> DOI: 10.1016/j.str.2013.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1016%2Fj.str.2013.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=23665168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVygtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=986-996&author=M.+Soundararajanauthor=A.+K.+Roosauthor=P.+Savitskyauthor=P.+Filippakopoulosauthor=A.+N.+Kettenbachauthor=J.+V.+Olsenauthor=S.+A.+Gerberauthor=J.+Eswaranauthor=S.+Knappauthor=J.+M.+Elkins&title=Structures+of+down+syndrome+kinases%2C+DYRKs%2C+reveal+mechanisms+of+kinase+activation+and+substrate+recognition&doi=10.1016%2Fj.str.2013.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Down Syndrome Kinases, DYRKs, Reveal Mechanisms of Kinase Activation and Substrate Recognition</span></div><div class="casAuthors">Soundararajan, Meera; Roos, Annette K.; Savitsky, Pavel; Filippakopoulos, Panagis; Kettenbach, Arminja N.; Olsen, Jesper V.; Gerber, Scott A.; Eswaran, Jeyanthy; Knapp, Stefan; Elkins, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">986-996</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine-(Y)-phosphorylation-regulated kinases (DYRKs) play key roles in brain development, regulation of splicing, and apoptosis, and are potential drug targets for neurodegenerative diseases and cancer.  We present crystal structures of one representative member of each DYRK subfamily: DYRK1A with an ATP-mimetic inhibitor and consensus peptide, and DYRK2 including NAPA and DH (DYRK homol.) box regions.  The current activation model suggests that DYRKs are Ser/Thr kinases that only autophosphorylate the second tyrosine of the activation loop YxY motif during protein translation.  The structures explain the roles of this tyrosine and of the DH box in DYRK activation and provide a structural model for DYRK substrate recognition.  Phosphorylation of a library of naturally occurring peptides identified substrate motifs that lack proline in the P+1 position, suggesting that DYRK1A is not a strictly proline-directed kinase.  Our data also show that DYRK1A wild-type and Y321F mutant retain tyrosine autophosphorylation activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDShaymgKcfLVg90H21EOLACvtfcHk0lh3mRKq1IlzCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVygtL0%253D&md5=f101707a987083c7d3d637b39332db35</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DRoos%26aufirst%3DA.%2BK.%26aulast%3DSavitsky%26aufirst%3DP.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKettenbach%26aufirst%3DA.%2BN.%26aulast%3DOlsen%26aufirst%3DJ.%2BV.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DEswaran%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26atitle%3DStructures%2520of%2520down%2520syndrome%2520kinases%252C%2520DYRKs%252C%2520reveal%2520mechanisms%2520of%2520kinase%2520activation%2520and%2520substrate%2520recognition%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D986%26epage%3D996%26doi%3D10.1016%2Fj.str.2013.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Paulini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Orthogonal multipolar interactions in structural chemistry and biology</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1788</span><span class="NLM_x">–</span> <span class="NLM_lpage">1805</span><span class="refDoi"> DOI: 10.1002/anie.200462213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1002%2Fanie.200462213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislWkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=1788-1805&author=R.+Pauliniauthor=K.+M%C3%BCllerauthor=F.+Diederich&title=Orthogonal+multipolar+interactions+in+structural+chemistry+and+biology&doi=10.1002%2Fanie.200462213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Orthogonal multipolar interactions in structural chemistry and biology</span></div><div class="casAuthors">Paulini, Ralph; Mueller, Klaus; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1788-1805</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The past few decades of mol. recognition studies have greatly enhanced our knowledge on apolar, ion-dipole, and hydrogen-bonding interactions.  However, much less attention has been given to the role that multipolar interactions, in particular those with orthogonal dipolar alignment, play in organizing a crystal lattice or stabilizing complexes involving biol. receptors.  By using results from database mining, this review attempts to give an overview of types and structural features of these previously rather overlooked interactions.  A no. of illustrative examples of these interactions found in X-ray crystal structures of small mols. and protein-ligand complexes demonstrate their propensity and thus potential importance for both, chem. and biol. mol. recognition processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTGHoutIq12LVg90H21EOLACvtfcHk0lg3THdWKXpoUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislWkt7s%253D&md5=6ad842547313b27fc1676e9c3a001909</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fanie.200462213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200462213%26sid%3Dliteratum%253Aachs%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DOrthogonal%2520multipolar%2520interactions%2520in%2520structural%2520chemistry%2520and%2520biology%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D1788%26epage%3D1805%26doi%3D10.1002%2Fanie.200462213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Olsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obst Sander, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: evidence for C-F...C=O interactions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2507</span><span class="NLM_x">–</span> <span class="NLM_lpage">2511</span><span class="refDoi"> DOI: 10.1002/anie.200351268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1002%2Fanie.200351268" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=2507-2511&author=J.+A.+Olsenauthor=D.+W.+Bannerauthor=P.+Seilerauthor=U.+Obst+Sanderauthor=A.+D%E2%80%99Arcyauthor=M.+Stihleauthor=K.+M%C3%BCllerauthor=F.+Diederich&title=A+fluorine+scan+of+thrombin+inhibitors+to+map+the+fluorophilicity%2Ffluorophobicity+of+an+enzyme+active+site%3A+evidence+for+C-F...C%3DO+interactions&doi=10.1002%2Fanie.200351268"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fanie.200351268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200351268%26sid%3Dliteratum%253Aachs%26aulast%3DOlsen%26aufirst%3DJ.%2BA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DSeiler%26aufirst%3DP.%26aulast%3DObst%2BSander%26aufirst%3DU.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DA%2520fluorine%2520scan%2520of%2520thrombin%2520inhibitors%2520to%2520map%2520the%2520fluorophilicity%252Ffluorophobicity%2520of%2520an%2520enzyme%2520active%2520site%253A%2520evidence%2520for%2520C-F...C%253DO%2520interactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D2507%26epage%3D2511%26doi%3D10.1002%2Fanie.200351268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Ogawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramatsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kii, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onogi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span> </span><span class="NLM_article-title">Development of a novel selective inhibitor of the down syndrome-related kinase Dyrk1A</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="refDoi"> DOI: 10.1038/ncomms1090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1038%2Fncomms1090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=20981014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=86&author=Y.+Ogawaauthor=Y.+Nonakaauthor=T.+Gotoauthor=E.+Ohnishiauthor=T.+Hiramatsuauthor=I.+Kiiauthor=M.+Yoshidaauthor=T.+Ikuraauthor=H.+Onogiauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=N.+Itoauthor=M.+Hagiwara&title=Development+of+a+novel+selective+inhibitor+of+the+down+syndrome-related+kinase+Dyrk1A&doi=10.1038%2Fncomms1090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span></div><div class="casAuthors">Ogawa Yasushi; Nonaka Yosuke; Goto Toshiyasu; Ohnishi Eriko; Hiramatsu Toshiyuki; Kii Isao; Yoshida Miyo; Ikura Teikichi; Onogi Hiroshi; Shibuya Hiroshi; Hosoya Takamitsu; Ito Nobutoshi; Hagiwara Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dyrk1A (dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A) is a serine/threonine kinase essential for brain development and function, and its excessive activity is considered a pathogenic factor in Down syndrome.  The development of potent, selective inhibitors of Dyrk1A would help to elucidate the molecular mechanisms of normal and diseased brains, and may provide a new lead compound for molecular-targeted drug discovery.  Here, we report a novel Dyrk1A inhibitor, INDY, a benzothiazole derivative showing a potent ATP-competitive inhibitory effect with IC(50) and K(i) values of 0.24 and 0.18 μM, respectively.  X-ray crystallography of the Dyrk1A/INDY complex revealed the binding of INDY in the ATP pocket of the enzyme.  INDY effectively reversed the aberrant tau-phosphorylation and rescued the repressed NFAT (nuclear factor of activated T cell) signalling induced by Dyrk1A overexpression.  Importantly, proINDY, a prodrug of INDY, effectively recovered Xenopus embryos from head malformation induced by Dyrk1A overexpression, resulting in normally developed embryos and demonstrating the utility of proINDY in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtenUz0lpNqnfW6udTcc2eYG23csmMsck7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D&md5=ac1d5972bec4085de101bb86194babd1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fncomms1090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1090%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DE.%26aulast%3DHiramatsu%26aufirst%3DT.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520the%2520down%2520syndrome-related%2520kinase%2520Dyrk1A%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D86%26doi%3D10.1038%2Fncomms1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Okano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagahara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murawaki, Y.</span><span> </span><span class="NLM_article-title">Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway</span> <span class="citation_source-journal">Basic Clin. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span><span class="refDoi"> DOI: 10.1111/j.1742-7843.2008.00231.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1111%2Fj.1742-7843.2008.00231.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=18346049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntFWmsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2008&pages=543-551&author=J.+Okanoauthor=T.+Nagaharaauthor=K.+Matsumotoauthor=Y.+Murawaki&title=Caffeine+inhibits+the+proliferation+of+liver+cancer+cells+and+activates+the+MEK%2FERK%2FEGFR+signalling+pathway&doi=10.1111%2Fj.1742-7843.2008.00231.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway</span></div><div class="casAuthors">Okano, Jun-ichi; Nagahara, Takakazu; Matsumoto, Kazuya; Murawaki, Yoshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">543-551</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Caffeine has been reported to prevent hepatocarcinogenesis.  We investigated the mol. mechanisms by which caffeine inhibits the growth of hepatocellular carcinoma (HCC) cells.  We found that caffeine inhibited the proliferation of HCC cells via cell cycle arrest independent of apoptosis.  We revealed a novel signaling axis for caffeine involving activation of the mitogen-activated ERK-regulating kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway that resulted in the downstream up-regulation of epidermal growth factor receptor (EGFR), although the MEK/ERK/EGFR signaling pathway was not involved in the growth inhibitory effect of caffeine.  Our data reveal that caffeine could be a promising candidate for the treatment of patients with HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe9I90o8I7wLVg90H21EOLACvtfcHk0lhcjVJc-F9IMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntFWmsLw%253D&md5=38b57f21f9c485c5e47ff2f6eea2ac3d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2008.00231.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2008.00231.x%26sid%3Dliteratum%253Aachs%26aulast%3DOkano%26aufirst%3DJ.%26aulast%3DNagahara%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DMurawaki%26aufirst%3DY.%26atitle%3DCaffeine%2520inhibits%2520the%2520proliferation%2520of%2520liver%2520cancer%2520cells%2520and%2520activates%2520the%2520MEK%252FERK%252FEGFR%2520signalling%2520pathway%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2008%26volume%3D102%26spage%3D543%26epage%3D551%26doi%3D10.1111%2Fj.1742-7843.2008.00231.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Sakuma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span> </span><span class="NLM_article-title">Deciphering targeting rules of splicing modulator compounds: case of TG003</span> <span class="citation_source-journal">BMC Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="refDoi"> DOI: 10.1186/s12867-015-0044-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1186%2Fs12867-015-0044-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=26400733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmt1Khsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=16&author=M.+Sakumaauthor=K.+Iidaauthor=M.+Hagiwara&title=Deciphering+targeting+rules+of+splicing+modulator+compounds%3A+case+of+TG003&doi=10.1186%2Fs12867-015-0044-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Deciphering targeting rules of splicing modulator compounds: case of TG003</span></div><div class="casAuthors">Sakuma, Maki; Iida, Kei; Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">BMC Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16/1-16/13</span>CODEN:
                <span class="NLM_cas:coden">BMBMC4</span>;
        ISSN:<span class="NLM_cas:issn">1471-2199</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Recent advances in the development of small chem. compds. that can modulate RNA splicing brought excitement to the field of splicing-targeting therapy.  Splicing-targeting therapy tries to ameliorate the disease by altering the exon combination of transcripts to reduce the undesired effect of genetic mutations.  However, the knowledge and tools to understand factors contributing to splicing modulator compd. sensitivity have been lacking.  Our goal was to establish a method to characterize sequence features found in compd. sensitive exons.  Results: Here we developed a comparative transcriptomic approach to explore features that make an exon sensitive to a chem. compd.  In this study, we chose TG003, a potential drug for Duchenne muscular dystrophy, and performed RNA-sequencing on samples from human and mouse skeletal muscle cells, with and without TG003 treatments.  We compared TG003 responsiveness between homologous exon pairs and identified 21 pairs in which human exons were skip-enhanced but not mouse exons.  We compared the sequence features; splice site scores, no. of splicing factor binding sites, and properties of branch sequence and polypyrimidine tracts, and found that polypyrimidine tracts were stronger (longer stretches and richer content of consecutive polypyrimidine) in the mouse TG003 insensitive exons.  We also compared the features between TG003 skip-enhanced and insensitive exons within the species, and discovered that human TG003 skip-enhanced exons were shorter and had less splicing factor binding sites than the group of human TG003 insensitive exons.  Mouse insensitive exons homologous to human TG003 skip-enhanced exons shared these properties.  Our results suggested that these features are prerequisites for TG003 skip-enhanced exons and weak polypyrimidine tracts are defining features, which were supported by a decision tree anal. on all cassette exons in human.  Conclusions: In this study we established a comparative transcriptomic approach, which shed lights on how small chem. compds. modulate RNA splicing.  The results described here was the first attempt to decipher the targeting rules of a splicing modulator compd.  We expect that this approach would contribute to the precise understanding of the mechanism of TG003-induced splicing modulation, expand target diseases of splicing modulators in general, as well as the development of new splicing modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoodIBTCDKQnLVg90H21EOLACvtfcHk0lhcjVJc-F9IMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmt1Khsbk%253D&md5=9bc9d7885d1e0bd0bfc9c0c943aba4a5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1186%2Fs12867-015-0044-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12867-015-0044-6%26sid%3Dliteratum%253Aachs%26aulast%3DSakuma%26aufirst%3DM.%26aulast%3DIida%26aufirst%3DK.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDeciphering%2520targeting%2520rules%2520of%2520splicing%2520modulator%2520compounds%253A%2520case%2520of%2520TG003%26jtitle%3DBMC%2520Mol.%2520Biol.%26date%3D2015%26volume%3D16%26spage%3D16%26doi%3D10.1186%2Fs12867-015-0044-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Schmitt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kail, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Empting, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of a library of lead-like 2,4-bisheterocyclic substituted thiophenes as selective Dyrk/Clk inhibitors</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e87851</span><span class="refDoi"> DOI: 10.1371/journal.pone.0087851</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1371%2Fjournal.pone.0087851" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e87851&author=C.+Schmittauthor=D.+Kailauthor=M.+Marianoauthor=M.+Emptingauthor=N.+Weberauthor=T.+Paulauthor=R.+W.+Hartmannauthor=M.+Engel&title=Design+and+synthesis+of+a+library+of+lead-like+2%2C4-bisheterocyclic+substituted+thiophenes+as+selective+Dyrk%2FClk+inhibitors&doi=10.1371%2Fjournal.pone.0087851"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0087851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0087851%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DC.%26aulast%3DKail%26aufirst%3DD.%26aulast%3DMariano%26aufirst%3DM.%26aulast%3DEmpting%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DN.%26aulast%3DPaul%26aufirst%3DT.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520library%2520of%2520lead-like%25202%252C4-bisheterocyclic%2520substituted%2520thiophenes%2520as%2520selective%2520Dyrk%252FClk%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De87851%26doi%3D10.1371%2Fjournal.pone.0087851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Mariano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, M.</span><span> </span><span class="NLM_article-title">Systematic diversification of benzylidene heterocycles yields novel inhibitor scaffolds selective for Dyrk1A, Clk1 and CK2</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1016%2Fj.ejmech.2016.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=26896709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVChsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2016&pages=209-216&author=M.+Marianoauthor=R.+W.+Hartmannauthor=M.+Engel&title=Systematic+diversification+of+benzylidene+heterocycles+yields+novel+inhibitor+scaffolds+selective+for+Dyrk1A%2C+Clk1+and+CK2&doi=10.1016%2Fj.ejmech.2016.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic diversification of benzylidene heterocycles yields novel inhibitor scaffolds selective for Dyrk1A, Clk1 and CK2</span></div><div class="casAuthors">Mariano, Marica; Hartmann, Rolf W.; Engel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">209-216</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The dual-specificity tyrosine-regulated kinase 1A (Dyrk1A) has gathered much interest as a pharmacol. target in Alzheimer's disease (AD), but it plays a role in malignant brain tumors as well.  As both diseases are multi-factorial, further protein kinases, such as Clk1 and CK2, were proposed to contribute to the pathogenesis.  The authors designed a new class of α-benzylidene-γ-butyrolactone inhibitors that showed low micromolar potencies against Dyrk1A and/or Clk1 and a good selectivity profile among the most frequently reported off-target kinases.  A systematic replacement of the heterocyclic moiety gave access to further inhibitor classes with interesting selectivity profiles, demonstrating that the benzylidene heterocycles provide a versatile tool box for developing inhibitors of the CMGC kinase family members Dyr1A/1B, Clk1/4 and CK2.  Efficacy for the inhibition of Dyrk1A-mediated tau phosphorylation was demonstrated in a cell-based assay.  Multi-targeted but not non-specific kinase inhibitors were also obtained, that co-inhibited the lipid kinases PI3Kα/γ.  These compds. were shown to inhibit the proliferation of U87MG cells in the low micromolar range.  Based on the mol. properties, the inhibitors described here hold promise for CNS activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6qXCl7IedNLVg90H21EOLACvtfcHk0lh1CP8bbJ_e6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVChsb4%253D&md5=85bec789a30e7da3dddfc731ed87b227</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DMariano%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3DSystematic%2520diversification%2520of%2520benzylidene%2520heterocycles%2520yields%2520novel%2520inhibitor%2520scaffolds%2520selective%2520for%2520Dyrk1A%252C%2520Clk1%2520and%2520CK2%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D112%26spage%3D209%26epage%3D216%26doi%3D10.1016%2Fj.ejmech.2016.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Tahtouh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soundararajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durieu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delhommel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberholzer, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreaux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazureau, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9312</span><span class="NLM_x">–</span> <span class="NLM_lpage">9330</span><span class="refDoi"> DOI: 10.1021/jm301034u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301034u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9312-9330&author=T.+Tahtouhauthor=J.+M.+Elkinsauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=G.+Burgyauthor=E.+Durieuauthor=C.+Cochetauthor=R.+S.+Schmidauthor=D.+C.+Loauthor=F.+Delhommelauthor=A.+E.+Oberholzerauthor=L.+H.+Pearlauthor=F.+Carreauxauthor=J.+P.+Bazureauauthor=S.+Knappauthor=L.+Meijer&title=Selectivity%2C+cocrystal+structures%2C+and+neuroprotective+properties+of+leucettines%2C+a+family+of+protein+kinase+inhibitors+derived+from+the+marine+sponge+alkaloid+leucettamine+B&doi=10.1021%2Fjm301034u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B</span></div><div class="casAuthors">Tahtouh, Tania; Elkins, Jonathan M.; Filippakopoulos, Panagis; Soundararajan, Meera; Burgy, Guillaume; Durieu, Emilie; Cochet, Claude; Schmid, Ralf S.; Lo, Donald C.; Delhommel, Florent; Oberholzer, Anselm E.; Pearl, Laurence H.; Carreaux, Francois; Bazureau, Jean-Pierre; Knapp, Stefan; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9312-9330</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRKs (dual specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases) are implicated in the onset and development of Alzheimer's disease and Down syndrome.  The marine sponge alkaloid leucettamine B was recently identified as an inhibitor of DYRKs/CLKs.  Synthesis of analogs (leucettines) led to an optimized product, leucettine L41.  Leucettines were cocrystd. with DYRK1A, DYRK2, CLK3, PIM1, and GSK-3β.  The selectivity of L41 was studied by activity and interaction assays of recombinant kinases and affinity chromatog. and competition affinity assays.  These approaches revealed unexpected potential secondary targets such as CK2, SLK, and the lipid kinase PIKfyve/Vac14.  L41 displayed neuroprotective effects on glutamate-induced HT22 cell death.  L41 also reduced amyloid precursor protein-induced cell death in cultured rat brain slices.  The unusual multitarget selectivity of leucettines may account for their neuroprotective effects.  This family of kinase inhibitors deserves further optimization as potential therapeutics against neurodegenerative diseases such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhwr44JiuCrVg90H21EOLACvtfcHk0lh1CP8bbJ_e6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF&md5=a1749c347c2e8e0409d8fdd475dc70f9</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm301034u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301034u%26sid%3Dliteratum%253Aachs%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DR.%2BS.%26aulast%3DLo%26aufirst%3DD.%2BC.%26aulast%3DDelhommel%26aufirst%3DF.%26aulast%3DOberholzer%26aufirst%3DA.%2BE.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.%2BP.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DSelectivity%252C%2520cocrystal%2520structures%252C%2520and%2520neuroprotective%2520properties%2520of%2520leucettines%252C%2520a%2520family%2520of%2520protein%2520kinase%2520inhibitors%2520derived%2520from%2520the%2520marine%2520sponge%2520alkaloid%2520leucettamine%2520B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9312%26epage%3D9330%26doi%3D10.1021%2Fjm301034u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The specificities of protein kinase inhibitors: an update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.1042/bj20021535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1042%2Fbj20021535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=12534346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=199-204&author=J.+Bainauthor=H.+McLauchlanauthor=M.+Elliottauthor=P.+Cohen&title=The+specificities+of+protein+kinase+inhibitors%3A+an+update&doi=10.1042%2Fbj20021535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The specificities of protein kinase inhibitors: an update</span></div><div class="casAuthors">Bain, Jenny; McLauchlan, Hilary; Elliott, Matthew; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-204</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">We have previously examd. the specificities of 28 com. available compds., reported to be relatively selective inhibitors of particular serine/threonine-specific protein kinases.  In the present study, we have extended this anal. to a further 14 compds.  Of these, indirubin-3'-monoxime, SP 600125, KT 5823 and ML-9 were found to inhibit a no. of protein kinases and conclusions drawn from their use in cell-based assays are likely to be erroneous.  Kenpaullone, Alsterpaullone, Purvalanol, Roscovitine, pyrazolopyrimidine 1 (PP1), PP2 and ML-7 were more specific, but still inhibited two or more protein kinases with similar potency.  Our results suggest that the combined use of Roscovitine and Kenpaullone may be useful for identifying substrates and physiol. roles of cyclin-dependent protein kinases, whereas the combined use of Kenpaullone and LiCl may be useful for identifying substrates and physiol. roles of glycogen synthase kinase 3.  The combined use of SU 6656 and either PP1 or PP2 may be useful for identifying substrates of Src family members.  Epigallocatechin 3-gallate, one of the main polyphenolic constituents of tea, inhibited two of the 28 protein kinases in the panel, dual-specificity, tyrosine-phosphorylated and regulated kinase 1A (DYRK1A; IC50 = 0.33 μM) and p38-regulated/activated kinase (PRAK; IC50 = 1.0 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKsdbPJWI3krVg90H21EOLACvtfcHk0lgWCLXPP2Zpzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D&md5=f1cd5b518b683906b398d9bb79dc14fc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1042%2Fbj20021535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021535%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520specificities%2520of%2520protein%2520kinase%2520inhibitors%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D199%26epage%3D204%26doi%3D10.1042%2Fbj20021535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Anastassiadis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devarajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. R.</span><span> </span><span class="NLM_article-title">Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1045</span><span class="refDoi"> DOI: 10.1038/nbt.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1038%2Fnbt.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=22037377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1039-1045&author=T.+Anastassiadisauthor=S.+W.+Deaconauthor=K.+Devarajanauthor=H.+Maauthor=J.+R.+Peterson&title=Comprehensive+assay+of+kinase+catalytic+activity+reveals+features+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity</span></div><div class="casAuthors">Anastassiadis, Theonie; Deacon, Sean W.; Devarajan, Karthik; Ma, Haiching; Peterson, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1039-1045</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small-mol. protein kinase inhibitors are widely used to elucidate cellular signaling pathways and are promising therapeutic agents.  Owing to evolutionary conservation of the ATP-binding site, most kinase inhibitors that target this site promiscuously inhibit multiple kinases.  Interpretation of expts. that use these compds. is confounded by a lack of data on the comprehensive kinase selectivity of most inhibitors.  Here we used functional assays to profile the activity of 178 com. available kinase inhibitors against a panel of 300 recombinant protein kinases.  Quant. anal. revealed complex and often unexpected interactions between protein kinases and kinase inhibitors, with a wide spectrum of promiscuity.  Many off-target interactions occur with seemingly unrelated kinases, revealing how large-scale profiling can identify multitargeted inhibitors of specific, diverse kinases.  The results have implications for drug development and provide a resource for selecting compds. to elucidate kinase function and for interpreting the results of expts. involving kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUljWIhZGPkrVg90H21EOLACvtfcHk0lgWCLXPP2Zpzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisL7E&md5=b2f705509b0e09afa46b01d4669f0515</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2017%26sid%3Dliteratum%253Aachs%26aulast%3DAnastassiadis%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DS.%2BW.%26aulast%3DDevarajan%26aufirst%3DK.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DPeterson%26aufirst%3DJ.%2BR.%26atitle%3DComprehensive%2520assay%2520of%2520kinase%2520catalytic%2520activity%2520reveals%2520features%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1039%26epage%3D1045%26doi%3D10.1038%2Fnbt.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Cuny, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulyanova, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pique, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glicksman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, J. M.</span><span> </span><span class="NLM_article-title">Structure-activity relationship study of acridine analogs as haspin and DYRK2 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3491</span><span class="NLM_x">–</span> <span class="NLM_lpage">3494</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.04.150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1016%2Fj.bmcl.2010.04.150" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3491-3494&author=G.+D.+Cunyauthor=M.+Robinauthor=N.+P.+Ulyanovaauthor=D.+Patnaikauthor=V.+Piqueauthor=G.+Casanoauthor=J.+F.+Liuauthor=X.+Linauthor=J.+Xianauthor=M.+A.+Glicksmanauthor=R.+L.+Steinauthor=J.+M.+Higgins&title=Structure-activity+relationship+study+of+acridine+analogs+as+haspin+and+DYRK2+kinase+inhibitors&doi=10.1016%2Fj.bmcl.2010.04.150"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.04.150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.04.150%26sid%3Dliteratum%253Aachs%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DRobin%26aufirst%3DM.%26aulast%3DUlyanova%26aufirst%3DN.%2BP.%26aulast%3DPatnaik%26aufirst%3DD.%26aulast%3DPique%26aufirst%3DV.%26aulast%3DCasano%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DXian%26aufirst%3DJ.%26aulast%3DGlicksman%26aufirst%3DM.%2BA.%26aulast%3DStein%26aufirst%3DR.%2BL.%26aulast%3DHiggins%26aufirst%3DJ.%2BM.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520acridine%2520analogs%2520as%2520haspin%2520and%2520DYRK2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3491%26epage%3D3494%26doi%3D10.1016%2Fj.bmcl.2010.04.150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 19 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yan-Long Zheng, <span class="NLM_string-name hlFld-ContribAuthor">Stephen G. Newman</span>. </span><span class="cited-content_cbyCitation_article-title">Methyl Esters as Cross-Coupling Electrophiles: Direct Synthesis of Amide Bonds. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2019,</strong> <em>9 </em>
                                    (5)
                                     , 4426-4433. <a href="https://doi.org/10.1021/acscatal.9b00884" title="DOI URL">https://doi.org/10.1021/acscatal.9b00884</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.9b00884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.9b00884%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DMethyl%252BEsters%252Bas%252BCross-Coupling%252BElectrophiles%25253A%252BDirect%252BSynthesis%252Bof%252BAmide%252BBonds%26aulast%3DZheng%26aufirst%3DYan-Long%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D28022019%26date%3D02042019%26date%3D18042019%26volume%3D9%26issue%3D5%26spage%3D4426%26epage%3D4433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Benoît Bestgen, Irina Kufareva, Weiguang Seetoh, Chris Abell, Rolf W. Hartmann, Ruben Abagyan, Marc Le Borgne, Odile Filhol, Claude Cochet, Thierry Lomberget, <span class="NLM_string-name hlFld-ContribAuthor">Matthias Engel</span>. </span><span class="cited-content_cbyCitation_article-title">2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 1817-1836. <a href="https://doi.org/10.1021/acs.jmedchem.8b01765" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01765</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01765%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2-Aminothiazole%252BDerivatives%252Bas%252BSelective%252BAllosteric%252BModulators%252Bof%252Bthe%252BProtein%252BKinase%252BCK2.%252B2.%252BStructure-Based%252BOptimization%252Band%252BInvestigation%252Bof%252BEffects%252BSpecific%252Bto%252Bthe%252BAllosteric%252BMode%252Bof%252BAction%26aulast%3DBestgen%26aufirst%3DBeno%25C3%25AEt%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D13112018%26date%3D13022019%26date%3D28012019%26volume%3D62%26issue%3D4%26spage%3D1817%26epage%3D1836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Benoît Bestgen, Isabelle Krimm, Irina Kufareva, Ahmed Ashraf Moustafa Kamal, Wei-Guang Seetoh, Chris Abell, Rolf W. Hartmann, Ruben Abagyan, Claude Cochet, Marc Le Borgne, Matthias Engel, <span class="NLM_string-name hlFld-ContribAuthor">Thierry Lomberget</span>. </span><span class="cited-content_cbyCitation_article-title">2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 1803-1816. <a href="https://doi.org/10.1021/acs.jmedchem.8b01766" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01766</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01766%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2-Aminothiazole%252BDerivatives%252Bas%252BSelective%252BAllosteric%252BModulators%252Bof%252Bthe%252BProtein%252BKinase%252BCK2.%252B1.%252BIdentification%252Bof%252Ban%252BAllosteric%252BBinding%252BSite%26aulast%3DBestgen%26aufirst%3DBeno%25C3%25AEt%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D13112018%26date%3D18022019%26date%3D28012019%26volume%3D62%26issue%3D4%26spage%3D1803%26epage%3D1816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samdani  Ansar</span>, <span class="hlFld-ContribAuthor ">Umashankar  Vetrivel</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design of small molecule and peptide inhibitors for selective targeting of ROCK1: an integrative computational approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>10 </em>, 1-19. <a href="https://doi.org/10.1080/07391102.2021.1898470" title="DOI URL">https://doi.org/10.1080/07391102.2021.1898470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1898470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1898470%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DStructure-based%252Bdesign%252Bof%252Bsmall%252Bmolecule%252Band%252Bpeptide%252Binhibitors%252Bfor%252Bselective%252Btargeting%252Bof%252BROCK1%25253A%252Ban%252Bintegrative%252Bcomputational%252Bapproach%26aulast%3DAnsar%26aufirst%3DSamdani%26date%3D2021%26date%3D2021%26volume%3D10%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed K.  ElHady</span>, <span class="hlFld-ContribAuthor ">Dalia S.  El-Gamil</span>, <span class="hlFld-ContribAuthor ">Po-Jen  Chen</span>, <span class="hlFld-ContribAuthor ">Tsong-Long  Hwang</span>, <span class="hlFld-ContribAuthor ">Ashraf H.  Abadi</span>, <span class="hlFld-ContribAuthor ">Mohammad  Abdel-Halim</span>, <span class="hlFld-ContribAuthor ">Matthias  Engel</span>. </span><span class="cited-content_cbyCitation_article-title">5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (4)
                                     , 1001. <a href="https://doi.org/10.3390/molecules26041001" title="DOI URL">https://doi.org/10.3390/molecules26041001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26041001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26041001%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3D5-Methoxybenzothiophene-2-Carboxamides%252Bas%252BInhibitors%252Bof%252BClk1%25252F4%25253A%252BOptimization%252Bof%252BSelectivity%252Band%252BCellular%252BPotency%26aulast%3DElHady%26aufirst%3DAhmed%2BK.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D4%26spage%3D1001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonietta Rosella  Farina</span>, <span class="hlFld-ContribAuthor ">Lucia  Cappabianca</span>, <span class="hlFld-ContribAuthor ">Michela  Sebastiano</span>, <span class="hlFld-ContribAuthor ">Veronica  Zelli</span>, <span class="hlFld-ContribAuthor ">Stefano  Guadagni</span>, <span class="hlFld-ContribAuthor ">Andrew Reay  Mackay</span>. </span><span class="cited-content_cbyCitation_article-title">Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2020,</strong> <em>39 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-020-01616-9" title="DOI URL">https://doi.org/10.1186/s13046-020-01616-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-020-01616-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-020-01616-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DHypoxia-induced%252Balternative%252Bsplicing%25253A%252Bthe%252B11th%252BHallmark%252Bof%252BCancer%26aulast%3DFarina%26aufirst%3DAntonietta%2BRosella%26date%3D2020%26date%3D2020%26volume%3D39%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Derya Anıl  Aktaş</span>, <span class="hlFld-ContribAuthor ">Gökçen  Akinalp</span>, <span class="hlFld-ContribAuthor ">Fatma  Sanli</span>, <span class="hlFld-ContribAuthor ">Mehmet Ali  Yucel</span>, <span class="hlFld-ContribAuthor ">Nicola  Gambacorta</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Omer Faruk  Karatas</span>, <span class="hlFld-ContribAuthor ">Oztekin  Algul</span>, <span class="hlFld-ContribAuthor ">Serdar  Burmaoglu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 3,5-diaryl isoxazole derivatives as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (19)
                                     , 127427. <a href="https://doi.org/10.1016/j.bmcl.2020.127427" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127427</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127427%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B3%25252C5-diaryl%252Bisoxazole%252Bderivatives%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DAkta%25C5%259F%26aufirst%3DDerya%2BAn%25C4%25B1l%26date%3D2020%26volume%3D30%26issue%3D19%26spage%3D127427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niraj  Babu</span>, <span class="hlFld-ContribAuthor ">Sneha M.  Pinto</span>, <span class="hlFld-ContribAuthor ">Manjusha  Biswas</span>, <span class="hlFld-ContribAuthor ">Tejaswini  Subbannayya</span>, <span class="hlFld-ContribAuthor ">Manoj  Rajappa</span>, <span class="hlFld-ContribAuthor ">Sonali V.  Mohan</span>, <span class="hlFld-ContribAuthor ">Jayshree  Advani</span>, <span class="hlFld-ContribAuthor ">Pavithra  Rajagopalan</span>, <span class="hlFld-ContribAuthor ">Gajanan  Sathe</span>, <span class="hlFld-ContribAuthor ">Nazia  Syed</span>, <span class="hlFld-ContribAuthor ">Vinod D.  Radhakrishna</span>, <span class="hlFld-ContribAuthor ">Oliyarasi  Muthusamy</span>, <span class="hlFld-ContribAuthor ">Sanjay  Navani</span>, <span class="hlFld-ContribAuthor ">Rekha V.  Kumar</span>, <span class="hlFld-ContribAuthor ">Gopal  Gopisetty</span>, <span class="hlFld-ContribAuthor ">Thangarajan  Rajkumar</span>, <span class="hlFld-ContribAuthor ">Padhma  Radhakrishnan</span>, <span class="hlFld-ContribAuthor ">Saravanan  Thiyagarajan</span>, <span class="hlFld-ContribAuthor ">Akhilesh  Pandey</span>, <span class="hlFld-ContribAuthor ">Harsha  Gowda</span>, <span class="hlFld-ContribAuthor ">Pradip  Majumder</span>, <span class="hlFld-ContribAuthor ">Aditi  Chatterjee</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphoproteomic analysis identifies CLK1 as a novel therapeutic target in gastric cancer. </span><span class="cited-content_cbyCitation_journal-name">Gastric Cancer</span><span> <strong>2020,</strong> <em>23 </em>
                                    (5)
                                     , 796-810. <a href="https://doi.org/10.1007/s10120-020-01062-8" title="DOI URL">https://doi.org/10.1007/s10120-020-01062-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10120-020-01062-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10120-020-01062-8%26sid%3Dliteratum%253Aachs%26jtitle%3DGastric%2520Cancer%26atitle%3DPhosphoproteomic%252Banalysis%252Bidentifies%252BCLK1%252Bas%252Ba%252Bnovel%252Btherapeutic%252Btarget%252Bin%252Bgastric%252Bcancer%26aulast%3DBabu%26aufirst%3DNiraj%26date%3D2020%26date%3D2020%26volume%3D23%26issue%3D5%26spage%3D796%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vellanki Ragha  Suma</span>, <span class="hlFld-ContribAuthor ">Reddymasu  Sreenivasulu</span>, <span class="hlFld-ContribAuthor ">Mandava Venkata Basaveswara  Rao</span>, <span class="hlFld-ContribAuthor ">Madala  Subramanyam</span>, <span class="hlFld-ContribAuthor ">Mohamed Jawed  Ahsan</span>, <span class="hlFld-ContribAuthor ">Ramesh  Alluri</span>, <span class="hlFld-ContribAuthor ">Kuppili Ram Mohan  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of chalcone-linked thiazole-imidazopyridine derivatives as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2020,</strong> <em>29 </em>
                                    (9)
                                     , 1643-1654. <a href="https://doi.org/10.1007/s00044-020-02590-9" title="DOI URL">https://doi.org/10.1007/s00044-020-02590-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02590-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02590-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bchalcone-linked%252Bthiazole-imidazopyridine%252Bderivatives%252Bas%252Banticancer%252Bagents%26aulast%3DSuma%26aufirst%3DVellanki%2BRagha%26date%3D2020%26date%3D2020%26volume%3D29%26issue%3D9%26spage%3D1643%26epage%3D1654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Jun  Fu</span>, <span class="hlFld-ContribAuthor ">Jian  Song</span>, <span class="hlFld-ContribAuthor ">Ting  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiao-Jing  Pang</span>, <span class="hlFld-ContribAuthor ">Sheng-Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Yan-Bing  Zhang</span>, <span class="hlFld-ContribAuthor ">Bo-Wen  Wu</span>, <span class="hlFld-ContribAuthor ">Jun-Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Zi</span>, <span class="hlFld-ContribAuthor ">Sai-Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel tertiary amide derivatives as NEDDylation pathway activators to inhibit the tumor progression in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>192 </em>, 112153. <a href="https://doi.org/10.1016/j.ejmech.2020.112153" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112153%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Btertiary%252Bamide%252Bderivatives%252Bas%252BNEDDylation%252Bpathway%252Bactivators%252Bto%252Binhibit%252Bthe%252Btumor%252Bprogression%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%26aulast%3DFu%26aufirst%3DDong-Jun%26date%3D2020%26volume%3D192%26spage%3D112153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Feng</span>, <span class="hlFld-ContribAuthor ">Ying  Che</span>, <span class="hlFld-ContribAuthor ">De-Qiang  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular mechanism of action of Liuwei Dihuang pill for the treatment of osteoporosis based on network pharmacology and molecular docking. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Integrative Medicine</span><span> <strong>2020,</strong> <em>33 </em>, 101009. <a href="https://doi.org/10.1016/j.eujim.2019.101009" title="DOI URL">https://doi.org/10.1016/j.eujim.2019.101009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.eujim.2019.101009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.eujim.2019.101009%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Integrative%2520Medicine%26atitle%3DMolecular%252Bmechanism%252Bof%252Baction%252Bof%252BLiuwei%252BDihuang%252Bpill%252Bfor%252Bthe%252Btreatment%252Bof%252Bosteoporosis%252Bbased%252Bon%252Bnetwork%252Bpharmacology%252Band%252Bmolecular%252Bdocking%26aulast%3DFeng%26aufirst%3DPeng%26date%3D2020%26volume%3D33%26spage%3D101009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huayao  Li</span>, <span class="hlFld-ContribAuthor ">Lijuan  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Zhuang</span>, <span class="hlFld-ContribAuthor ">Cun  Liu</span>, <span class="hlFld-ContribAuthor ">Chao  Zhou</span>, <span class="hlFld-ContribAuthor ">Jing  Yang</span>, <span class="hlFld-ContribAuthor ">Chundi  Gao</span>, <span class="hlFld-ContribAuthor ">Gongxi  Liu</span>, <span class="hlFld-ContribAuthor ">Changgang  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of key candidate targets and pathways for the targeted treatment of leukemia stem cells of chronic myelogenous leukemia using bioinformatics analysis. </span><span class="cited-content_cbyCitation_journal-name">Molecular Genetics & Genomic Medicine</span><span> <strong>2019,</strong> <em>7 </em>
                                    (9)
                                     <a href="https://doi.org/10.1002/mgg3.851" title="DOI URL">https://doi.org/10.1002/mgg3.851</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mgg3.851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmgg3.851%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Genetics%2520%2526%2520Genomic%2520Medicine%26atitle%3DIdentification%252Bof%252Bkey%252Bcandidate%252Btargets%252Band%252Bpathways%252Bfor%252Bthe%252Btargeted%252Btreatment%252Bof%252Bleukemia%252Bstem%252Bcells%252Bof%252Bchronic%252Bmyelogenous%252Bleukemia%252Busing%252Bbioinformatics%252Banalysis%26aulast%3DLi%26aufirst%3DHuayao%26date%3D2019%26date%3D2019%26volume%3D7%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wael  Zeinyeh</span>, <span class="hlFld-ContribAuthor ">Yannick J.  Esvan</span>, <span class="hlFld-ContribAuthor ">Béatrice  Josselin</span>, <span class="hlFld-ContribAuthor ">Blandine  Baratte</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bach</span>, <span class="hlFld-ContribAuthor ">Lionel  Nauton</span>, <span class="hlFld-ContribAuthor ">Vincent  Théry</span>, <span class="hlFld-ContribAuthor ">Sandrine  Ruchaud</span>, <span class="hlFld-ContribAuthor ">Fabrice  Anizon</span>, <span class="hlFld-ContribAuthor ">Francis  Giraud</span>, <span class="hlFld-ContribAuthor ">Pascale  Moreau</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase inhibitions in pyrido[4,3-h] and [3,4-g]quinazolines: Synthesis, SAR and molecular modeling studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (10)
                                     , 2083-2089. <a href="https://doi.org/10.1016/j.bmc.2019.04.005" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.04.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.04.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DKinase%252Binhibitions%252Bin%252Bpyrido%25255B4%25252C3-h%25255D%252Band%252B%25255B3%25252C4-g%25255Dquinazolines%25253A%252BSynthesis%25252C%252BSAR%252Band%252Bmolecular%252Bmodeling%252Bstudies%26aulast%3DZeinyeh%26aufirst%3DWael%26date%3D2019%26volume%3D27%26issue%3D10%26spage%3D2083%26epage%3D2089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth  Bowler</span>, <span class="hlFld-ContribAuthor ">Sean  Porazinski</span>, <span class="hlFld-ContribAuthor ">Simon  Uzor</span>, <span class="hlFld-ContribAuthor ">Philippe  Thibault</span>, <span class="hlFld-ContribAuthor ">Mathieu  Durand</span>, <span class="hlFld-ContribAuthor ">Elvy  Lapointe</span>, <span class="hlFld-ContribAuthor ">Kasper M. A.  Rouschop</span>, <span class="hlFld-ContribAuthor ">John  Hancock</span>, <span class="hlFld-ContribAuthor ">Ian  Wilson</span>, <span class="hlFld-ContribAuthor ">Michael  Ladomery</span>. </span><span class="cited-content_cbyCitation_article-title">Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells. </span><span class="cited-content_cbyCitation_journal-name">BMC Cancer</span><span> <strong>2018,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12885-018-4227-7" title="DOI URL">https://doi.org/10.1186/s12885-018-4227-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12885-018-4227-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12885-018-4227-7%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Cancer%26atitle%3DHypoxia%252Bleads%252Bto%252Bsignificant%252Bchanges%252Bin%252Balternative%252Bsplicing%252Band%252Belevated%252Bexpression%252Bof%252BCLK%252Bsplice%252Bfactor%252Bkinases%252Bin%252BPC3%252Bprostate%252Bcancer%252Bcells%26aulast%3DBowler%26aufirst%3DElizabeth%26date%3D2018%26date%3D2018%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah S.  Darwish</span>, <span class="hlFld-ContribAuthor ">Mohammad  Abdel-Halim</span>, <span class="hlFld-ContribAuthor ">Ahmed K.  ElHady</span>, <span class="hlFld-ContribAuthor ">Mohamed  Salah</span>, <span class="hlFld-ContribAuthor ">Ashraf H.  Abadi</span>, <span class="hlFld-ContribAuthor ">Walter  Becker</span>, <span class="hlFld-ContribAuthor ">Matthias  Engel</span>. </span><span class="cited-content_cbyCitation_article-title">Development of novel amide–derivatized 2,4-bispyridyl thiophenes as highly potent and selective Dyrk1A inhibitors. Part II: Identification of the cyclopropylamide moiety as a key modification. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 270-285. <a href="https://doi.org/10.1016/j.ejmech.2018.08.097" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.097</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.097%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bnovel%252Bamide%2525E2%252580%252593derivatized%252B2%25252C4-bispyridyl%252Bthiophenes%252Bas%252Bhighly%252Bpotent%252Band%252Bselective%252BDyrk1A%252Binhibitors.%252BPart%252BII%25253A%252BIdentification%252Bof%252Bthe%252Bcyclopropylamide%252Bmoiety%252Bas%252Ba%252Bkey%252Bmodification%26aulast%3DDarwish%26aufirst%3DSarah%2BS.%26date%3D2018%26volume%3D158%26spage%3D270%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah S.  Darwish</span>, <span class="hlFld-ContribAuthor ">Mohammad  Abdel-Halim</span>, <span class="hlFld-ContribAuthor ">Mohamed  Salah</span>, <span class="hlFld-ContribAuthor ">Ashraf H.  Abadi</span>, <span class="hlFld-ContribAuthor ">Walter  Becker</span>, <span class="hlFld-ContribAuthor ">Matthias  Engel</span>. </span><span class="cited-content_cbyCitation_article-title">Development of novel 2,4-bispyridyl thiophene–based compounds as highly potent and selective Dyrk1A inhibitors. Part I: Benzamide and benzylamide derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 1031-1050. <a href="https://doi.org/10.1016/j.ejmech.2018.07.050" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.07.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.07.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.07.050%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bnovel%252B2%25252C4-bispyridyl%252Bthiophene%2525E2%252580%252593based%252Bcompounds%252Bas%252Bhighly%252Bpotent%252Band%252Bselective%252BDyrk1A%252Binhibitors.%252BPart%252BI%25253A%252BBenzamide%252Band%252Bbenzylamide%252Bderivatives%26aulast%3DDarwish%26aufirst%3DSarah%2BS.%26date%3D2018%26volume%3D157%26spage%3D1031%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon  Uzor</span>, <span class="hlFld-ContribAuthor ">Panagiota  Zorzou</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Bowler</span>, <span class="hlFld-ContribAuthor ">Sean  Porazinski</span>, <span class="hlFld-ContribAuthor ">Ian  Wilson</span>, <span class="hlFld-ContribAuthor ">Michael  Ladomery</span>. </span><span class="cited-content_cbyCitation_article-title">Autoregulation of the human splice factor kinase CLK1 through exon skipping and intron retention. </span><span class="cited-content_cbyCitation_journal-name">Gene</span><span> <strong>2018,</strong> <em>670 </em>, 46-54. <a href="https://doi.org/10.1016/j.gene.2018.05.095" title="DOI URL">https://doi.org/10.1016/j.gene.2018.05.095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.gene.2018.05.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.gene.2018.05.095%26sid%3Dliteratum%253Aachs%26jtitle%3DGene%26atitle%3DAutoregulation%252Bof%252Bthe%252Bhuman%252Bsplice%252Bfactor%252Bkinase%252BCLK1%252Bthrough%252Bexon%252Bskipping%252Band%252Bintron%252Bretention%26aulast%3DUzor%26aufirst%3DSimon%26date%3D2018%26volume%3D670%26spage%3D46%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne  Walter</span>, <span class="hlFld-ContribAuthor ">Apirat  Chaikuad</span>, <span class="hlFld-ContribAuthor ">Renate  Helmer</span>, <span class="hlFld-ContribAuthor ">Nadège  Loaëc</span>, <span class="hlFld-ContribAuthor ">Lutz  Preu</span>, <span class="hlFld-ContribAuthor ">Ingo  Ott</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Conrad  Kunick</span>, . </span><span class="cited-content_cbyCitation_article-title">Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2018,</strong> <em>13 </em>
                                    (5)
                                     , e0196761. <a href="https://doi.org/10.1371/journal.pone.0196761" title="DOI URL">https://doi.org/10.1371/journal.pone.0196761</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0196761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0196761%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DMolecular%252Bstructures%252Bof%252Bcdc2-like%252Bkinases%252Bin%252Bcomplex%252Bwith%252Ba%252Bnew%252Binhibitor%252Bchemotype%26aulast%3DWalter%26aufirst%3DAnne%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D5%26spage%3De0196761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Salah</span>, <span class="hlFld-ContribAuthor ">Mohammad  Abdel-Halim</span>, <span class="hlFld-ContribAuthor ">Matthias  Engel</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of conformationally constraint Dyrk1A inhibitors by creating an intramolecular H-bond involving a benzothiazole core. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (6)
                                     , 1045-1053. <a href="https://doi.org/10.1039/C8MD00142A" title="DOI URL">https://doi.org/10.1039/C8MD00142A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00142A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00142A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bconformationally%252Bconstraint%252BDyrk1A%252Binhibitors%252Bby%252Bcreating%252Ban%252Bintramolecular%252BH-bond%252Binvolving%252Ba%252Bbenzothiazole%252Bcore%26aulast%3DSalah%26aufirst%3DMohamed%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D6%26spage%3D1045%26epage%3D1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01915&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. From previous hit compounds against Clk1 to the design of a diverse library of methoxybenzothiophene amides. Previously identified co-inhibitors of Clk1 and Dyrk1A such as <b>28</b> could be downsized to the fragment-like compound <b>29</b> without loss of potency, and the carboxamide derivative <b>30</b> was also tolerated by the Clk1 binding site.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a>A hypothetical binding model was derived, in which both <i>N</i>- and <i>O</i>-methyl groups of <b>30</b> pointed outside the ATP-binding pocket (marked by small yellow circles); thus, several H-bond donor/acceptor functions (e.g., from the peptide backbones of Ala171 and Glu292), an acidic (Asp325), and an aromatic moiety (Phe172) were all located within a 4.5 Å radius (large yellow circle), which could potentially be addressed by amide-linked molecule extensions. Following these considerations, a focused library of methoxybenzothiophene amides was designed and synthesized (see <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01915&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1a</b>–<b>27a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01915&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) K<sub>2</sub>CO<sub>3</sub> in DMF at 0 °C, 1.2 equiv of ethyl thioglyoclate, 20 min, 1 equiv of 2-fluoro-5-methoxybenzaldehyde in DMF, 70 °C, 4 h; (ii) 4 equiv of KOH in ethanol/water, 80 °C, 3 h; (iii) 2 equiv of HBTU, 4 equiv of triethylamine, 4 equiv of the appropriate amine in DCM, room temperature, overnight.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of N-Methylated Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01915&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 3 equiv of KHMDS, 0 °C, 1 h, 1.5 equiv of CH<sub>3</sub>I, room temperature, 24 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Carboxylic Acids <b>8c</b>–<b>10c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01915&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 4 equiv of KOH in ethanol/water, 80 °C, 3 h.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Model for the hypothetical interaction of <b>21b</b> with Clk1 as supported by the SAR. <b>21b</b> (cyan) was docked into the ATP binding-pocket of Clk1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z57">1Z57</a>) using MOE. Some residues that might be important for the binding are labeled. In the binding model, <b>21b</b> is anchored between the conserved Lys191 and the hinge region residue Leu244 via two hydrogen bonds (indicated in red). In addition, two CH−π interactions involving Val324 and an edge-to-face CH−π interaction with the Phe241 benzene ring were predicted. The 3-fluorophenyl ring probably binds in a partially lipophilic pocket enframed by the glycine-rich loop, also involving an orthogonal dipolar interaction of the 3-fluorine with the Glu169 carbonyl. Interactions are indicated by dashed lines, and distances between the heavy atoms are given in Å (H-bonds, red; CH−π and orthogonal dipolar interactions, brown). In the color code of the ATP binding pocket surface, green denotes the most lipophilic and magenta the most hydrophilic areas.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01915&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/medium/jm-2016-019157_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0011.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>21b</b> induces cellular depletion of cancer-relevant proteins. T24 (A) and MDA-MB-231 cells (B) were treated by <b>21b</b> and the weak Clk1 inhibitor <b>21a</b> as a comparison for 3 days at the indicated concentrations. The total cellular proteins extracted from the cells were analyzed by immunoblotting using a set of antibodies directed against eight cancer-related proteins (EGFR, p70S6 kinase α, PARP-1, ERK2, HDAC1, CD44, PCNA, GRP94). Shown are the signals belonging to proteins that were significantly reduced depending on the <b>21b</b> concentrations; for comparison, one of the unchanged signal sets is also exemplarily shown (corresponding to CD44). In parts A and B, one representative result out of two separate experiments is shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01915/20170707/images/large/jm-2016-019157_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01915&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Duncan, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojdl, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marius, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheit, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, J. C.</span><span> </span><span class="NLM_article-title">The Clk2 and Clk3 dual-specificity protein kinases regulate the intranuclear distribution of SR proteins and influence pre-mRNA splicing</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">241</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span><span class="refDoi"> DOI: 10.1006/excr.1998.4083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1006%2Fexcr.1998.4083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=9637771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADyaK1cXktVShsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=1998&pages=300-308&author=P.+I.+Duncanauthor=D.+F.+Stojdlauthor=R.+M.+Mariusauthor=K.+H.+Scheitauthor=J.+C.+Bell&title=The+Clk2+and+Clk3+dual-specificity+protein+kinases+regulate+the+intranuclear+distribution+of+SR+proteins+and+influence+pre-mRNA+splicing&doi=10.1006%2Fexcr.1998.4083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Clk2 and Clk3 dual-specificity protein kinases regulate the intranuclear distribution of SR proteins and influence pre-mRNA splicing</span></div><div class="casAuthors">Duncan, Peter I.; Stojdl, David F.; Marius, Ricardo M.; Scheit, Karl H.; Bell, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-308</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The three members of the Clk family of kinases (Clk1, 2, and 3) have been shown to undergo conserved alternative splicing to generate catalytically active (Clk) and inactive (ClkT) isoforms.  The prototype, murine Clk1 (mClk1), is a nuclear dual-specificity kinase that can interact with, and cause the nuclear redistribution of, SR proteins.  In this study, we demonstrate that the human Clk2 and Clk3 (hClk2 and 3) are also found within the nucleus and display dual-specificity kinase activity.  The truncated isoforms, hClk2T and hClk3T, colocalize with SR proteins in nuclear speckles.  We also show catalytically active hClk2 and hClk3 cause the redistribution of SR proteins and can regulate the alternative splicing of a model precursor mRNA substrate in vivo.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozcPUoUEj-ArVg90H21EOLACvtfcHk0ljn74McREhdxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktVShsbY%253D&md5=470be0643b247eefc754e0865439cdb0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1006%2Fexcr.1998.4083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.1998.4083%26sid%3Dliteratum%253Aachs%26aulast%3DDuncan%26aufirst%3DP.%2BI.%26aulast%3DStojdl%26aufirst%3DD.%2BF.%26aulast%3DMarius%26aufirst%3DR.%2BM.%26aulast%3DScheit%26aufirst%3DK.%2BH.%26aulast%3DBell%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520Clk2%2520and%2520Clk3%2520dual-specificity%2520protein%2520kinases%2520regulate%2520the%2520intranuclear%2520distribution%2520of%2520SR%2520proteins%2520and%2520influence%2520pre-mRNA%2520splicing%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1998%26volume%3D241%26spage%3D300%26epage%3D308%26doi%3D10.1006%2Fexcr.1998.4083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Menegay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeslein, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G.</span><span> </span><span class="NLM_article-title">The dual specificity protein kinase CLK3 is abundantly expressed in mature mouse spermatozoa</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span><span class="refDoi"> DOI: 10.1006/excr.1999.4655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1006%2Fexcr.1999.4655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10585269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADyaK1MXns1anu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1999&pages=463-473&author=H.+Menegayauthor=F.+Moesleinauthor=G.+Landreth&title=The+dual+specificity+protein+kinase+CLK3+is+abundantly+expressed+in+mature+mouse+spermatozoa&doi=10.1006%2Fexcr.1999.4655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The Dual Specificity Protein Kinase CLK3 Is Abundantly Expressed in Mature Mouse Spermatozoa</span></div><div class="casAuthors">Menegay, Harry; Moeslein, Fred; Landreth, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">463-473</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">CLK3, a member of the LAMMER family of dual-specificity protein kinases, is abundantly expressed in the reproductive system of male mice.  Specifically, high levels of CLK3 protein expression are found in mature spermatozoa in the testis and epididymis.  The majority of the CLK3 protein in the testis is a full-length kinase-contg. form, and only a small amt. of a catalytically inactive N-terminally truncated splice variant protein product is obsd.  Within the mature spermatozoa CLK3 is localized to the acrosome and tail.  CLK3 is expelled from the sperm following the acrosome reaction and inactivated, likely by degrdn. by the proteases released by the sperm during the acrosome reaction.  The CLK family of kinases has previously been implicated in mRNA splicing; however, the bulk of the CLK3 protein in these cells is located in the cytoplasm, suggesting that CLK3 may have addnl. roles in the cell.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoscRF4gBjzvrVg90H21EOLACvtfcHk0lhYs_3dkONFKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXns1anu7k%253D&md5=4a2b48b9388183e95145a5e4919c704f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1006%2Fexcr.1999.4655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.1999.4655%26sid%3Dliteratum%253Aachs%26aulast%3DMenegay%26aufirst%3DH.%26aulast%3DMoeslein%26aufirst%3DF.%26aulast%3DLandreth%26aufirst%3DG.%26atitle%3DThe%2520dual%2520specificity%2520protein%2520kinase%2520CLK3%2520is%2520abundantly%2520expressed%2520in%2520mature%2520mouse%2520spermatozoa%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1999%26volume%3D253%26spage%3D463%26epage%3D473%26doi%3D10.1006%2Fexcr.1999.4655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balachandran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray-Owen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochrane, A.</span><span> </span><span class="NLM_article-title">Differential effect of CLK SR kinases on HIV-1 gene expression: potential novel targets for therapy</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="refDoi"> DOI: 10.1186/1742-4690-8-47</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1186%2F1742-4690-8-47" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=47&author=R.+Wongauthor=A.+Balachandranauthor=A.+Y.+Maoauthor=W.+Dobsonauthor=S.+Gray-Owenauthor=A.+Cochrane&title=Differential+effect+of+CLK+SR+kinases+on+HIV-1+gene+expression%3A+potential+novel+targets+for+therapy&doi=10.1186%2F1742-4690-8-47"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-8-47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-8-47%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DR.%26aulast%3DBalachandran%26aufirst%3DA.%26aulast%3DMao%26aufirst%3DA.%2BY.%26aulast%3DDobson%26aufirst%3DW.%26aulast%3DGray-Owen%26aufirst%3DS.%26aulast%3DCochrane%26aufirst%3DA.%26atitle%3DDifferential%2520effect%2520of%2520CLK%2520SR%2520kinases%2520on%2520HIV-1%2520gene%2520expression%253A%2520potential%2520novel%2520targets%2520for%2520therapy%26jtitle%3DRetrovirology%26date%3D2011%26volume%3D8%26spage%3D47%26doi%3D10.1186%2F1742-4690-8-47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debreczeni, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rellos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niesen, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papagrigoriou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amos, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span><span class="refDoi"> DOI: 10.1016/j.str.2008.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1016%2Fj.str.2008.12.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=352-362&author=A.+N.+Bullockauthor=S.+Dasauthor=J.+E.+Debreczeniauthor=P.+Rellosauthor=O.+Fedorovauthor=F.+H.+Niesenauthor=K.+Guoauthor=E.+Papagrigoriouauthor=A.+L.+Amosauthor=S.+Choauthor=B.+E.+Turkauthor=G.+Ghoshauthor=S.+Knapp&title=Kinase+domain+insertions+define+distinct+roles+of+CLK+kinases+in+SR+protein+phosphorylation&doi=10.1016%2Fj.str.2008.12.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2008.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2008.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DDebreczeni%26aufirst%3DJ.%2BE.%26aulast%3DRellos%26aufirst%3DP.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DNiesen%26aufirst%3DF.%2BH.%26aulast%3DGuo%26aufirst%3DK.%26aulast%3DPapagrigoriou%26aufirst%3DE.%26aulast%3DAmos%26aufirst%3DA.%2BL.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DTurk%26aufirst%3DB.%2BE.%26aulast%3DGhosh%26aufirst%3DG.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DKinase%2520domain%2520insertions%2520define%2520distinct%2520roles%2520of%2520CLK%2520kinases%2520in%2520SR%2520protein%2520phosphorylation%26jtitle%3DStructure%26date%3D2009%26volume%3D17%26spage%3D352%26epage%3D362%26doi%3D10.1016%2Fj.str.2008.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Colwill, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeakley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cáceres, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X. D.</span><span> </span><span class="NLM_article-title">SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">24569</span><span class="NLM_x">–</span> <span class="NLM_lpage">24575</span><span class="refDoi"> DOI: 10.1074/jbc.271.40.24569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1074%2Fjbc.271.40.24569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=8798720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADyaK28XmtFehsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=24569-24575&author=K.+Colwillauthor=L.+L.+Fengauthor=J.+M.+Yeakleyauthor=G.+D.+Gishauthor=J.+F.+C%C3%A1ceresauthor=T.+Pawsonauthor=X.+D.+Fu&title=SRPK1+and+Clk%2FSty+protein+kinases+show+distinct+substrate+specificities+for+serine%2Farginine-rich+splicing+factors&doi=10.1074%2Fjbc.271.40.24569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors</span></div><div class="casAuthors">Colwill, Karen; Feng, Lana L.; Yeakley, Joanne M.; Gish, Gerald D.; Caceres, Javier F.; Pawson, Tony; Fu, Xiang-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">24569-24575</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Serine/arginine-rich (SR) proteins are essential for pre-mRNA splicing, and modify the choice of splice site during alternative splicing in a process apparently regulated by protein phosphorylation.  Two protein kinases have been cloned that can phosphorylate SR proteins in vitro: SRPK1 and Clk/Sty.  These 2 kinases are shown to phosphorylate the same SR proteins in vitro, but SRPK1 has the higher specific activity toward ASF/SF2.  SRPK1, like Clk/Sty, phosphorylates ASF/SF2 in vitro on sites that are also phosphorylated in vivo.  Tryptic peptide mapping of ASF/SF2 revealed that 3 of the phosphopeptides from full-length ASF/SF2 phosphorylated in vitro contain consecutive phosphoserine-arginine residues or phosphoserine-proline residues.  In vitro, the Clk/Sty kinase phosphorylated Ser-Arg, Ser-Lys, or Ser-Pro sites, whereas SRPK1 had a strong preference for Ser-Arg sites.  These results suggest that SRPK1 and Clk/Sty may play different roles in regulating SR splicing factors, and suggest that Clk/Sty has a broader substrate specificity than SRPK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRlThMXIzMFrVg90H21EOLACvtfcHk0lhYs_3dkONFKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtFehsLs%253D&md5=03cbddc0f785f952147945c61381acdc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.40.24569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.40.24569%26sid%3Dliteratum%253Aachs%26aulast%3DColwill%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DL.%2BL.%26aulast%3DYeakley%26aufirst%3DJ.%2BM.%26aulast%3DGish%26aufirst%3DG.%2BD.%26aulast%3DC%25C3%25A1ceres%26aufirst%3DJ.%2BF.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DFu%26aufirst%3DX.%2BD.%26atitle%3DSRPK1%2520and%2520Clk%252FSty%2520protein%2520kinases%2520show%2520distinct%2520substrate%2520specificities%2520for%2520serine%252Farginine-rich%2520splicing%2520factors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D24569%26epage%3D24575%26doi%3D10.1074%2Fjbc.271.40.24569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Eisenreich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdanov, V. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakrzewicz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pries, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antoniak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poller, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultheiss, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, U.</span><span> </span><span class="NLM_article-title">Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span><span class="refDoi"> DOI: 10.1161/CIRCRESAHA.108.183905</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1161%2FCIRCRESAHA.108.183905" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2009&pages=589-599&author=A.+Eisenreichauthor=V.+Y.+Bogdanovauthor=A.+Zakrzewiczauthor=A.+Priesauthor=S.+Antoniakauthor=W.+Pollerauthor=H.+P.+Schultheissauthor=U.+Rauch&title=Cdc2-like+kinases+and+DNA+topoisomerase+I+regulate+alternative+splicing+of+tissue+factor+in+human+endothelial+cells&doi=10.1161%2FCIRCRESAHA.108.183905"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.108.183905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.108.183905%26sid%3Dliteratum%253Aachs%26aulast%3DEisenreich%26aufirst%3DA.%26aulast%3DBogdanov%26aufirst%3DV.%2BY.%26aulast%3DZakrzewicz%26aufirst%3DA.%26aulast%3DPries%26aufirst%3DA.%26aulast%3DAntoniak%26aufirst%3DS.%26aulast%3DPoller%26aufirst%3DW.%26aulast%3DSchultheiss%26aufirst%3DH.%2BP.%26aulast%3DRauch%26aufirst%3DU.%26atitle%3DCdc2-like%2520kinases%2520and%2520DNA%2520topoisomerase%2520I%2520regulate%2520alternative%2520splicing%2520of%2520tissue%2520factor%2520in%2520human%2520endothelial%2520cells%26jtitle%3DCirc.%2520Res.%26date%3D2009%26volume%3D104%26spage%3D589%26epage%3D599%26doi%3D10.1161%2FCIRCRESAHA.108.183905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conaway, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford Bethard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Ayoubi, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson Bradley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weed, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eblen, S. T.</span><span> </span><span class="NLM_article-title">Phosphorylation of the alternative mRNA splicing factor 45 (SPF45) by Clk1 regulates its splice site utilization, cell migration and invasion</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4949</span><span class="NLM_x">–</span> <span class="NLM_lpage">4962</span><span class="refDoi"> DOI: 10.1093/nar/gkt170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1093%2Fnar%2Fgkt170" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=4949-4962&author=Y.+Liuauthor=L.+Conawayauthor=J.+Rutherford+Bethardauthor=A.+M.+Al-Ayoubiauthor=A.+Thompson+Bradleyauthor=H.+Zhengauthor=S.+A.+Weedauthor=S.+T.+Eblen&title=Phosphorylation+of+the+alternative+mRNA+splicing+factor+45+%28SPF45%29+by+Clk1+regulates+its+splice+site+utilization%2C+cell+migration+and+invasion&doi=10.1093%2Fnar%2Fgkt170"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt170%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DConaway%26aufirst%3DL.%26aulast%3DRutherford%2BBethard%26aufirst%3DJ.%26aulast%3DAl-Ayoubi%26aufirst%3DA.%2BM.%26aulast%3DThompson%2BBradley%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DWeed%26aufirst%3DS.%2BA.%26aulast%3DEblen%26aufirst%3DS.%2BT.%26atitle%3DPhosphorylation%2520of%2520the%2520alternative%2520mRNA%2520splicing%2520factor%252045%2520%2528SPF45%2529%2520by%2520Clk1%2520regulates%2520its%2520splice%2520site%2520utilization%252C%2520cell%2520migration%2520and%2520invasion%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2013%26volume%3D41%26spage%3D4949%26epage%3D4962%26doi%3D10.1093%2Fnar%2Fgkt170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Araki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairiki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyashita, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, O.</span><span> </span><span class="NLM_article-title">Inhibitors of CLK protein kinases suppress cell growth and induce apoptosis by modulating pre-mRNA splicing</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0116929</span><span class="refDoi"> DOI: 10.1371/journal.pone.0116929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1371%2Fjournal.pone.0116929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=25581376" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0116929&author=S.+Arakiauthor=R.+Dairikiauthor=Y.+Nakayamaauthor=A.+Muraiauthor=R.+Miyashitaauthor=M.+Iwataniauthor=T.+Nomuraauthor=O.+Nakanishi&title=Inhibitors+of+CLK+protein+kinases+suppress+cell+growth+and+induce+apoptosis+by+modulating+pre-mRNA+splicing&doi=10.1371%2Fjournal.pone.0116929"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0116929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0116929%26sid%3Dliteratum%253Aachs%26aulast%3DAraki%26aufirst%3DS.%26aulast%3DDairiki%26aufirst%3DR.%26aulast%3DNakayama%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DA.%26aulast%3DMiyashita%26aufirst%3DR.%26aulast%3DIwatani%26aufirst%3DM.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DO.%26atitle%3DInhibitors%2520of%2520CLK%2520protein%2520kinases%2520suppress%2520cell%2520growth%2520and%2520induce%2520apoptosis%2520by%2520modulating%2520pre-mRNA%2520splicing%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0116929%26doi%3D10.1371%2Fjournal.pone.0116929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Jakubauskiene, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilys, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poellinger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanopka, A.</span><span> </span><span class="NLM_article-title">Increased serine-arginine (SR) protein phosphorylation changes pre-mRNA splicing in hypoxia</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">18079</span><span class="NLM_x">–</span> <span class="NLM_lpage">18089</span><span class="refDoi"> DOI: 10.1074/jbc.M115.639690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1074%2Fjbc.M115.639690" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=18079-18089&author=E.+Jakubauskieneauthor=L.+Vilysauthor=Y.+Makinoauthor=L.+Poellingerauthor=A.+Kanopka&title=Increased+serine-arginine+%28SR%29+protein+phosphorylation+changes+pre-mRNA+splicing+in+hypoxia&doi=10.1074%2Fjbc.M115.639690"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.639690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.639690%26sid%3Dliteratum%253Aachs%26aulast%3DJakubauskiene%26aufirst%3DE.%26aulast%3DVilys%26aufirst%3DL.%26aulast%3DMakino%26aufirst%3DY.%26aulast%3DPoellinger%26aufirst%3DL.%26aulast%3DKanopka%26aufirst%3DA.%26atitle%3DIncreased%2520serine-arginine%2520%2528SR%2529%2520protein%2520phosphorylation%2520changes%2520pre-mRNA%2520splicing%2520in%2520hypoxia%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D18079%26epage%3D18089%26doi%3D10.1074%2Fjbc.M115.639690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Eisenreich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakrzewicz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thierbach, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepke, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldin-Lang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultheiss, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pries, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, U.</span><span> </span><span class="NLM_article-title">Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span><span class="refDoi"> DOI: 10.3892/or.2013.2413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.3892%2For.2013.2413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=23604472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Wit7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=462-470&author=A.+Eisenreichauthor=A.+Zakrzewiczauthor=K.+Huberauthor=H.+Thierbachauthor=W.+Pepkeauthor=P.+Goldin-Langauthor=H.+P.+Schultheissauthor=A.+Priesauthor=U.+Rauch&title=Regulation+of+pro-angiogenic+tissue+factor+expression+in+hypoxia-induced+human+lung+cancer+cells&doi=10.3892%2For.2013.2413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells</span></div><div class="casAuthors">Eisenreich, Andreas; Zakrzewicz, Andreas; Huber, Kilian; Thierbach, Hannes; Pepke, Wojciech; Goldin-Lang, Petra; Schultheiss, Heinz-Peter; Pries, Axel; Rauch, Ursula</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">462-470</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Alternative splicing is a key regulatory mechanism for cellular metab. controlling cell proliferation and angiogenesis, both of which are crucial processes for tumorigenesis under hypoxia.  Human cells express two tissue factor (TF) isoforms, alternatively spliced TF (asTF) and 'full length' TF (flTF).  FlTF is the major source of thrombogenicity whereas, the function of sol. asTF, particularly in cancer, is widely unknown.  In the present study, we examd. the impact of alternative splicing on the pro-angiogenic potential and the TF expression pattern of A549 cells under hypoxia.  We focused our efforts toward alternative splicing factors, such as Clk1, and pro-angiogenic proliferation-regulating factors, such as Cyr61.  We further examd. the influence of asTF overexpression on the expression of MCP-1, Cyr61 and VEGF, as well as on cell no. and pro-angiogenic properties of A549 cells.  Notably, we found hypoxia to induce the expression of alternative splicing factors (Clk1 and Clk4) as well as proliferation- and angiogenesis-promoting factors (Cyr61 and flTF).  AsTF overexpression in A549 cells also increased both cell no. and tube formation.  These effects were mediated by the induction of Cyr61, MCP-1 and VEGF, as well as by integrin αvβ3.  Taken together, our results suggest that the pro-angiogenic potential of A549 lung cancer cells is modulated under hypoxic conditions via modulation of TF isoform expression which in turn is controlled by alternative splicing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrymkTrMsmF7Vg90H21EOLACvtfcHk0li26RUkLzPNOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Wit7fJ&md5=22fb1eca27baaf2921b8b04eb6405b44</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3892%2For.2013.2413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2013.2413%26sid%3Dliteratum%253Aachs%26aulast%3DEisenreich%26aufirst%3DA.%26aulast%3DZakrzewicz%26aufirst%3DA.%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DThierbach%26aufirst%3DH.%26aulast%3DPepke%26aufirst%3DW.%26aulast%3DGoldin-Lang%26aufirst%3DP.%26aulast%3DSchultheiss%26aufirst%3DH.%2BP.%26aulast%3DPries%26aufirst%3DA.%26aulast%3DRauch%26aufirst%3DU.%26atitle%3DRegulation%2520of%2520pro-angiogenic%2520tissue%2520factor%2520expression%2520in%2520hypoxia-induced%2520human%2520lung%2520cancer%2520cells%26jtitle%3DOncol.%2520Rep.%26date%3D2013%26volume%3D30%26spage%3D462%26epage%3D470%26doi%3D10.3892%2For.2013.2413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Capra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuciforo, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Confalonieri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quarto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebuloni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boldorini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallotti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viale, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gishizky, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draetta, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, P. P.</span><span> </span><span class="NLM_article-title">Frequent alterations in the expression of serine/threonine kinases in human cancers</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8147</span><span class="NLM_x">–</span> <span class="NLM_lpage">8154</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-3489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1158%2F0008-5472.CAN-05-3489" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=8147-8154&author=M.+Capraauthor=P.+G.+Nuciforoauthor=S.+Confalonieriauthor=M.+Quartoauthor=M.+Bianchiauthor=M.+Nebuloniauthor=R.+Boldoriniauthor=F.+Pallottiauthor=G.+Vialeauthor=M.+L.+Gishizkyauthor=G.+F.+Draettaauthor=P.+P.+Di+Fiore&title=Frequent+alterations+in+the+expression+of+serine%2Fthreonine+kinases+in+human+cancers&doi=10.1158%2F0008-5472.CAN-05-3489"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-3489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-3489%26sid%3Dliteratum%253Aachs%26aulast%3DCapra%26aufirst%3DM.%26aulast%3DNuciforo%26aufirst%3DP.%2BG.%26aulast%3DConfalonieri%26aufirst%3DS.%26aulast%3DQuarto%26aufirst%3DM.%26aulast%3DBianchi%26aufirst%3DM.%26aulast%3DNebuloni%26aufirst%3DM.%26aulast%3DBoldorini%26aufirst%3DR.%26aulast%3DPallotti%26aufirst%3DF.%26aulast%3DViale%26aufirst%3DG.%26aulast%3DGishizky%26aufirst%3DM.%2BL.%26aulast%3DDraetta%26aufirst%3DG.%2BF.%26aulast%3DDi%2BFiore%26aufirst%3DP.%2BP.%26atitle%3DFrequent%2520alterations%2520in%2520the%2520expression%2520of%2520serine%252Fthreonine%2520kinases%2520in%2520human%2520cancers%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8147%26epage%3D8154%26doi%3D10.1158%2F0008-5472.CAN-05-3489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weremowicz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polyak, K.</span><span> </span><span class="NLM_article-title">CLK2 is an oncogenic kinase and splicing regulator in breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1516</span><span class="NLM_x">–</span> <span class="NLM_lpage">1526</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-2443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1158%2F0008-5472.CAN-14-2443" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=1516-1526&author=T.+Yoshidaauthor=J.+H.+Kimauthor=K.+Carverauthor=Y.+Suauthor=S.+Weremowiczauthor=L.+Mulveyauthor=S.+Yamamotoauthor=C.+Brennanauthor=S.+Meiauthor=H.+Longauthor=J.+Yaoauthor=K.+Polyak&title=CLK2+is+an+oncogenic+kinase+and+splicing+regulator+in+breast+cancer&doi=10.1158%2F0008-5472.CAN-14-2443"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-2443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-2443%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DCarver%26aufirst%3DK.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DWeremowicz%26aufirst%3DS.%26aulast%3DMulvey%26aufirst%3DL.%26aulast%3DYamamoto%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DC.%26aulast%3DMei%26aufirst%3DS.%26aulast%3DLong%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DPolyak%26aufirst%3DK.%26atitle%3DCLK2%2520is%2520an%2520oncogenic%2520kinase%2520and%2520splicing%2520regulator%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D1516%26epage%3D1526%26doi%3D10.1158%2F0008-5472.CAN-14-2443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Muraki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkawara, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onogi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yomoda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krainer, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span> </span><span class="NLM_article-title">Manipulation of alternative splicing by a newly developed inhibitor of Clks</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">24246</span><span class="NLM_x">–</span> <span class="NLM_lpage">24254</span><span class="refDoi"> DOI: 10.1074/jbc.M314298200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1074%2Fjbc.M314298200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=24246-24254&author=M.+Murakiauthor=B.+Ohkawaraauthor=T.+Hosoyaauthor=H.+Onogiauthor=J.+Koizumiauthor=T.+Koizumiauthor=K.+Sumiauthor=J.+Yomodaauthor=M.+V.+Murrayauthor=H.+Kimuraauthor=K.+Furuichiauthor=H.+Shibuyaauthor=A.+R.+Krainerauthor=M.+Suzukiauthor=M.+Hagiwara&title=Manipulation+of+alternative+splicing+by+a+newly+developed+inhibitor+of+Clks&doi=10.1074%2Fjbc.M314298200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M314298200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M314298200%26sid%3Dliteratum%253Aachs%26aulast%3DMuraki%26aufirst%3DM.%26aulast%3DOhkawara%26aufirst%3DB.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DKoizumi%26aufirst%3DJ.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DSumi%26aufirst%3DK.%26aulast%3DYomoda%26aufirst%3DJ.%26aulast%3DMurray%26aufirst%3DM.%2BV.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DFuruichi%26aufirst%3DK.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DKrainer%26aufirst%3DA.%2BR.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DManipulation%2520of%2520alternative%2520splicing%2520by%2520a%2520newly%2520developed%2520inhibitor%2520of%2520Clks%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D24246%26epage%3D24254%26doi%3D10.1074%2Fjbc.M314298200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenreich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szklarczyk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trappe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracher, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2010.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1016%2Fj.chembiol.2010.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=21276940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlarsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=67-76&author=O.+Fedorovauthor=K.+Huberauthor=A.+Eisenreichauthor=P.+Filippakopoulosauthor=O.+Kingauthor=A.+N.+Bullockauthor=D.+Szklarczykauthor=L.+J.+Jensenauthor=D.+Fabbroauthor=J.+Trappeauthor=U.+Rauchauthor=F.+Bracherauthor=S.+Knapp&title=Specific+CLK+inhibitors+from+a+novel+chemotype+for+regulation+of+alternative+splicing&doi=10.1016%2Fj.chembiol.2010.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing</span></div><div class="casAuthors">Fedorov, Oleg; Huber, Kilian; Eisenreich, Andreas; Filippakopoulos, Panagis; King, Oliver; Bullock, Alex N.; Szklarczyk, Damian; Jensen, Lars J.; Fabbro, Doriano; Trappe, Jorg; Rauch, Ursula; Bracher, Franz; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-76</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">There is a growing recognition of the importance of protein kinases in the control of alternative splicing.  To define the underlying regulatory mechanisms, highly selective inhibitors are needed.  Here, we report the discovery and characterization of the dichloroindolyl enaminonitrile KH-CB19, a potent and highly specific inhibitor of the CDC2-like kinase isoforms 1 and 4 (CLK1/CLK4).  Cocrystal structures of KH-CB19 with CLK1 and CLK3 revealed a non-ATP mimetic binding mode, conformational changes in helix αC and the phosphate binding loop and halogen bonding to the kinase hinge region.  KH-CB19 effectively suppressed phosphorylation of SR (serine/arginine) proteins in cells, consistent with its expected mechanism of action.  Chem. inhibition of CLK1/CLK4 generated a unique pattern of splicing factor dephosphorylation and had at low nM concn. a profound effect on splicing of the two tissue factor isoforms flTF (full-length TF) and asHTF (alternatively spliced human TF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqnKjNEjPBHbVg90H21EOLACvtfcHk0liaW1h3aEFW2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlarsLw%253D&md5=b2b17a9934f15f2d0d9a76a8d3179e95</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DEisenreich%26aufirst%3DA.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKing%26aufirst%3DO.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DSzklarczyk%26aufirst%3DD.%26aulast%3DJensen%26aufirst%3DL.%2BJ.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DRauch%26aufirst%3DU.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DSpecific%2520CLK%2520inhibitors%2520from%2520a%2520novel%2520chemotype%2520for%2520regulation%2520of%2520alternative%2520splicing%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D67%26epage%3D76%26doi%3D10.1016%2Fj.chembiol.2010.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Mott, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanega, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marugan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misteli, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auld, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, C. J.</span><span> </span><span class="NLM_article-title">Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6700</span><span class="NLM_x">–</span> <span class="NLM_lpage">6705</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.09.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1016%2Fj.bmcl.2009.09.121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6700-6705&author=B.+T.+Mottauthor=C.+Tanegaauthor=M.+Shenauthor=D.+J.+Maloneyauthor=P.+Shinnauthor=W.+Leisterauthor=J.+J.+Maruganauthor=J.+Ingleseauthor=C.+P.+Austinauthor=T.+Misteliauthor=D.+S.+Auldauthor=C.+J.+Thomas&title=Evaluation+of+substituted+6-arylquinazolin-4-amines+as+potent+and+selective+inhibitors+of+cdc2-like+kinases+%28Clk%29&doi=10.1016%2Fj.bmcl.2009.09.121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.09.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.09.121%26sid%3Dliteratum%253Aachs%26aulast%3DMott%26aufirst%3DB.%2BT.%26aulast%3DTanega%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26aulast%3DShinn%26aufirst%3DP.%26aulast%3DLeister%26aufirst%3DW.%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DMisteli%26aufirst%3DT.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26atitle%3DEvaluation%2520of%2520substituted%25206-arylquinazolin-4-amines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520cdc2-like%2520kinases%2520%2528Clk%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6700%26epage%3D6705%26doi%3D10.1016%2Fj.bmcl.2009.09.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovelman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, K. J.</span><span> </span><span class="NLM_article-title">A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">451</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span><span class="refDoi"> DOI: 10.1042/BJ20121418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1042%2FBJ20121418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=23398362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFOgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=451&publication_year=2013&pages=313-328&author=Y.+Gaoauthor=S.+P.+Daviesauthor=M.+Augustinauthor=A.+Woodwardauthor=U.+A.+Patelauthor=R.+Kovelmanauthor=K.+J.+Harvey&title=A+broad+activity+screen+in+support+of+a+chemogenomic+map+for+kinase+signalling+research+and+drug+discovery&doi=10.1042%2FBJ20121418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery</span></div><div class="casAuthors">Gao, Yinghong; Davies, Stephen P.; Augustin, Martin; Woodward, Anna; Patel, Umesh A.; Kovelman, Robert; Harvey, Kevin J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">451</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">313-328</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Despite the development of a no. of efficacious kinase inhibitors, the strategies for rational design of these compds. have been limited by target promiscuity.  In an effort to better understand the nature of kinase inhibition across the kinome, esp. as it relates to off-target effects, we screened a well-defined collection of kinase inhibitors using biochem. assays for inhibitory activity against 234 active human kinases and kinase complexes, representing all branches of the kinome tree.  For our study we employed 158 small mols. initially identified in the literature as potent and specific inhibitors of kinases important as therapeutic targets and/or signal transduction regulators.  Hierarchical clustering of these benchmark kinase inhibitors on the basis of their kinome activity profiles illustrates how they relate to chem. structure similarities and provides new insights into inhibitor specificity and potential applications for probing new targets.  Using this broad dataset, we provide a framework for assessing polypharmacol.  We not only discover likely off-target inhibitor activities and recommend specific inhibitors for existing targets, but also identify potential new uses for known small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNLU0ONM4SALVg90H21EOLACvtfcHk0ljwq9jx_xrz1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFOgs7g%253D&md5=9e0f17ec5cac10198fe28b27e70b4966</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1042%2FBJ20121418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20121418%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DDavies%26aufirst%3DS.%2BP.%26aulast%3DAugustin%26aufirst%3DM.%26aulast%3DWoodward%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DU.%2BA.%26aulast%3DKovelman%26aufirst%3DR.%26aulast%3DHarvey%26aufirst%3DK.%2BJ.%26atitle%3DA%2520broad%2520activity%2520screen%2520in%2520support%2520of%2520a%2520chemogenomic%2520map%2520for%2520kinase%2520signalling%2520research%2520and%2520drug%2520discovery%26jtitle%3DBiochem.%2520J.%26date%3D2013%26volume%3D451%26spage%3D313%26epage%3D328%26doi%3D10.1042%2FBJ20121418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Schmitt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miralinaghi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, M.</span><span> </span><span class="NLM_article-title">Hydroxybenzothiophene ketones are efficient pre-mRNA splicing modulators due to dual inhibition of Dyrk1A and Clk1/4</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span><span class="refDoi"> DOI: 10.1021/ml500059y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500059y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=963-907&author=C.+Schmittauthor=P.+Miralinaghiauthor=M.+Marianoauthor=R.+W.+Hartmannauthor=M.+Engel&title=Hydroxybenzothiophene+ketones+are+efficient+pre-mRNA+splicing+modulators+due+to+dual+inhibition+of+Dyrk1A+and+Clk1%2F4&doi=10.1021%2Fml500059y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fml500059y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500059y%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DC.%26aulast%3DMiralinaghi%26aufirst%3DP.%26aulast%3DMariano%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3DHydroxybenzothiophene%2520ketones%2520are%2520efficient%2520pre-mRNA%2520splicing%2520modulators%2520due%2520to%2520dual%2520inhibition%2520of%2520Dyrk1A%2520and%2520Clk1%252F4%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D963%26epage%3D907%26doi%3D10.1021%2Fml500059y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kuhn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaschinski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frauen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katus, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, N.</span><span> </span><span class="NLM_article-title">DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">17320</span><span class="NLM_x">–</span> <span class="NLM_lpage">17327</span><span class="refDoi"> DOI: 10.1074/jbc.M109.006759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1074%2Fjbc.M109.006759" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=17320-17327&author=C.+Kuhnauthor=D.+Frankauthor=R.+Willauthor=C.+Jaschinskiauthor=R.+Frauenauthor=H.+A.+Katusauthor=N.+Frey&title=DYRK1A+is+a+novel+negative+regulator+of+cardiomyocyte+hypertrophy&doi=10.1074%2Fjbc.M109.006759"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.006759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.006759%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DC.%26aulast%3DFrank%26aufirst%3DD.%26aulast%3DWill%26aufirst%3DR.%26aulast%3DJaschinski%26aufirst%3DC.%26aulast%3DFrauen%26aufirst%3DR.%26aulast%3DKatus%26aufirst%3DH.%2BA.%26aulast%3DFrey%26aufirst%3DN.%26atitle%3DDYRK1A%2520is%2520a%2520novel%2520negative%2520regulator%2520of%2520cardiomyocyte%2520hypertrophy%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D17320%26epage%3D17327%26doi%3D10.1074%2Fjbc.M109.006759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Bendjeddou, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loaëc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villiers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Späth, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galons, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oumata, N.</span><span> </span><span class="NLM_article-title">Exploration of the imidazo[1,2-b]pyridazine scaffold as a protein kinase inhibitor</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">696</span><span class="NLM_x">–</span> <span class="NLM_lpage">709</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.09.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1016%2Fj.ejmech.2016.09.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2017&pages=696-709&author=L.+Z.+Bendjeddouauthor=N.+Loa%C3%ABcauthor=B.+Villiersauthor=E.+Prinaauthor=G.+F.+Sp%C3%A4thauthor=H.+Galonsauthor=L.+Meijerauthor=N.+Oumata&title=Exploration+of+the+imidazo%5B1%2C2-b%5Dpyridazine+scaffold+as+a+protein+kinase+inhibitor&doi=10.1016%2Fj.ejmech.2016.09.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.09.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.09.064%26sid%3Dliteratum%253Aachs%26aulast%3DBendjeddou%26aufirst%3DL.%2BZ.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DVilliers%26aufirst%3DB.%26aulast%3DPrina%26aufirst%3DE.%26aulast%3DSp%25C3%25A4th%26aufirst%3DG.%2BF.%26aulast%3DGalons%26aufirst%3DH.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DOumata%26aufirst%3DN.%26atitle%3DExploration%2520of%2520the%2520imidazo%255B1%252C2-b%255Dpyridazine%2520scaffold%2520as%2520a%2520protein%2520kinase%2520inhibitor%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D125%26spage%3D696%26epage%3D709%26doi%3D10.1016%2Fj.ejmech.2016.09.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Prak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriston-Vizi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pengo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketteler, R.</span><span> </span><span class="NLM_article-title">Benzobisthiazoles represent a novel scaffold for kinase inhibitors of CLK family members</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">608</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span><span class="refDoi"> DOI: 10.1021/acs.biochem.5b01128</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.5b01128" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=608-617&author=K.+Prakauthor=J.+Kriston-Viziauthor=A.+W.+Chanauthor=C.+Luftauthor=J.+R.+Costaauthor=N.+Pengoauthor=R.+Ketteler&title=Benzobisthiazoles+represent+a+novel+scaffold+for+kinase+inhibitors+of+CLK+family+members&doi=10.1021%2Facs.biochem.5b01128"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.5b01128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.5b01128%26sid%3Dliteratum%253Aachs%26aulast%3DPrak%26aufirst%3DK.%26aulast%3DKriston-Vizi%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DA.%2BW.%26aulast%3DLuft%26aufirst%3DC.%26aulast%3DCosta%26aufirst%3DJ.%2BR.%26aulast%3DPengo%26aufirst%3DN.%26aulast%3DKetteler%26aufirst%3DR.%26atitle%3DBenzobisthiazoles%2520represent%2520a%2520novel%2520scaffold%2520for%2520kinase%2520inhibitors%2520of%2520CLK%2520family%2520members%26jtitle%3DBiochemistry%26date%3D2016%26volume%3D55%26spage%3D608%26epage%3D617%26doi%3D10.1021%2Facs.biochem.5b01128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Soundararajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitsky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettenbach, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eswaran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, J. M.</span><span> </span><span class="NLM_article-title">Structures of down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">986</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span><span class="refDoi"> DOI: 10.1016/j.str.2013.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1016%2Fj.str.2013.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=23665168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVygtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=986-996&author=M.+Soundararajanauthor=A.+K.+Roosauthor=P.+Savitskyauthor=P.+Filippakopoulosauthor=A.+N.+Kettenbachauthor=J.+V.+Olsenauthor=S.+A.+Gerberauthor=J.+Eswaranauthor=S.+Knappauthor=J.+M.+Elkins&title=Structures+of+down+syndrome+kinases%2C+DYRKs%2C+reveal+mechanisms+of+kinase+activation+and+substrate+recognition&doi=10.1016%2Fj.str.2013.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Down Syndrome Kinases, DYRKs, Reveal Mechanisms of Kinase Activation and Substrate Recognition</span></div><div class="casAuthors">Soundararajan, Meera; Roos, Annette K.; Savitsky, Pavel; Filippakopoulos, Panagis; Kettenbach, Arminja N.; Olsen, Jesper V.; Gerber, Scott A.; Eswaran, Jeyanthy; Knapp, Stefan; Elkins, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">986-996</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine-(Y)-phosphorylation-regulated kinases (DYRKs) play key roles in brain development, regulation of splicing, and apoptosis, and are potential drug targets for neurodegenerative diseases and cancer.  We present crystal structures of one representative member of each DYRK subfamily: DYRK1A with an ATP-mimetic inhibitor and consensus peptide, and DYRK2 including NAPA and DH (DYRK homol.) box regions.  The current activation model suggests that DYRKs are Ser/Thr kinases that only autophosphorylate the second tyrosine of the activation loop YxY motif during protein translation.  The structures explain the roles of this tyrosine and of the DH box in DYRK activation and provide a structural model for DYRK substrate recognition.  Phosphorylation of a library of naturally occurring peptides identified substrate motifs that lack proline in the P+1 position, suggesting that DYRK1A is not a strictly proline-directed kinase.  Our data also show that DYRK1A wild-type and Y321F mutant retain tyrosine autophosphorylation activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDShaymgKcfLVg90H21EOLACvtfcHk0ljNRa8GPSW28w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVygtL0%253D&md5=f101707a987083c7d3d637b39332db35</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DRoos%26aufirst%3DA.%2BK.%26aulast%3DSavitsky%26aufirst%3DP.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKettenbach%26aufirst%3DA.%2BN.%26aulast%3DOlsen%26aufirst%3DJ.%2BV.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DEswaran%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26atitle%3DStructures%2520of%2520down%2520syndrome%2520kinases%252C%2520DYRKs%252C%2520reveal%2520mechanisms%2520of%2520kinase%2520activation%2520and%2520substrate%2520recognition%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D986%26epage%3D996%26doi%3D10.1016%2Fj.str.2013.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Paulini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Orthogonal multipolar interactions in structural chemistry and biology</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1788</span><span class="NLM_x">–</span> <span class="NLM_lpage">1805</span><span class="refDoi"> DOI: 10.1002/anie.200462213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1002%2Fanie.200462213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislWkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=1788-1805&author=R.+Pauliniauthor=K.+M%C3%BCllerauthor=F.+Diederich&title=Orthogonal+multipolar+interactions+in+structural+chemistry+and+biology&doi=10.1002%2Fanie.200462213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Orthogonal multipolar interactions in structural chemistry and biology</span></div><div class="casAuthors">Paulini, Ralph; Mueller, Klaus; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1788-1805</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The past few decades of mol. recognition studies have greatly enhanced our knowledge on apolar, ion-dipole, and hydrogen-bonding interactions.  However, much less attention has been given to the role that multipolar interactions, in particular those with orthogonal dipolar alignment, play in organizing a crystal lattice or stabilizing complexes involving biol. receptors.  By using results from database mining, this review attempts to give an overview of types and structural features of these previously rather overlooked interactions.  A no. of illustrative examples of these interactions found in X-ray crystal structures of small mols. and protein-ligand complexes demonstrate their propensity and thus potential importance for both, chem. and biol. mol. recognition processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTGHoutIq12LVg90H21EOLACvtfcHk0ljNRa8GPSW28w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislWkt7s%253D&md5=6ad842547313b27fc1676e9c3a001909</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fanie.200462213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200462213%26sid%3Dliteratum%253Aachs%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DOrthogonal%2520multipolar%2520interactions%2520in%2520structural%2520chemistry%2520and%2520biology%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D1788%26epage%3D1805%26doi%3D10.1002%2Fanie.200462213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Olsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obst Sander, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: evidence for C-F...C=O interactions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2507</span><span class="NLM_x">–</span> <span class="NLM_lpage">2511</span><span class="refDoi"> DOI: 10.1002/anie.200351268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1002%2Fanie.200351268" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=2507-2511&author=J.+A.+Olsenauthor=D.+W.+Bannerauthor=P.+Seilerauthor=U.+Obst+Sanderauthor=A.+D%E2%80%99Arcyauthor=M.+Stihleauthor=K.+M%C3%BCllerauthor=F.+Diederich&title=A+fluorine+scan+of+thrombin+inhibitors+to+map+the+fluorophilicity%2Ffluorophobicity+of+an+enzyme+active+site%3A+evidence+for+C-F...C%3DO+interactions&doi=10.1002%2Fanie.200351268"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fanie.200351268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200351268%26sid%3Dliteratum%253Aachs%26aulast%3DOlsen%26aufirst%3DJ.%2BA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DSeiler%26aufirst%3DP.%26aulast%3DObst%2BSander%26aufirst%3DU.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DA%2520fluorine%2520scan%2520of%2520thrombin%2520inhibitors%2520to%2520map%2520the%2520fluorophilicity%252Ffluorophobicity%2520of%2520an%2520enzyme%2520active%2520site%253A%2520evidence%2520for%2520C-F...C%253DO%2520interactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D2507%26epage%3D2511%26doi%3D10.1002%2Fanie.200351268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Ogawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramatsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kii, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onogi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span> </span><span class="NLM_article-title">Development of a novel selective inhibitor of the down syndrome-related kinase Dyrk1A</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="refDoi"> DOI: 10.1038/ncomms1090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1038%2Fncomms1090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=20981014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=86&author=Y.+Ogawaauthor=Y.+Nonakaauthor=T.+Gotoauthor=E.+Ohnishiauthor=T.+Hiramatsuauthor=I.+Kiiauthor=M.+Yoshidaauthor=T.+Ikuraauthor=H.+Onogiauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=N.+Itoauthor=M.+Hagiwara&title=Development+of+a+novel+selective+inhibitor+of+the+down+syndrome-related+kinase+Dyrk1A&doi=10.1038%2Fncomms1090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span></div><div class="casAuthors">Ogawa Yasushi; Nonaka Yosuke; Goto Toshiyasu; Ohnishi Eriko; Hiramatsu Toshiyuki; Kii Isao; Yoshida Miyo; Ikura Teikichi; Onogi Hiroshi; Shibuya Hiroshi; Hosoya Takamitsu; Ito Nobutoshi; Hagiwara Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dyrk1A (dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A) is a serine/threonine kinase essential for brain development and function, and its excessive activity is considered a pathogenic factor in Down syndrome.  The development of potent, selective inhibitors of Dyrk1A would help to elucidate the molecular mechanisms of normal and diseased brains, and may provide a new lead compound for molecular-targeted drug discovery.  Here, we report a novel Dyrk1A inhibitor, INDY, a benzothiazole derivative showing a potent ATP-competitive inhibitory effect with IC(50) and K(i) values of 0.24 and 0.18 μM, respectively.  X-ray crystallography of the Dyrk1A/INDY complex revealed the binding of INDY in the ATP pocket of the enzyme.  INDY effectively reversed the aberrant tau-phosphorylation and rescued the repressed NFAT (nuclear factor of activated T cell) signalling induced by Dyrk1A overexpression.  Importantly, proINDY, a prodrug of INDY, effectively recovered Xenopus embryos from head malformation induced by Dyrk1A overexpression, resulting in normally developed embryos and demonstrating the utility of proINDY in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtenUz0lpNqnfW6udTcc2ebsZWD3MUYhbrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D&md5=ac1d5972bec4085de101bb86194babd1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fncomms1090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1090%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DE.%26aulast%3DHiramatsu%26aufirst%3DT.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520the%2520down%2520syndrome-related%2520kinase%2520Dyrk1A%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D86%26doi%3D10.1038%2Fncomms1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Okano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagahara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murawaki, Y.</span><span> </span><span class="NLM_article-title">Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway</span> <span class="citation_source-journal">Basic Clin. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span><span class="refDoi"> DOI: 10.1111/j.1742-7843.2008.00231.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1111%2Fj.1742-7843.2008.00231.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=18346049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntFWmsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2008&pages=543-551&author=J.+Okanoauthor=T.+Nagaharaauthor=K.+Matsumotoauthor=Y.+Murawaki&title=Caffeine+inhibits+the+proliferation+of+liver+cancer+cells+and+activates+the+MEK%2FERK%2FEGFR+signalling+pathway&doi=10.1111%2Fj.1742-7843.2008.00231.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway</span></div><div class="casAuthors">Okano, Jun-ichi; Nagahara, Takakazu; Matsumoto, Kazuya; Murawaki, Yoshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">543-551</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Caffeine has been reported to prevent hepatocarcinogenesis.  We investigated the mol. mechanisms by which caffeine inhibits the growth of hepatocellular carcinoma (HCC) cells.  We found that caffeine inhibited the proliferation of HCC cells via cell cycle arrest independent of apoptosis.  We revealed a novel signaling axis for caffeine involving activation of the mitogen-activated ERK-regulating kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway that resulted in the downstream up-regulation of epidermal growth factor receptor (EGFR), although the MEK/ERK/EGFR signaling pathway was not involved in the growth inhibitory effect of caffeine.  Our data reveal that caffeine could be a promising candidate for the treatment of patients with HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe9I90o8I7wLVg90H21EOLACvtfcHk0lj__Y-FTeQ6qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntFWmsLw%253D&md5=38b57f21f9c485c5e47ff2f6eea2ac3d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2008.00231.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2008.00231.x%26sid%3Dliteratum%253Aachs%26aulast%3DOkano%26aufirst%3DJ.%26aulast%3DNagahara%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DMurawaki%26aufirst%3DY.%26atitle%3DCaffeine%2520inhibits%2520the%2520proliferation%2520of%2520liver%2520cancer%2520cells%2520and%2520activates%2520the%2520MEK%252FERK%252FEGFR%2520signalling%2520pathway%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2008%26volume%3D102%26spage%3D543%26epage%3D551%26doi%3D10.1111%2Fj.1742-7843.2008.00231.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Sakuma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span> </span><span class="NLM_article-title">Deciphering targeting rules of splicing modulator compounds: case of TG003</span> <span class="citation_source-journal">BMC Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="refDoi"> DOI: 10.1186/s12867-015-0044-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1186%2Fs12867-015-0044-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=26400733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmt1Khsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=16&author=M.+Sakumaauthor=K.+Iidaauthor=M.+Hagiwara&title=Deciphering+targeting+rules+of+splicing+modulator+compounds%3A+case+of+TG003&doi=10.1186%2Fs12867-015-0044-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Deciphering targeting rules of splicing modulator compounds: case of TG003</span></div><div class="casAuthors">Sakuma, Maki; Iida, Kei; Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">BMC Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16/1-16/13</span>CODEN:
                <span class="NLM_cas:coden">BMBMC4</span>;
        ISSN:<span class="NLM_cas:issn">1471-2199</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Recent advances in the development of small chem. compds. that can modulate RNA splicing brought excitement to the field of splicing-targeting therapy.  Splicing-targeting therapy tries to ameliorate the disease by altering the exon combination of transcripts to reduce the undesired effect of genetic mutations.  However, the knowledge and tools to understand factors contributing to splicing modulator compd. sensitivity have been lacking.  Our goal was to establish a method to characterize sequence features found in compd. sensitive exons.  Results: Here we developed a comparative transcriptomic approach to explore features that make an exon sensitive to a chem. compd.  In this study, we chose TG003, a potential drug for Duchenne muscular dystrophy, and performed RNA-sequencing on samples from human and mouse skeletal muscle cells, with and without TG003 treatments.  We compared TG003 responsiveness between homologous exon pairs and identified 21 pairs in which human exons were skip-enhanced but not mouse exons.  We compared the sequence features; splice site scores, no. of splicing factor binding sites, and properties of branch sequence and polypyrimidine tracts, and found that polypyrimidine tracts were stronger (longer stretches and richer content of consecutive polypyrimidine) in the mouse TG003 insensitive exons.  We also compared the features between TG003 skip-enhanced and insensitive exons within the species, and discovered that human TG003 skip-enhanced exons were shorter and had less splicing factor binding sites than the group of human TG003 insensitive exons.  Mouse insensitive exons homologous to human TG003 skip-enhanced exons shared these properties.  Our results suggested that these features are prerequisites for TG003 skip-enhanced exons and weak polypyrimidine tracts are defining features, which were supported by a decision tree anal. on all cassette exons in human.  Conclusions: In this study we established a comparative transcriptomic approach, which shed lights on how small chem. compds. modulate RNA splicing.  The results described here was the first attempt to decipher the targeting rules of a splicing modulator compd.  We expect that this approach would contribute to the precise understanding of the mechanism of TG003-induced splicing modulation, expand target diseases of splicing modulators in general, as well as the development of new splicing modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoodIBTCDKQnLVg90H21EOLACvtfcHk0lj__Y-FTeQ6qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmt1Khsbk%253D&md5=9bc9d7885d1e0bd0bfc9c0c943aba4a5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1186%2Fs12867-015-0044-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12867-015-0044-6%26sid%3Dliteratum%253Aachs%26aulast%3DSakuma%26aufirst%3DM.%26aulast%3DIida%26aufirst%3DK.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDeciphering%2520targeting%2520rules%2520of%2520splicing%2520modulator%2520compounds%253A%2520case%2520of%2520TG003%26jtitle%3DBMC%2520Mol.%2520Biol.%26date%3D2015%26volume%3D16%26spage%3D16%26doi%3D10.1186%2Fs12867-015-0044-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Schmitt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kail, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Empting, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of a library of lead-like 2,4-bisheterocyclic substituted thiophenes as selective Dyrk/Clk inhibitors</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e87851</span><span class="refDoi"> DOI: 10.1371/journal.pone.0087851</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1371%2Fjournal.pone.0087851" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e87851&author=C.+Schmittauthor=D.+Kailauthor=M.+Marianoauthor=M.+Emptingauthor=N.+Weberauthor=T.+Paulauthor=R.+W.+Hartmannauthor=M.+Engel&title=Design+and+synthesis+of+a+library+of+lead-like+2%2C4-bisheterocyclic+substituted+thiophenes+as+selective+Dyrk%2FClk+inhibitors&doi=10.1371%2Fjournal.pone.0087851"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0087851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0087851%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DC.%26aulast%3DKail%26aufirst%3DD.%26aulast%3DMariano%26aufirst%3DM.%26aulast%3DEmpting%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DN.%26aulast%3DPaul%26aufirst%3DT.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520library%2520of%2520lead-like%25202%252C4-bisheterocyclic%2520substituted%2520thiophenes%2520as%2520selective%2520Dyrk%252FClk%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De87851%26doi%3D10.1371%2Fjournal.pone.0087851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Mariano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, M.</span><span> </span><span class="NLM_article-title">Systematic diversification of benzylidene heterocycles yields novel inhibitor scaffolds selective for Dyrk1A, Clk1 and CK2</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1016%2Fj.ejmech.2016.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=26896709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVChsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2016&pages=209-216&author=M.+Marianoauthor=R.+W.+Hartmannauthor=M.+Engel&title=Systematic+diversification+of+benzylidene+heterocycles+yields+novel+inhibitor+scaffolds+selective+for+Dyrk1A%2C+Clk1+and+CK2&doi=10.1016%2Fj.ejmech.2016.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic diversification of benzylidene heterocycles yields novel inhibitor scaffolds selective for Dyrk1A, Clk1 and CK2</span></div><div class="casAuthors">Mariano, Marica; Hartmann, Rolf W.; Engel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">209-216</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The dual-specificity tyrosine-regulated kinase 1A (Dyrk1A) has gathered much interest as a pharmacol. target in Alzheimer's disease (AD), but it plays a role in malignant brain tumors as well.  As both diseases are multi-factorial, further protein kinases, such as Clk1 and CK2, were proposed to contribute to the pathogenesis.  The authors designed a new class of α-benzylidene-γ-butyrolactone inhibitors that showed low micromolar potencies against Dyrk1A and/or Clk1 and a good selectivity profile among the most frequently reported off-target kinases.  A systematic replacement of the heterocyclic moiety gave access to further inhibitor classes with interesting selectivity profiles, demonstrating that the benzylidene heterocycles provide a versatile tool box for developing inhibitors of the CMGC kinase family members Dyr1A/1B, Clk1/4 and CK2.  Efficacy for the inhibition of Dyrk1A-mediated tau phosphorylation was demonstrated in a cell-based assay.  Multi-targeted but not non-specific kinase inhibitors were also obtained, that co-inhibited the lipid kinases PI3Kα/γ.  These compds. were shown to inhibit the proliferation of U87MG cells in the low micromolar range.  Based on the mol. properties, the inhibitors described here hold promise for CNS activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6qXCl7IedNLVg90H21EOLACvtfcHk0lhsZZ6KDM9fqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVChsb4%253D&md5=85bec789a30e7da3dddfc731ed87b227</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DMariano%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3DSystematic%2520diversification%2520of%2520benzylidene%2520heterocycles%2520yields%2520novel%2520inhibitor%2520scaffolds%2520selective%2520for%2520Dyrk1A%252C%2520Clk1%2520and%2520CK2%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D112%26spage%3D209%26epage%3D216%26doi%3D10.1016%2Fj.ejmech.2016.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Tahtouh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soundararajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durieu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delhommel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberholzer, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreaux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazureau, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9312</span><span class="NLM_x">–</span> <span class="NLM_lpage">9330</span><span class="refDoi"> DOI: 10.1021/jm301034u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301034u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9312-9330&author=T.+Tahtouhauthor=J.+M.+Elkinsauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=G.+Burgyauthor=E.+Durieuauthor=C.+Cochetauthor=R.+S.+Schmidauthor=D.+C.+Loauthor=F.+Delhommelauthor=A.+E.+Oberholzerauthor=L.+H.+Pearlauthor=F.+Carreauxauthor=J.+P.+Bazureauauthor=S.+Knappauthor=L.+Meijer&title=Selectivity%2C+cocrystal+structures%2C+and+neuroprotective+properties+of+leucettines%2C+a+family+of+protein+kinase+inhibitors+derived+from+the+marine+sponge+alkaloid+leucettamine+B&doi=10.1021%2Fjm301034u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B</span></div><div class="casAuthors">Tahtouh, Tania; Elkins, Jonathan M.; Filippakopoulos, Panagis; Soundararajan, Meera; Burgy, Guillaume; Durieu, Emilie; Cochet, Claude; Schmid, Ralf S.; Lo, Donald C.; Delhommel, Florent; Oberholzer, Anselm E.; Pearl, Laurence H.; Carreaux, Francois; Bazureau, Jean-Pierre; Knapp, Stefan; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9312-9330</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRKs (dual specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases) are implicated in the onset and development of Alzheimer's disease and Down syndrome.  The marine sponge alkaloid leucettamine B was recently identified as an inhibitor of DYRKs/CLKs.  Synthesis of analogs (leucettines) led to an optimized product, leucettine L41.  Leucettines were cocrystd. with DYRK1A, DYRK2, CLK3, PIM1, and GSK-3β.  The selectivity of L41 was studied by activity and interaction assays of recombinant kinases and affinity chromatog. and competition affinity assays.  These approaches revealed unexpected potential secondary targets such as CK2, SLK, and the lipid kinase PIKfyve/Vac14.  L41 displayed neuroprotective effects on glutamate-induced HT22 cell death.  L41 also reduced amyloid precursor protein-induced cell death in cultured rat brain slices.  The unusual multitarget selectivity of leucettines may account for their neuroprotective effects.  This family of kinase inhibitors deserves further optimization as potential therapeutics against neurodegenerative diseases such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhwr44JiuCrVg90H21EOLACvtfcHk0lhsZZ6KDM9fqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF&md5=a1749c347c2e8e0409d8fdd475dc70f9</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm301034u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301034u%26sid%3Dliteratum%253Aachs%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DR.%2BS.%26aulast%3DLo%26aufirst%3DD.%2BC.%26aulast%3DDelhommel%26aufirst%3DF.%26aulast%3DOberholzer%26aufirst%3DA.%2BE.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.%2BP.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DSelectivity%252C%2520cocrystal%2520structures%252C%2520and%2520neuroprotective%2520properties%2520of%2520leucettines%252C%2520a%2520family%2520of%2520protein%2520kinase%2520inhibitors%2520derived%2520from%2520the%2520marine%2520sponge%2520alkaloid%2520leucettamine%2520B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9312%26epage%3D9330%26doi%3D10.1021%2Fjm301034u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The specificities of protein kinase inhibitors: an update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.1042/bj20021535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1042%2Fbj20021535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=12534346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=199-204&author=J.+Bainauthor=H.+McLauchlanauthor=M.+Elliottauthor=P.+Cohen&title=The+specificities+of+protein+kinase+inhibitors%3A+an+update&doi=10.1042%2Fbj20021535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The specificities of protein kinase inhibitors: an update</span></div><div class="casAuthors">Bain, Jenny; McLauchlan, Hilary; Elliott, Matthew; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-204</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">We have previously examd. the specificities of 28 com. available compds., reported to be relatively selective inhibitors of particular serine/threonine-specific protein kinases.  In the present study, we have extended this anal. to a further 14 compds.  Of these, indirubin-3'-monoxime, SP 600125, KT 5823 and ML-9 were found to inhibit a no. of protein kinases and conclusions drawn from their use in cell-based assays are likely to be erroneous.  Kenpaullone, Alsterpaullone, Purvalanol, Roscovitine, pyrazolopyrimidine 1 (PP1), PP2 and ML-7 were more specific, but still inhibited two or more protein kinases with similar potency.  Our results suggest that the combined use of Roscovitine and Kenpaullone may be useful for identifying substrates and physiol. roles of cyclin-dependent protein kinases, whereas the combined use of Kenpaullone and LiCl may be useful for identifying substrates and physiol. roles of glycogen synthase kinase 3.  The combined use of SU 6656 and either PP1 or PP2 may be useful for identifying substrates of Src family members.  Epigallocatechin 3-gallate, one of the main polyphenolic constituents of tea, inhibited two of the 28 protein kinases in the panel, dual-specificity, tyrosine-phosphorylated and regulated kinase 1A (DYRK1A; IC50 = 0.33 μM) and p38-regulated/activated kinase (PRAK; IC50 = 1.0 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKsdbPJWI3krVg90H21EOLACvtfcHk0lhsZZ6KDM9fqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D&md5=f1cd5b518b683906b398d9bb79dc14fc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1042%2Fbj20021535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021535%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520specificities%2520of%2520protein%2520kinase%2520inhibitors%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D199%26epage%3D204%26doi%3D10.1042%2Fbj20021535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Anastassiadis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devarajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. R.</span><span> </span><span class="NLM_article-title">Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1045</span><span class="refDoi"> DOI: 10.1038/nbt.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1038%2Fnbt.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=22037377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1039-1045&author=T.+Anastassiadisauthor=S.+W.+Deaconauthor=K.+Devarajanauthor=H.+Maauthor=J.+R.+Peterson&title=Comprehensive+assay+of+kinase+catalytic+activity+reveals+features+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity</span></div><div class="casAuthors">Anastassiadis, Theonie; Deacon, Sean W.; Devarajan, Karthik; Ma, Haiching; Peterson, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1039-1045</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small-mol. protein kinase inhibitors are widely used to elucidate cellular signaling pathways and are promising therapeutic agents.  Owing to evolutionary conservation of the ATP-binding site, most kinase inhibitors that target this site promiscuously inhibit multiple kinases.  Interpretation of expts. that use these compds. is confounded by a lack of data on the comprehensive kinase selectivity of most inhibitors.  Here we used functional assays to profile the activity of 178 com. available kinase inhibitors against a panel of 300 recombinant protein kinases.  Quant. anal. revealed complex and often unexpected interactions between protein kinases and kinase inhibitors, with a wide spectrum of promiscuity.  Many off-target interactions occur with seemingly unrelated kinases, revealing how large-scale profiling can identify multitargeted inhibitors of specific, diverse kinases.  The results have implications for drug development and provide a resource for selecting compds. to elucidate kinase function and for interpreting the results of expts. involving kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUljWIhZGPkrVg90H21EOLACvtfcHk0lgJ9OS2rLF_xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisL7E&md5=b2f705509b0e09afa46b01d4669f0515</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2017%26sid%3Dliteratum%253Aachs%26aulast%3DAnastassiadis%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DS.%2BW.%26aulast%3DDevarajan%26aufirst%3DK.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DPeterson%26aufirst%3DJ.%2BR.%26atitle%3DComprehensive%2520assay%2520of%2520kinase%2520catalytic%2520activity%2520reveals%2520features%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1039%26epage%3D1045%26doi%3D10.1038%2Fnbt.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Cuny, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulyanova, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pique, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glicksman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, J. M.</span><span> </span><span class="NLM_article-title">Structure-activity relationship study of acridine analogs as haspin and DYRK2 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3491</span><span class="NLM_x">–</span> <span class="NLM_lpage">3494</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.04.150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;key=10.1016%2Fj.bmcl.2010.04.150" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3491-3494&author=G.+D.+Cunyauthor=M.+Robinauthor=N.+P.+Ulyanovaauthor=D.+Patnaikauthor=V.+Piqueauthor=G.+Casanoauthor=J.+F.+Liuauthor=X.+Linauthor=J.+Xianauthor=M.+A.+Glicksmanauthor=R.+L.+Steinauthor=J.+M.+Higgins&title=Structure-activity+relationship+study+of+acridine+analogs+as+haspin+and+DYRK2+kinase+inhibitors&doi=10.1016%2Fj.bmcl.2010.04.150"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.04.150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.04.150%26sid%3Dliteratum%253Aachs%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DRobin%26aufirst%3DM.%26aulast%3DUlyanova%26aufirst%3DN.%2BP.%26aulast%3DPatnaik%26aufirst%3DD.%26aulast%3DPique%26aufirst%3DV.%26aulast%3DCasano%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DXian%26aufirst%3DJ.%26aulast%3DGlicksman%26aufirst%3DM.%2BA.%26aulast%3DStein%26aufirst%3DR.%2BL.%26aulast%3DHiggins%26aufirst%3DJ.%2BM.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520acridine%2520analogs%2520as%2520haspin%2520and%2520DYRK2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3491%26epage%3D3494%26doi%3D10.1016%2Fj.bmcl.2010.04.150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z57" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z57','PDB','1Z57'); return false;">PDB: 1Z57</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WO6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WO6','PDB','2WO6'); return false;">PDB: 2WO6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VX3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VX3','PDB','2VX3'); return false;">PDB: 2VX3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W06" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W06','PDB','2W06'); return false;">PDB: 2W06</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i69"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01915">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_34433"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01915">10.1021/acs.jmedchem.6b01915</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Figures S1 and S2 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01915/suppl_file/jm6b01915_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01915/suppl_file/jm6b01915_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01915/suppl_file/jm6b01915_si_001.pdf">jm6b01915_si_001.pdf (577.53 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01915/suppl_file/jm6b01915_si_002.csv">jm6b01915_si_002.csv (1.69 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-13%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01915%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01915" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a6f16b8633ce8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
